Background  ||| S:24 E:43 ||| NNP
Two  ||| S:43 E:47 ||| CD
known  ||| S:47 E:53 ||| JJ
enzymes  ||| S:53 E:61 ||| NNS
catabolize  ||| S:61 E:72 ||| VBP
the  ||| S:72 E:76 ||| DT
essential  ||| S:76 E:86 ||| JJ
amino  ||| S:86 E:92 ||| JJ
acid  ||| S:92 E:105 ||| NN
tryptophan  ||| S:105 E:116 ||| NN
in  ||| S:116 E:119 ||| IN
mammals ||| S:119 E:126 ||| NN
.  ||| S:126 E:128 ||| .
Tryptophan  ||| S:128 E:139 ||| NNP
2 ||| S:139 E:140 ||| CD
,  ||| S:140 E:142 ||| ,
3  ||| S:142 E:144 ||| CD
dioxygenase  ||| S:144 E:156 ||| NNS
( ||| S:156 E:157 ||| -LRB-
TDO ||| S:157 E:160 ||| NNP
)  ||| S:160 E:162 ||| -RRB-
is  ||| S:162 E:173 ||| VBZ
expressed  ||| S:173 E:183 ||| VBN
predominantly  ||| S:183 E:197 ||| RB
in  ||| S:197 E:200 ||| IN
hepatic  ||| S:200 E:208 ||| JJ
tissues  ||| S:208 E:216 ||| NNS
and  ||| S:216 E:220 ||| CC
was  ||| S:220 E:224 ||| VBD
the  ||| S:224 E:236 ||| DT
first  ||| S:236 E:242 ||| JJ
inducible  ||| S:242 E:252 ||| JJ
enzyme  ||| S:252 E:259 ||| JJ
system  ||| S:259 E:266 ||| NN
discovered  ||| S:266 E:277 ||| VBN
in  ||| S:277 E:280 ||| IN
mammals  ||| S:280 E:288 ||| NNS
[  ||| S:288 E:290 ||| -LRB-
1 ||| S:290 E:291 ||| LS
] ||| S:291 E:292 ||| -RRB-
.  ||| S:292 E:302 ||| .
It  ||| S:302 E:305 ||| PRP
controls  ||| S:305 E:314 ||| VBZ
serum  ||| S:314 E:320 ||| JJ
tryptophan  ||| S:320 E:331 ||| JJ
homeostasis  ||| S:331 E:343 ||| NN
and  ||| S:343 E:347 ||| CC
is  ||| S:347 E:350 ||| VBZ
induced  ||| S:350 E:366 ||| VBN
following  ||| S:366 E:376 ||| VBG
ingestion  ||| S:376 E:386 ||| NN
of  ||| S:386 E:389 ||| IN
tryptophan ||| S:389 E:399 ||| NN
.  ||| S:399 E:401 ||| .
A  ||| S:401 E:403 ||| DT
second  ||| S:403 E:410 ||| JJ
enzyme ||| S:410 E:416 ||| NN
,  ||| S:416 E:418 ||| ,
IDO ||| S:418 E:421 ||| NNP
,  ||| S:421 E:423 ||| ,
is  ||| S:423 E:434 ||| VBZ
distinguished  ||| S:434 E:448 ||| VBN
from  ||| S:448 E:453 ||| IN
TDO  ||| S:453 E:457 ||| NNP
by  ||| S:457 E:460 ||| IN
its  ||| S:460 E:464 ||| PRP$
expression  ||| S:464 E:475 ||| NN
pattern ||| S:475 E:482 ||| NN
,  ||| S:482 E:484 ||| ,
substrate  ||| S:484 E:502 ||| JJ
specificity  ||| S:502 E:514 ||| NN
and  ||| S:514 E:518 ||| CC
inducibility ||| S:518 E:530 ||| NN
.  ||| S:530 E:532 ||| .
IDO  ||| S:532 E:536 ||| NNP
is  ||| S:536 E:539 ||| VBZ
expressed  ||| S:539 E:549 ||| VBN
in  ||| S:549 E:552 ||| IN
a  ||| S:552 E:554 ||| DT
variety  ||| S:554 E:570 ||| NN
of  ||| S:570 E:573 ||| IN
non-hepatic  ||| S:573 E:585 ||| JJ
tissues ||| S:585 E:592 ||| NNS
,  ||| S:592 E:594 ||| ,
including  ||| S:594 E:604 ||| VBG
placenta ||| S:604 E:612 ||| NN
,  ||| S:612 E:614 ||| ,
lung ||| S:614 E:618 ||| NN
,  ||| S:618 E:620 ||| ,
gut  ||| S:620 E:624 ||| NN
and  ||| S:624 E:636 ||| CC
epididymis  ||| S:636 E:647 ||| NNS
[  ||| S:647 E:649 ||| -LRB-
2 ||| S:649 E:650 ||| LS
,  ||| S:650 E:652 ||| ,
3 ||| S:652 E:653 ||| CD
,  ||| S:653 E:655 ||| ,
4 ||| S:655 E:656 ||| LS
] ||| S:656 E:657 ||| -RRB-
.  ||| S:657 E:659 ||| .
Except  ||| S:659 E:666 ||| IN
for  ||| S:666 E:670 ||| IN
the  ||| S:670 E:674 ||| DT
last  ||| S:674 E:679 ||| JJ
named  ||| S:679 E:685 ||| VBN
tissue  ||| S:685 E:700 ||| NN
where  ||| S:700 E:706 ||| WRB
IDO  ||| S:706 E:710 ||| NNP
is  ||| S:710 E:713 ||| VBZ
expressed  ||| S:713 E:723 ||| VBN
constitutively ||| S:723 E:737 ||| NN
,  ||| S:737 E:739 ||| ,
IDO  ||| S:739 E:743 ||| NNP
is  ||| S:743 E:746 ||| VBZ
inducible  ||| S:746 E:756 ||| VBN
by  ||| S:756 E:767 ||| IN
inflammatory  ||| S:767 E:780 ||| JJ
mediators ||| S:780 E:789 ||| NNS
,  ||| S:789 E:791 ||| ,
including  ||| S:791 E:801 ||| VBG
interferons ||| S:801 E:812 ||| NNS
.  ||| S:812 E:814 ||| .
In  ||| S:814 E:817 ||| IN
addition ||| S:817 E:825 ||| NN
,  ||| S:825 E:835 ||| ,
IDO  ||| S:835 E:839 ||| NNP
catalyzes  ||| S:839 E:849 ||| VBD
the  ||| S:849 E:853 ||| DT
breakdown  ||| S:853 E:863 ||| NN
of  ||| S:863 E:866 ||| IN
a  ||| S:866 E:868 ||| DT
variety  ||| S:868 E:876 ||| NN
of  ||| S:876 E:879 ||| IN
compounds  ||| S:879 E:889 ||| NNS
which  ||| S:889 E:903 ||| WDT
contain  ||| S:903 E:911 ||| VBP
an  ||| S:911 E:914 ||| DT
indole  ||| S:914 E:921 ||| JJ
ring ||| S:921 E:925 ||| NN
,  ||| S:925 E:927 ||| ,
including  ||| S:927 E:937 ||| VBG
D-tryptophan  ||| S:937 E:950 ||| JJ
and  ||| S:950 E:962 ||| CC
serotonin ||| S:962 E:971 ||| NN
,  ||| S:971 E:973 ||| ,
marking  ||| S:973 E:981 ||| VBG
another  ||| S:981 E:989 ||| DT
difference  ||| S:989 E:1000 ||| NN
from  ||| S:1000 E:1005 ||| IN
TDO ||| S:1005 E:1008 ||| NNP
,  ||| S:1008 E:1010 ||| ,
which  ||| S:1010 E:1016 ||| WDT
is  ||| S:1016 E:1027 ||| VBZ
specific  ||| S:1027 E:1036 ||| JJ
for  ||| S:1036 E:1040 ||| IN
L-tryptophan ||| S:1040 E:1052 ||| JJ
.  ||| S:1052 E:1054 ||| .
Curiously ||| S:1054 E:1063 ||| NNP
,  ||| S:1063 E:1065 ||| ,
it  ||| S:1065 E:1068 ||| PRP
appears  ||| S:1068 E:1076 ||| VBZ
as  ||| S:1076 E:1079 ||| RB
if  ||| S:1079 E:1090 ||| IN
tryptophan  ||| S:1090 E:1101 ||| FW
itself  ||| S:1101 E:1108 ||| FW
cannot  ||| S:1108 E:1115 ||| FW
induce  ||| S:1115 E:1122 ||| FW
IDO  ||| S:1122 E:1126 ||| FW
synthesis  ||| S:1126 E:1136 ||| FW
[  ||| S:1136 E:1138 ||| -LRB-
5 ||| S:1138 E:1139 ||| LS
] ||| S:1139 E:1140 ||| -RRB-
.  ||| S:1140 E:1142 ||| .
IDO  ||| S:1142 E:1146 ||| NNP
is  ||| S:1146 E:1157 ||| VBZ
also  ||| S:1157 E:1162 ||| RB
suggested  ||| S:1162 E:1172 ||| VBN
to  ||| S:1172 E:1175 ||| TO
be  ||| S:1175 E:1178 ||| VB
the  ||| S:1178 E:1182 ||| DT
evolutionary  ||| S:1182 E:1195 ||| JJ
ancestor  ||| S:1195 E:1204 ||| NN
of  ||| S:1204 E:1207 ||| IN
certain  ||| S:1207 E:1223 ||| JJ
novel  ||| S:1223 E:1229 ||| NN
myoglobins  ||| S:1229 E:1240 ||| NNS
which  ||| S:1240 E:1246 ||| WDT
occur  ||| S:1246 E:1252 ||| VBP
in  ||| S:1252 E:1255 ||| IN
molluscs ||| S:1255 E:1263 ||| NN
,  ||| S:1263 E:1265 ||| ,
marking  ||| S:1265 E:1273 ||| VBG
IDO  ||| S:1273 E:1277 ||| NNP
as  ||| S:1277 E:1280 ||| IN
an  ||| S:1280 E:1291 ||| DT
evolutionarily  ||| S:1291 E:1306 ||| JJ
primitive  ||| S:1306 E:1316 ||| JJ
enzyme  ||| S:1316 E:1323 ||| NNS
[  ||| S:1323 E:1325 ||| -LRB-
6 ||| S:1325 E:1326 ||| CD
] ||| S:1326 E:1327 ||| -RRB-
.  ||| S:1327 E:1337 ||| .
IDO  ||| S:1337 E:1341 ||| NNP
is  ||| S:1341 E:1344 ||| VBZ
known  ||| S:1344 E:1350 ||| VBN
to  ||| S:1350 E:1353 ||| TO
be  ||| S:1353 E:1356 ||| VB
expressed  ||| S:1356 E:1366 ||| VBN
in  ||| S:1366 E:1369 ||| IN
cells  ||| S:1369 E:1375 ||| NNS
infected  ||| S:1375 E:1384 ||| VBN
with  ||| S:1384 E:1397 ||| IN
intracellular  ||| S:1397 E:1411 ||| JJ
pathogens  ||| S:1411 E:1421 ||| JJ
such  ||| S:1421 E:1426 ||| JJ
as  ||| S:1426 E:1438 ||| IN
Toxoplasma  ||| S:1438 E:1449 ||| NNP
and  ||| S:1449 E:1462 ||| CC
Chlamydia  ||| S:1462 E:1472 ||| NNP
species  ||| S:1472 E:1480 ||| NNS
and  ||| S:1480 E:1484 ||| CC
also  ||| S:1484 E:1489 ||| RB
by  ||| S:1489 E:1492 ||| IN
viruses  ||| S:1492 E:1508 ||| NNS
[  ||| S:1508 E:1510 ||| -LRB-
7 ||| S:1510 E:1511 ||| CD
,  ||| S:1511 E:1513 ||| ,
8 ||| S:1513 E:1514 ||| CD
,  ||| S:1514 E:1516 ||| ,
9 ||| S:1516 E:1517 ||| CD
,  ||| S:1517 E:1519 ||| ,
10 ||| S:1519 E:1521 ||| CD
] ||| S:1521 E:1522 ||| -RRB-
.  ||| S:1522 E:1524 ||| .
In  ||| S:1524 E:1527 ||| IN
the  ||| S:1527 E:1531 ||| DT
case  ||| S:1531 E:1536 ||| NN
of  ||| S:1536 E:1548 ||| IN
Toxoplasma  ||| S:1548 E:1559 ||| NNP
and  ||| S:1559 E:1572 ||| CC
Chlamydia  ||| S:1572 E:1582 ||| NNP
it  ||| S:1582 E:1585 ||| PRP
has  ||| S:1585 E:1589 ||| VBZ
been  ||| S:1589 E:1594 ||| VBN
proposed  ||| S:1594 E:1603 ||| VBN
that  ||| S:1603 E:1616 ||| IN
IDO  ||| S:1616 E:1620 ||| NNP
induction  ||| S:1620 E:1630 ||| NN
is  ||| S:1630 E:1633 ||| VBZ
a  ||| S:1633 E:1635 ||| DT
cellular  ||| S:1635 E:1644 ||| JJ
defense  ||| S:1644 E:1652 ||| NN
mechanism ||| S:1652 E:1661 ||| NN
,  ||| S:1661 E:1663 ||| ,
designed  ||| S:1663 E:1672 ||| VBN
to  ||| S:1672 E:1683 ||| TO
limit  ||| S:1683 E:1689 ||| VB
the  ||| S:1689 E:1693 ||| DT
proliferation  ||| S:1693 E:1707 ||| NN
of  ||| S:1707 E:1710 ||| IN
the  ||| S:1710 E:1714 ||| DT
invading  ||| S:1714 E:1723 ||| JJ
pathogen  ||| S:1723 E:1732 ||| NN
by  ||| S:1732 E:1743 ||| IN
depleting  ||| S:1743 E:1753 ||| VBG
the  ||| S:1753 E:1757 ||| DT
essential  ||| S:1757 E:1767 ||| JJ
amino  ||| S:1767 E:1773 ||| JJ
acid  ||| S:1773 E:1778 ||| NN
tryptophan ||| S:1778 E:1788 ||| NN
.  ||| S:1788 E:1790 ||| .
IDO  ||| S:1790 E:1802 ||| NNP
expressed  ||| S:1802 E:1812 ||| VBD
in  ||| S:1812 E:1815 ||| IN
monocyte  ||| S:1815 E:1824 ||| JJ
derived  ||| S:1824 E:1832 ||| JJ
macrophages  ||| S:1832 E:1844 ||| NN
has  ||| S:1844 E:1848 ||| VBZ
also  ||| S:1848 E:1853 ||| RB
been  ||| S:1853 E:1866 ||| VBN
found  ||| S:1866 E:1872 ||| VBN
to  ||| S:1872 E:1875 ||| TO
inhibit  ||| S:1875 E:1883 ||| VB
the  ||| S:1883 E:1887 ||| DT
growth  ||| S:1887 E:1894 ||| NN
of  ||| S:1894 E:1897 ||| IN
extracellular  ||| S:1897 E:1911 ||| JJ
bacteria  ||| S:1911 E:1920 ||| NNS
such  ||| S:1920 E:1933 ||| JJ
as  ||| S:1933 E:1936 ||| IN
group  ||| S:1936 E:1942 ||| NN
B  ||| S:1942 E:1944 ||| NN
streptococci  ||| S:1944 E:1957 ||| NNS
[  ||| S:1957 E:1959 ||| -LRB-
11 ||| S:1959 E:1961 ||| CD
] ||| S:1961 E:1962 ||| -RRB-
,  ||| S:1962 E:1964 ||| ,
and  ||| S:1964 E:1968 ||| CC
is  ||| S:1968 E:1971 ||| VBZ
also  ||| S:1971 E:1976 ||| RB
induced  ||| S:1976 E:1984 ||| VBN
in  ||| S:1984 E:1995 ||| IN
tumors  ||| S:1995 E:2002 ||| NNS
taken  ||| S:2002 E:2008 ||| VBN
from  ||| S:2008 E:2013 ||| IN
cancer  ||| S:2013 E:2020 ||| NN
patients  ||| S:2020 E:2029 ||| NNS
[  ||| S:2029 E:2031 ||| -LRB-
12 ||| S:2031 E:2033 ||| CD
] ||| S:2033 E:2034 ||| -RRB-
.  ||| S:2034 E:2036 ||| .
In  ||| S:2036 E:2039 ||| IN
all  ||| S:2039 E:2043 ||| DT
of  ||| S:2043 E:2046 ||| IN
these  ||| S:2046 E:2060 ||| DT
systems  ||| S:2060 E:2068 ||| NNS
the  ||| S:2068 E:2072 ||| DT
proximal  ||| S:2072 E:2081 ||| JJ
inducer  ||| S:2081 E:2089 ||| NN
of  ||| S:2089 E:2092 ||| IN
IDO  ||| S:2092 E:2096 ||| NNP
activity  ||| S:2096 E:2105 ||| NN
is  ||| S:2105 E:2116 ||| VBZ
interferon-γ  ||| S:2116 E:2129 ||| JJ
( ||| S:2129 E:2130 ||| -LRB-
IFN-γ ||| S:2130 E:2135 ||| NNP
) ||| S:2135 E:2136 ||| -RRB-
.  ||| S:2136 E:2138 ||| .
Response  ||| S:2138 E:2147 ||| NN
elements  ||| S:2147 E:2156 ||| NNS
for  ||| S:2156 E:2160 ||| IN
this  ||| S:2160 E:2165 ||| DT
cytokine  ||| S:2165 E:2182 ||| NNS
have  ||| S:2182 E:2187 ||| VBP
been  ||| S:2187 E:2192 ||| VBN
identified  ||| S:2192 E:2203 ||| VBN
in  ||| S:2203 E:2206 ||| IN
the  ||| S:2206 E:2210 ||| DT
human  ||| S:2210 E:2216 ||| JJ
IDO  ||| S:2216 E:2220 ||| NNP
promoter  ||| S:2220 E:2229 ||| NN
and  ||| S:2229 E:2233 ||| CC
have  ||| S:2233 E:2246 ||| VBP
been  ||| S:2246 E:2251 ||| VBN
shown  ||| S:2251 E:2257 ||| VBN
to  ||| S:2257 E:2260 ||| TO
be  ||| S:2260 E:2263 ||| VB
essential  ||| S:2263 E:2273 ||| JJ
for  ||| S:2273 E:2277 ||| IN
IFN-γ  ||| S:2277 E:2283 ||| JJ
induction  ||| S:2283 E:2293 ||| NN
of  ||| S:2293 E:2296 ||| IN
reporter  ||| S:2296 E:2313 ||| NN
gene  ||| S:2313 E:2318 ||| NN
expression  ||| S:2318 E:2338 ||| NN
in  ||| S:2338 E:2341 ||| IN
vitro  ||| S:2341 E:2347 ||| NNS
[  ||| S:2347 E:2349 ||| -LRB-
13 ||| S:2349 E:2351 ||| CD
,  ||| S:2351 E:2353 ||| ,
14 ||| S:2353 E:2355 ||| CD
,  ||| S:2355 E:2357 ||| ,
15 ||| S:2357 E:2359 ||| CD
] ||| S:2359 E:2360 ||| -RRB-
.  ||| S:2360 E:2370 ||| .
The  ||| S:2370 E:2374 ||| DT
unusual  ||| S:2374 E:2382 ||| JJ
tissue  ||| S:2382 E:2389 ||| NN
distribution  ||| S:2389 E:2402 ||| NN
of  ||| S:2402 E:2405 ||| IN
IDO  ||| S:2405 E:2409 ||| NNP
suggests  ||| S:2409 E:2418 ||| VBZ
that  ||| S:2418 E:2431 ||| DT
combating  ||| S:2431 E:2441 ||| JJ
infection  ||| S:2441 E:2451 ||| NN
is  ||| S:2451 E:2454 ||| VBZ
not  ||| S:2454 E:2458 ||| RB
its  ||| S:2458 E:2462 ||| PRP$
only  ||| S:2462 E:2467 ||| JJ
function ||| S:2467 E:2475 ||| NN
.  ||| S:2475 E:2477 ||| .
Our  ||| S:2477 E:2481 ||| PRP$
interest  ||| S:2481 E:2498 ||| NN
in  ||| S:2498 E:2501 ||| IN
IDO  ||| S:2501 E:2505 ||| NNP
arose  ||| S:2505 E:2511 ||| VBD
when  ||| S:2511 E:2516 ||| WRB
we  ||| S:2516 E:2519 ||| PRP
observed  ||| S:2519 E:2528 ||| VBD
that  ||| S:2528 E:2533 ||| DT
tryptophan  ||| S:2533 E:2544 ||| JJ
depletion  ||| S:2544 E:2554 ||| NN
was  ||| S:2554 E:2566 ||| VBD
responsible  ||| S:2566 E:2578 ||| JJ
for  ||| S:2578 E:2582 ||| IN
macrophage-induced  ||| S:2582 E:2601 ||| JJ
inhibition  ||| S:2601 E:2612 ||| NN
of  ||| S:2612 E:2615 ||| IN
T  ||| S:2615 E:2617 ||| NN
cell  ||| S:2617 E:2630 ||| NN
proliferation  ||| S:2630 E:2653 ||| NN
in  ||| S:2653 E:2656 ||| IN
vitro  ||| S:2656 E:2662 ||| NNS
[  ||| S:2662 E:2664 ||| -LRB-
16 ||| S:2664 E:2666 ||| CD
] ||| S:2666 E:2667 ||| -RRB-
.  ||| S:2667 E:2669 ||| .
Furthermore ||| S:2669 E:2680 ||| RB
,  ||| S:2680 E:2682 ||| ,
we  ||| S:2682 E:2693 ||| PRP
reported  ||| S:2693 E:2702 ||| VBD
that  ||| S:2702 E:2707 ||| IN
a  ||| S:2707 E:2709 ||| DT
pharmacologic  ||| S:2709 E:2723 ||| JJ
inhibitor  ||| S:2723 E:2733 ||| NN
of  ||| S:2733 E:2736 ||| IN
IDO ||| S:2736 E:2739 ||| NNP
,  ||| S:2739 E:2741 ||| ,
1-methyl  ||| S:2741 E:2758 ||| CD
tryptophan ||| S:2758 E:2768 ||| NN
,  ||| S:2768 E:2770 ||| ,
induced  ||| S:2770 E:2778 ||| VBN
maternal  ||| S:2778 E:2787 ||| JJ
rejection  ||| S:2787 E:2797 ||| NN
of  ||| S:2797 E:2800 ||| IN
allogeneic  ||| S:2800 E:2811 ||| NN
but  ||| S:2811 E:2823 ||| CC
not  ||| S:2823 E:2827 ||| RB
syngeneic  ||| S:2827 E:2837 ||| JJ
murine  ||| S:2837 E:2844 ||| JJ
fetuses  ||| S:2844 E:2852 ||| NNS
[  ||| S:2852 E:2854 ||| -LRB-
17 ||| S:2854 E:2856 ||| CD
] ||| S:2856 E:2857 ||| -RRB-
.  ||| S:2857 E:2859 ||| .
As  ||| S:2859 E:2862 ||| IN
IDO  ||| S:2862 E:2866 ||| NNP
is  ||| S:2866 E:2869 ||| VBZ
strongly  ||| S:2869 E:2886 ||| RB
expressed  ||| S:2886 E:2896 ||| VBN
at  ||| S:2896 E:2899 ||| IN
the  ||| S:2899 E:2903 ||| DT
maternal-fetal  ||| S:2903 E:2918 ||| JJ
interface  ||| S:2918 E:2928 ||| NN
in  ||| S:2928 E:2931 ||| IN
pregnant  ||| S:2931 E:2940 ||| JJ
mice  ||| S:2940 E:2953 ||| NNS
and  ||| S:2953 E:2957 ||| CC
women ||| S:2957 E:2962 ||| NNS
,  ||| S:2962 E:2964 ||| ,
we  ||| S:2964 E:2967 ||| PRP
have  ||| S:2967 E:2972 ||| VBP
suggested  ||| S:2972 E:2982 ||| VBN
that  ||| S:2982 E:2987 ||| IN
IDO  ||| S:2987 E:2991 ||| NNP
plays  ||| S:2991 E:2997 ||| VBZ
a  ||| S:2997 E:2999 ||| DT
role  ||| S:2999 E:3004 ||| NN
in  ||| S:3004 E:3007 ||| IN
fetal  ||| S:3007 E:3021 ||| JJ
defense  ||| S:3021 E:3029 ||| NN
against  ||| S:3029 E:3037 ||| IN
the  ||| S:3037 E:3041 ||| DT
maternal  ||| S:3041 E:3050 ||| JJ
immune  ||| S:3050 E:3057 ||| JJ
system  ||| S:3057 E:3064 ||| NN
and  ||| S:3064 E:3068 ||| CC
could  ||| S:3068 E:3082 ||| MD
represent  ||| S:3082 E:3092 ||| VB
a  ||| S:3092 E:3094 ||| DT
novel  ||| S:3094 E:3100 ||| NN
means  ||| S:3100 E:3106 ||| VBZ
of  ||| S:3106 E:3109 ||| IN
immunoregulation ||| S:3109 E:3125 ||| NN
.  ||| S:3125 E:3127 ||| .
The  ||| S:3127 E:3131 ||| DT
apparently  ||| S:3131 E:3150 ||| RB
diverse  ||| S:3150 E:3158 ||| JJ
functions  ||| S:3158 E:3168 ||| NNS
and  ||| S:3168 E:3172 ||| CC
tissue  ||| S:3172 E:3179 ||| NN
distribution  ||| S:3179 E:3192 ||| NN
of  ||| S:3192 E:3195 ||| IN
IDO  ||| S:3195 E:3199 ||| NNP
may  ||| S:3199 E:3203 ||| MD
have  ||| S:3203 E:3216 ||| VB
as  ||| S:3216 E:3219 ||| IN
a  ||| S:3219 E:3221 ||| DT
common  ||| S:3221 E:3228 ||| JJ
theme  ||| S:3228 E:3234 ||| NN
the  ||| S:3234 E:3238 ||| DT
fact  ||| S:3238 E:3243 ||| NN
that  ||| S:3243 E:3248 ||| IN
tryptophan  ||| S:3248 E:3259 ||| NN
is  ||| S:3259 E:3262 ||| VBZ
the  ||| S:3262 E:3266 ||| DT
rarest  ||| S:3266 E:3281 ||| JJ
essential  ||| S:3281 E:3291 ||| JJ
amino  ||| S:3291 E:3297 ||| JJ
acid  ||| S:3297 E:3302 ||| NN
and  ||| S:3302 E:3306 ||| CC
could  ||| S:3306 E:3312 ||| MD
be  ||| S:3312 E:3315 ||| VB
the  ||| S:3315 E:3319 ||| DT
target  ||| S:3319 E:3326 ||| NN
for  ||| S:3326 E:3330 ||| IN
cellular  ||| S:3330 E:3347 ||| JJ
regulatory  ||| S:3347 E:3358 ||| JJ
mechanisms ||| S:3358 E:3368 ||| NNS
.  ||| S:3368 E:3370 ||| .
If  ||| S:3370 E:3373 ||| IN
so ||| S:3373 E:3375 ||| RB
,  ||| S:3375 E:3377 ||| ,
tryptophan  ||| S:3377 E:3388 ||| JJ
concentrations  ||| S:3388 E:3403 ||| NNS
in  ||| S:3403 E:3414 ||| IN
cellular  ||| S:3414 E:3423 ||| JJ
microenvironments  ||| S:3423 E:3441 ||| NN
might  ||| S:3441 E:3447 ||| MD
play  ||| S:3447 E:3452 ||| VB
a  ||| S:3452 E:3454 ||| DT
critical  ||| S:3454 E:3463 ||| JJ
role  ||| S:3463 E:3468 ||| NN
in  ||| S:3468 E:3479 ||| IN
modulating  ||| S:3479 E:3490 ||| JJ
various  ||| S:3490 E:3498 ||| JJ
cellular  ||| S:3498 E:3507 ||| JJ
processes  ||| S:3507 E:3517 ||| NNS
in  ||| S:3517 E:3520 ||| IN
a  ||| S:3520 E:3522 ||| DT
way  ||| S:3522 E:3526 ||| NN
that  ||| S:3526 E:3531 ||| WDT
cannot  ||| S:3531 E:3546 ||| RB
be  ||| S:3546 E:3549 ||| VB
achieved  ||| S:3549 E:3558 ||| VBN
by  ||| S:3558 E:3561 ||| IN
the  ||| S:3561 E:3565 ||| DT
hepatic  ||| S:3565 E:3573 ||| JJ
enzyme  ||| S:3573 E:3580 ||| JJ
TDO  ||| S:3580 E:3584 ||| NN
which  ||| S:3584 E:3590 ||| WDT
regulates  ||| S:3590 E:3608 ||| VBZ
systemic  ||| S:3608 E:3617 ||| JJ
tryptophan  ||| S:3617 E:3628 ||| JJ
concentrations ||| S:3628 E:3642 ||| NNS
.  ||| S:3642 E:3652 ||| .
The  ||| S:3652 E:3656 ||| DT
IDO  ||| S:3656 E:3660 ||| NNP
promoter  ||| S:3660 E:3669 ||| NN
contains  ||| S:3669 E:3678 ||| VBZ
a  ||| S:3678 E:3680 ||| DT
diverse  ||| S:3680 E:3688 ||| JJ
collection  ||| S:3688 E:3699 ||| NN
of  ||| S:3699 E:3702 ||| IN
motifs  ||| S:3702 E:3717 ||| NNS
together  ||| S:3717 E:3726 ||| RB
with  ||| S:3726 E:3731 ||| IN
the  ||| S:3731 E:3735 ||| DT
IFN-γ  ||| S:3735 E:3741 ||| JJ
response  ||| S:3741 E:3750 ||| NN
elements ||| S:3750 E:3758 ||| NNS
.  ||| S:3758 E:3760 ||| .
These  ||| S:3760 E:3766 ||| DT
include  ||| S:3766 E:3782 ||| VBP
motifs  ||| S:3782 E:3789 ||| VBN
for  ||| S:3789 E:3793 ||| IN
transcription  ||| S:3793 E:3807 ||| JJ
factors  ||| S:3807 E:3815 ||| NNS
that  ||| S:3815 E:3820 ||| IN
bind  ||| S:3820 E:3825 ||| NN
to  ||| S:3825 E:3828 ||| TO
collagenase  ||| S:3828 E:3848 ||| VB
and  ||| S:3848 E:3852 ||| CC
elastase  ||| S:3852 E:3861 ||| JJ
genes  ||| S:3861 E:3867 ||| NNS
and  ||| S:3867 E:3871 ||| CC
motifs  ||| S:3871 E:3878 ||| NNS
for  ||| S:3878 E:3882 ||| IN
the  ||| S:3882 E:3886 ||| DT
transcription  ||| S:3886 E:3900 ||| JJ
factor  ||| S:3900 E:3915 ||| NN
MEP-1 ||| S:3915 E:3920 ||| NN
,  ||| S:3920 E:3922 ||| ,
which  ||| S:3922 E:3928 ||| WDT
regulates  ||| S:3928 E:3938 ||| VBZ
transcription  ||| S:3938 E:3952 ||| VBN
from  ||| S:3952 E:3957 ||| IN
the  ||| S:3957 E:3970 ||| DT
stromelysin-1  ||| S:3970 E:3984 ||| NNP
( ||| S:3984 E:3985 ||| -LRB-
MMP-3 ||| S:3985 E:3990 ||| NNP
)  ||| S:3990 E:3992 ||| -RRB-
and  ||| S:3992 E:4005 ||| CC
metallothionein  ||| S:4005 E:4021 ||| JJ
genes  ||| S:4021 E:4027 ||| NNS
[  ||| S:4027 E:4029 ||| -LRB-
18 ||| S:4029 E:4031 ||| CD
,  ||| S:4031 E:4033 ||| ,
19 ||| S:4033 E:4035 ||| CD
] ||| S:4035 E:4036 ||| -RRB-
.  ||| S:4036 E:4046 ||| .
Matrix  ||| S:4046 E:4053 ||| JJ
metalloproteinases  ||| S:4053 E:4072 ||| NNS
( ||| S:4072 E:4073 ||| -LRB-
MMPs ||| S:4073 E:4077 ||| NNP
)  ||| S:4077 E:4079 ||| -RRB-
are  ||| S:4079 E:4083 ||| VBP
responsible  ||| S:4083 E:4095 ||| JJ
for  ||| S:4095 E:4107 ||| IN
modification  ||| S:4107 E:4120 ||| NN
of  ||| S:4120 E:4123 ||| IN
the  ||| S:4123 E:4127 ||| DT
extracellular  ||| S:4127 E:4141 ||| JJ
matrix  ||| S:4141 E:4148 ||| NN
and  ||| S:4148 E:4152 ||| CC
are  ||| S:4152 E:4156 ||| VBP
involved  ||| S:4156 E:4173 ||| VBN
in  ||| S:4173 E:4176 ||| IN
wound  ||| S:4176 E:4182 ||| JJ
healing ||| S:4182 E:4189 ||| NN
,  ||| S:4189 E:4191 ||| ,
tumorigenesis ||| S:4191 E:4204 ||| NN
,  ||| S:4204 E:4206 ||| ,
pregnancy  ||| S:4206 E:4216 ||| NN
and  ||| S:4216 E:4228 ||| CC
inflammation ||| S:4228 E:4240 ||| NN
.  ||| S:4240 E:4242 ||| .
In  ||| S:4242 E:4245 ||| IN
general ||| S:4245 E:4252 ||| JJ
,  ||| S:4252 E:4254 ||| ,
they  ||| S:4254 E:4259 ||| PRP
regulate  ||| S:4259 E:4268 ||| VB
how  ||| S:4268 E:4272 ||| WRB
cells  ||| S:4272 E:4278 ||| NNS
interact  ||| S:4278 E:4295 ||| VBN
with  ||| S:4295 E:4300 ||| IN
each  ||| S:4300 E:4305 ||| DT
other  ||| S:4305 E:4311 ||| JJ
and  ||| S:4311 E:4315 ||| CC
with  ||| S:4315 E:4320 ||| IN
the  ||| S:4320 E:4324 ||| DT
extra-cellular  ||| S:4324 E:4339 ||| JJ
matrix ||| S:4339 E:4345 ||| NN
.  ||| S:4345 E:4355 ||| .
Evidence  ||| S:4355 E:4364 ||| NN
for  ||| S:4364 E:4368 ||| IN
a  ||| S:4368 E:4370 ||| DT
tryptophan-reversible  ||| S:4370 E:4392 ||| JJ
inhibition  ||| S:4392 E:4403 ||| NN
of  ||| S:4403 E:4406 ||| IN
MMP  ||| S:4406 E:4418 ||| NNP
expression  ||| S:4418 E:4429 ||| NN
by  ||| S:4429 E:4432 ||| IN
IFN-γ  ||| S:4432 E:4438 ||| NNP
has  ||| S:4438 E:4442 ||| VBZ
previously  ||| S:4442 E:4453 ||| RB
been  ||| S:4453 E:4458 ||| VBN
presented  ||| S:4458 E:4468 ||| VBN
[  ||| S:4468 E:4470 ||| -LRB-
20 ||| S:4470 E:4472 ||| CD
,  ||| S:4472 E:4482 ||| ,
21 ||| S:4482 E:4484 ||| CD
] ||| S:4484 E:4485 ||| -RRB-
,  ||| S:4485 E:4487 ||| ,
although  ||| S:4487 E:4496 ||| IN
the  ||| S:4496 E:4500 ||| DT
exact  ||| S:4500 E:4506 ||| JJ
mechanism  ||| S:4506 E:4516 ||| NN
is  ||| S:4516 E:4519 ||| VBZ
unclear ||| S:4519 E:4526 ||| JJ
.  ||| S:4526 E:4528 ||| .
Therefore  ||| S:4528 E:4538 ||| RB
we  ||| S:4538 E:4549 ||| PRP
decided  ||| S:4549 E:4557 ||| VBD
to  ||| S:4557 E:4560 ||| TO
directly  ||| S:4560 E:4569 ||| RB
test  ||| S:4569 E:4574 ||| VB
whether  ||| S:4574 E:4582 ||| IN
IDO  ||| S:4582 E:4586 ||| NNP
plays  ||| S:4586 E:4592 ||| VBZ
a  ||| S:4592 E:4594 ||| DT
role  ||| S:4594 E:4599 ||| NN
in  ||| S:4599 E:4610 ||| IN
controlling  ||| S:4610 E:4622 ||| VBG
interactions  ||| S:4622 E:4635 ||| NNS
with  ||| S:4635 E:4640 ||| IN
other  ||| S:4640 E:4646 ||| JJ
cells  ||| S:4646 E:4652 ||| NNS
and  ||| S:4652 E:4656 ||| CC
also  ||| S:4656 E:4661 ||| RB
the  ||| S:4661 E:4673 ||| DT
surrounding  ||| S:4673 E:4685 ||| VBG
extracellular  ||| S:4685 E:4699 ||| JJ
environment ||| S:4699 E:4710 ||| NN
.  ||| S:4710 E:4720 ||| .
We  ||| S:4720 E:4723 ||| PRP
have  ||| S:4723 E:4728 ||| VBP
identified  ||| S:4728 E:4739 ||| VBN
cells  ||| S:4739 E:4745 ||| NNS
expressing  ||| S:4745 E:4756 ||| VBG
IDO  ||| S:4756 E:4769 ||| NNP
in  ||| S:4769 E:4772 ||| IN
vitro  ||| S:4772 E:4778 ||| NN
and  ||| S:4778 E:4782 ||| CC
used  ||| S:4782 E:4787 ||| VBD
IDO  ||| S:4787 E:4791 ||| NNP
antisense  ||| S:4791 E:4809 ||| VBD
constructs  ||| S:4809 E:4820 ||| VBN
to  ||| S:4820 E:4823 ||| TO
inhibit  ||| S:4823 E:4831 ||| VB
this  ||| S:4831 E:4836 ||| DT
expression ||| S:4836 E:4846 ||| NN
.  ||| S:4846 E:4848 ||| .
In  ||| S:4848 E:4851 ||| IN
addition ||| S:4851 E:4859 ||| NN
,  ||| S:4859 E:4861 ||| ,
we  ||| S:4861 E:4864 ||| PRP
have  ||| S:4864 E:4877 ||| VBP
constitutively  ||| S:4877 E:4892 ||| JJ
overexpressed  ||| S:4892 E:4906 ||| JJ
IDO  ||| S:4906 E:4910 ||| NN
in  ||| S:4910 E:4913 ||| IN
adherent  ||| S:4913 E:4922 ||| NN
and  ||| S:4922 E:4934 ||| CC
non-adherent  ||| S:4934 E:4947 ||| JJ
cell  ||| S:4947 E:4952 ||| NN
lines  ||| S:4952 E:4967 ||| NNS
in  ||| S:4967 E:4970 ||| IN
vitro ||| S:4970 E:4975 ||| NN
.  ||| S:4975 E:4977 ||| .
Our  ||| S:4977 E:4981 ||| PRP$
results  ||| S:4981 E:4989 ||| NNS
demonstrate  ||| S:4989 E:5009 ||| VBP
that  ||| S:5009 E:5014 ||| IN
tryptophan  ||| S:5014 E:5025 ||| JJ
catabolism  ||| S:5025 E:5036 ||| NN
has  ||| S:5036 E:5040 ||| VBZ
significant  ||| S:5040 E:5052 ||| JJ
effects  ||| S:5052 E:5060 ||| NNS
on  ||| S:5060 E:5063 ||| IN
cell  ||| S:5063 E:5076 ||| NN
adhesion  ||| S:5076 E:5085 ||| NNS
and  ||| S:5085 E:5089 ||| CC
regulates  ||| S:5089 E:5099 ||| VBZ
the  ||| S:5099 E:5103 ||| DT
activity  ||| S:5103 E:5112 ||| NN
and  ||| S:5112 E:5116 ||| CC
expression  ||| S:5116 E:5127 ||| NN
of  ||| S:5127 E:5138 ||| IN
cyclooxygenases  ||| S:5138 E:5154 ||| CD
1  ||| S:5154 E:5156 ||| CD
and  ||| S:5156 E:5160 ||| CC
2  ||| S:5160 E:5162 ||| CD
( ||| S:5162 E:5163 ||| -LRB-
COX-1  ||| S:5163 E:5169 ||| NNP
and  ||| S:5169 E:5173 ||| CC
-2 ||| S:5173 E:5175 ||| CD
) ||| S:5175 E:5176 ||| -RRB-
.  ||| S:5176 E:5200 ||| .
Results  ||| S:5200 E:5227 ||| NNS
Constitutive  ||| S:5227 E:5240 ||| JJ
overexpression  ||| S:5240 E:5255 ||| NN
of  ||| S:5255 E:5258 ||| IN
IDO  ||| S:5258 E:5262 ||| NNP
alters  ||| S:5262 E:5269 ||| JJ
cell  ||| S:5269 E:5284 ||| NN
adhesion  ||| S:5284 E:5303 ||| NN
To  ||| S:5303 E:5306 ||| TO
determine  ||| S:5306 E:5316 ||| VB
whether  ||| S:5316 E:5324 ||| IN
IDO  ||| S:5324 E:5328 ||| NNP
plays  ||| S:5328 E:5334 ||| VBZ
a  ||| S:5334 E:5336 ||| DT
role  ||| S:5336 E:5341 ||| NN
in  ||| S:5341 E:5344 ||| IN
regulating  ||| S:5344 E:5365 ||| VBG
cell  ||| S:5365 E:5370 ||| NN
adhesion ||| S:5370 E:5378 ||| NN
,  ||| S:5378 E:5380 ||| ,
we  ||| S:5380 E:5383 ||| PRP
expressed  ||| S:5383 E:5393 ||| VBD
a  ||| S:5393 E:5395 ||| DT
full-length  ||| S:5395 E:5407 ||| JJ
IDO  ||| S:5407 E:5411 ||| NNP
cDNA  ||| S:5411 E:5416 ||| NNP
in  ||| S:5416 E:5429 ||| IN
cell  ||| S:5429 E:5434 ||| NN
lines  ||| S:5434 E:5451 ||| NNS
in  ||| S:5451 E:5454 ||| IN
vitro  ||| S:5454 E:5460 ||| NN
.  ||| S:5460 E:5462 ||| .
We  ||| S:5462 E:5465 ||| PRP
transfected  ||| S:5465 E:5477 ||| VBD
the  ||| S:5477 E:5491 ||| DT
murine  ||| S:5491 E:5498 ||| JJ
macrophage  ||| S:5498 E:5509 ||| JJ
cell  ||| S:5509 E:5514 ||| NN
line  ||| S:5514 E:5519 ||| NN
RAW  ||| S:5519 E:5523 ||| NNP
264.7  ||| S:5523 E:5529 ||| NNP
with  ||| S:5529 E:5534 ||| IN
a  ||| S:5534 E:5536 ||| DT
construct  ||| S:5536 E:5546 ||| NN
in  ||| S:5546 E:5559 ||| IN
which  ||| S:5559 E:5565 ||| WDT
IDO  ||| S:5565 E:5569 ||| NNP
was  ||| S:5569 E:5573 ||| VBD
expressed  ||| S:5573 E:5583 ||| VBN
under  ||| S:5583 E:5589 ||| IN
the  ||| S:5589 E:5593 ||| DT
control  ||| S:5593 E:5601 ||| NN
of  ||| S:5601 E:5604 ||| IN
the  ||| S:5604 E:5608 ||| DT
murine  ||| S:5608 E:5625 ||| JJ
MHC  ||| S:5625 E:5629 ||| NNP
Class  ||| S:5629 E:5635 ||| NNP
II  ||| S:5635 E:5638 ||| NNP
promoter  ||| S:5638 E:5647 ||| NN
( ||| S:5647 E:5648 ||| -LRB-
Fig  ||| S:5648 E:5652 ||| NNP
1A ||| S:5652 E:5654 ||| NNP
) ||| S:5654 E:5655 ||| -RRB-
.  ||| S:5655 E:5657 ||| .
IDO-transfected  ||| S:5657 E:5673 ||| NNP
RAW  ||| S:5673 E:5677 ||| NNP
cell  ||| S:5677 E:5692 ||| NN
clones ||| S:5692 E:5698 ||| NNS
,  ||| S:5698 E:5700 ||| ,
which  ||| S:5700 E:5706 ||| WDT
expressed  ||| S:5706 E:5716 ||| VBD
IDO  ||| S:5716 E:5720 ||| NNP
under  ||| S:5720 E:5726 ||| IN
the  ||| S:5726 E:5730 ||| DT
control  ||| S:5730 E:5738 ||| NN
of  ||| S:5738 E:5741 ||| IN
the  ||| S:5741 E:5745 ||| DT
MHC  ||| S:5745 E:5759 ||| NNP
Class  ||| S:5759 E:5765 ||| NNP
II  ||| S:5765 E:5768 ||| NNP
promoter ||| S:5768 E:5776 ||| NN
,  ||| S:5776 E:5778 ||| ,
were  ||| S:5778 E:5783 ||| VBD
characterized  ||| S:5783 E:5797 ||| VBN
for  ||| S:5797 E:5801 ||| IN
IDO  ||| S:5801 E:5805 ||| NNP
expression ||| S:5805 E:5815 ||| NN
.  ||| S:5815 E:5827 ||| .
We  ||| S:5827 E:5830 ||| PRP
selected  ||| S:5830 E:5839 ||| VBD
four  ||| S:5839 E:5844 ||| CD
clones  ||| S:5844 E:5851 ||| NNS
with  ||| S:5851 E:5856 ||| IN
varying  ||| S:5856 E:5864 ||| VBG
capacities  ||| S:5864 E:5875 ||| NN
for  ||| S:5875 E:5879 ||| IN
IDO  ||| S:5879 E:5893 ||| NNP
expression  ||| S:5893 E:5904 ||| NN
and  ||| S:5904 E:5908 ||| CC
tryptophan  ||| S:5908 E:5919 ||| JJ
depletion  ||| S:5919 E:5929 ||| NN
from  ||| S:5929 E:5934 ||| IN
culture  ||| S:5934 E:5942 ||| NN
medium  ||| S:5942 E:5959 ||| NN
( ||| S:5959 E:5960 ||| -LRB-
Fig  ||| S:5960 E:5964 ||| NNP
1B ||| S:5964 E:5966 ||| NNP
, ||| S:5966 E:5967 ||| ,
C ||| S:5967 E:5968 ||| NNP
, ||| S:5968 E:5969 ||| ,
D ||| S:5969 E:5970 ||| NNP
, ||| S:5970 E:5971 ||| ,
E ||| S:5971 E:5972 ||| NNP
) ||| S:5972 E:5973 ||| -RRB-
.  ||| S:5973 E:5975 ||| .
Following  ||| S:5975 E:5985 ||| VBG
48  ||| S:5985 E:5988 ||| CD
hours  ||| S:5988 E:5994 ||| NNS
in  ||| S:5994 E:5997 ||| IN
culture ||| S:5997 E:6004 ||| NN
,  ||| S:6004 E:6006 ||| ,
clones  ||| S:6006 E:6013 ||| CD
22  ||| S:6013 E:6026 ||| CD
and  ||| S:6026 E:6030 ||| CC
11  ||| S:6030 E:6033 ||| CD
depleted  ||| S:6033 E:6042 ||| JJ
tryptophan  ||| S:6042 E:6053 ||| NN
to  ||| S:6053 E:6056 ||| TO
a  ||| S:6056 E:6058 ||| DT
greater  ||| S:6058 E:6066 ||| JJR
extent  ||| S:6066 E:6073 ||| NN
than  ||| S:6073 E:6088 ||| IN
clones  ||| S:6088 E:6095 ||| CD
6  ||| S:6095 E:6097 ||| CD
and  ||| S:6097 E:6101 ||| CC
8  ||| S:6101 E:6103 ||| CD
or  ||| S:6103 E:6106 ||| CC
vector  ||| S:6106 E:6113 ||| JJ
only  ||| S:6113 E:6118 ||| JJ
control ||| S:6118 E:6125 ||| NN
,  ||| S:6125 E:6127 ||| ,
consistent  ||| S:6127 E:6138 ||| JJ
with  ||| S:6138 E:6153 ||| IN
the  ||| S:6153 E:6157 ||| DT
greater  ||| S:6157 E:6165 ||| JJR
vector  ||| S:6165 E:6172 ||| NN
copy  ||| S:6172 E:6177 ||| NN
number  ||| S:6177 E:6184 ||| NN
of  ||| S:6184 E:6187 ||| IN
these  ||| S:6187 E:6193 ||| DT
clones ||| S:6193 E:6199 ||| NNS
.  ||| S:6199 E:6201 ||| .
However ||| S:6201 E:6208 ||| RB
,  ||| S:6208 E:6220 ||| ,
none  ||| S:6220 E:6225 ||| NN
of  ||| S:6225 E:6228 ||| IN
the  ||| S:6228 E:6232 ||| DT
clones  ||| S:6232 E:6239 ||| NNS
depleted  ||| S:6239 E:6248 ||| VBD
a  ||| S:6248 E:6250 ||| DT
substantial  ||| S:6250 E:6262 ||| JJ
proportion  ||| S:6262 E:6273 ||| NN
of  ||| S:6273 E:6286 ||| IN
the  ||| S:6286 E:6290 ||| DT
tryptophan  ||| S:6290 E:6301 ||| JJ
present  ||| S:6301 E:6309 ||| NN
in  ||| S:6309 E:6312 ||| IN
medium  ||| S:6312 E:6319 ||| NN
even  ||| S:6319 E:6324 ||| RB
with  ||| S:6324 E:6329 ||| IN
longer  ||| S:6329 E:6346 ||| RBR
incubation  ||| S:6346 E:6357 ||| JJ
times ||| S:6357 E:6362 ||| NNS
.  ||| S:6362 E:6364 ||| .
A  ||| S:6364 E:6366 ||| DT
common  ||| S:6366 E:6373 ||| JJ
feature  ||| S:6373 E:6381 ||| NN
of  ||| S:6381 E:6384 ||| IN
the  ||| S:6384 E:6388 ||| DT
tryptophan  ||| S:6388 E:6409 ||| JJ
depleting  ||| S:6409 E:6419 ||| JJ
clones  ||| S:6419 E:6426 ||| NNS
was  ||| S:6426 E:6430 ||| VBD
their  ||| S:6430 E:6436 ||| PRP$
tendency  ||| S:6436 E:6445 ||| NN
to  ||| S:6445 E:6448 ||| TO
form  ||| S:6448 E:6453 ||| VB
macroscopic  ||| S:6453 E:6475 ||| JJ
foci ||| S:6475 E:6479 ||| NN
,  ||| S:6479 E:6481 ||| ,
which  ||| S:6481 E:6487 ||| WDT
were  ||| S:6487 E:6492 ||| VBD
visible  ||| S:6492 E:6500 ||| JJ
to  ||| S:6500 E:6503 ||| TO
the  ||| S:6503 E:6507 ||| DT
naked  ||| S:6507 E:6513 ||| JJ
eye  ||| S:6513 E:6517 ||| NN
( ||| S:6517 E:6518 ||| -LRB-
Fig  ||| S:6518 E:6522 ||| NNP
2 ||| S:6522 E:6523 ||| CD
, ||| S:6523 E:6524 ||| ,
A ||| S:6524 E:6525 ||| NNP
, ||| S:6525 E:6526 ||| ,
B ||| S:6526 E:6527 ||| NNP
, ||| S:6527 E:6528 ||| ,
C ||| S:6528 E:6529 ||| NNP
) ||| S:6529 E:6530 ||| -RRB-
.  ||| S:6530 E:6542 ||| .
At  ||| S:6542 E:6545 ||| IN
a  ||| S:6545 E:6547 ||| DT
certain  ||| S:6547 E:6555 ||| JJ
point  ||| S:6555 E:6561 ||| NN
in  ||| S:6561 E:6564 ||| IN
focus  ||| S:6564 E:6570 ||| NN
growth ||| S:6570 E:6576 ||| NN
,  ||| S:6576 E:6578 ||| ,
multicellular  ||| S:6578 E:6602 ||| JJ
aggregates  ||| S:6602 E:6613 ||| NNS
of  ||| S:6613 E:6616 ||| IN
RAW  ||| S:6616 E:6620 ||| NNP
cells  ||| S:6620 E:6626 ||| NNS
would  ||| S:6626 E:6632 ||| MD
break  ||| S:6632 E:6638 ||| VB
off  ||| S:6638 E:6642 ||| RP
from  ||| S:6642 E:6647 ||| IN
the  ||| S:6647 E:6651 ||| DT
focus  ||| S:6651 E:6667 ||| NN
and  ||| S:6667 E:6671 ||| CC
could  ||| S:6671 E:6677 ||| MD
be  ||| S:6677 E:6680 ||| VB
seen  ||| S:6680 E:6685 ||| VBN
floating  ||| S:6685 E:6694 ||| VBG
in  ||| S:6694 E:6697 ||| IN
suspension  ||| S:6697 E:6708 ||| NN
in  ||| S:6708 E:6711 ||| IN
the  ||| S:6711 E:6715 ||| DT
tissue  ||| S:6715 E:6732 ||| NN
culture  ||| S:6732 E:6740 ||| NN
medium ||| S:6740 E:6746 ||| NN
.  ||| S:6746 E:6748 ||| .
Wild  ||| S:6748 E:6753 ||| JJ
type  ||| S:6753 E:6758 ||| NN
RAW  ||| S:6758 E:6762 ||| NN
cells  ||| S:6762 E:6768 ||| NNS
or  ||| S:6768 E:6771 ||| CC
RAW  ||| S:6771 E:6775 ||| NNP
cells  ||| S:6775 E:6791 ||| NNS
transfected  ||| S:6791 E:6803 ||| VBN
with  ||| S:6803 E:6808 ||| IN
vector  ||| S:6808 E:6815 ||| NN
alone  ||| S:6815 E:6821 ||| RB
and ||| S:6821 E:6824 ||| CC
,  ||| S:6824 E:6826 ||| ,
to  ||| S:6826 E:6829 ||| TO
a  ||| S:6829 E:6831 ||| DT
lesser  ||| S:6831 E:6838 ||| JJR
extent ||| S:6838 E:6844 ||| NN
,  ||| S:6844 E:6856 ||| ,
clones  ||| S:6856 E:6863 ||| CD
6  ||| S:6863 E:6865 ||| CD
and  ||| S:6865 E:6869 ||| CC
8  ||| S:6869 E:6871 ||| CD
demonstrated  ||| S:6871 E:6884 ||| VBD
a  ||| S:6884 E:6886 ||| DT
reduced  ||| S:6886 E:6894 ||| JJ
ability  ||| S:6894 E:6902 ||| NN
to  ||| S:6902 E:6905 ||| TO
form  ||| S:6905 E:6920 ||| VB
macroscopic  ||| S:6920 E:6932 ||| JJ
foci ||| S:6932 E:6936 ||| NN
.  ||| S:6936 E:6948 ||| .
To  ||| S:6948 E:6951 ||| TO
determine  ||| S:6951 E:6961 ||| VB
if  ||| S:6961 E:6964 ||| IN
this  ||| S:6964 E:6969 ||| DT
phenomenon  ||| S:6969 E:6980 ||| NN
was  ||| S:6980 E:6984 ||| VBD
unique  ||| S:6984 E:6991 ||| JJ
to  ||| S:6991 E:6994 ||| TO
RAW  ||| S:6994 E:7008 ||| NNP
cells ||| S:7008 E:7013 ||| NNS
,  ||| S:7013 E:7015 ||| ,
we  ||| S:7015 E:7018 ||| PRP
also  ||| S:7018 E:7023 ||| RB
transfected  ||| S:7023 E:7035 ||| VB
the  ||| S:7035 E:7039 ||| DT
MC57  ||| S:7039 E:7044 ||| JJ
murine  ||| S:7044 E:7051 ||| JJ
fibrosarcoma  ||| S:7051 E:7074 ||| JJ
cell  ||| S:7074 E:7079 ||| NN
line  ||| S:7079 E:7084 ||| NN
[  ||| S:7084 E:7086 ||| -LRB-
22 ||| S:7086 E:7088 ||| CD
]  ||| S:7088 E:7090 ||| -RRB-
which  ||| S:7090 E:7096 ||| WDT
grows  ||| S:7096 E:7102 ||| VBZ
as  ||| S:7102 E:7105 ||| IN
a  ||| S:7105 E:7107 ||| DT
monolayer ||| S:7107 E:7116 ||| NN
.  ||| S:7116 E:7118 ||| .
MC  ||| S:7118 E:7121 ||| NNP
57  ||| S:7121 E:7124 ||| CD
cells  ||| S:7124 E:7140 ||| NNS
are  ||| S:7140 E:7144 ||| VBP
fibroblastic  ||| S:7144 E:7157 ||| VBN
in  ||| S:7157 E:7160 ||| IN
appearance  ||| S:7160 E:7171 ||| NN
and  ||| S:7171 E:7175 ||| CC
disperse  ||| S:7175 E:7184 ||| NN
across  ||| S:7184 E:7191 ||| IN
the  ||| S:7191 E:7205 ||| DT
surface  ||| S:7205 E:7213 ||| NN
of  ||| S:7213 E:7216 ||| IN
a  ||| S:7216 E:7218 ||| DT
tissue  ||| S:7218 E:7225 ||| NN
culture  ||| S:7225 E:7233 ||| NN
dish  ||| S:7233 E:7238 ||| NN
in  ||| S:7238 E:7241 ||| IN
a  ||| S:7241 E:7243 ||| DT
uniform  ||| S:7243 E:7251 ||| JJ
manner ||| S:7251 E:7257 ||| NN
.  ||| S:7257 E:7269 ||| .
Transfection  ||| S:7269 E:7282 ||| NNP
of  ||| S:7282 E:7285 ||| IN
a  ||| S:7285 E:7287 ||| DT
full  ||| S:7287 E:7292 ||| JJ
length ||| S:7292 E:7298 ||| NN
,  ||| S:7298 E:7300 ||| ,
constitutively  ||| S:7300 E:7315 ||| NN
expressed  ||| S:7315 E:7335 ||| VBD
IDO  ||| S:7335 E:7339 ||| NNP
cDNA  ||| S:7339 E:7344 ||| NNP
into  ||| S:7344 E:7349 ||| IN
MC57  ||| S:7349 E:7354 ||| CD
cells  ||| S:7354 E:7360 ||| NNS
in  ||| S:7360 E:7363 ||| IN
the  ||| S:7363 E:7367 ||| DT
pcDNA3  ||| S:7367 E:7374 ||| JJ
expression  ||| S:7374 E:7385 ||| NN
vector ||| S:7385 E:7391 ||| NN
,  ||| S:7391 E:7403 ||| ,
resulted  ||| S:7403 E:7412 ||| VBD
in  ||| S:7412 E:7415 ||| IN
MC57  ||| S:7415 E:7420 ||| CD
cells  ||| S:7420 E:7426 ||| NNS
developing  ||| S:7426 E:7437 ||| VBG
a  ||| S:7437 E:7439 ||| DT
more  ||| S:7439 E:7444 ||| RBR
rounded  ||| S:7444 E:7462 ||| JJ
phenotype ||| S:7462 E:7471 ||| NN
.  ||| S:7471 E:7473 ||| .
Furthermore ||| S:7473 E:7484 ||| RB
,  ||| S:7484 E:7486 ||| ,
cells  ||| S:7486 E:7492 ||| NNS
grew  ||| S:7492 E:7497 ||| VBD
as  ||| S:7497 E:7500 ||| IN
multicellular  ||| S:7500 E:7514 ||| JJ
foci ||| S:7514 E:7518 ||| NN
,  ||| S:7518 E:7530 ||| ,
in  ||| S:7530 E:7533 ||| IN
a  ||| S:7533 E:7535 ||| DT
confined  ||| S:7535 E:7544 ||| JJ
area ||| S:7544 E:7548 ||| NN
,  ||| S:7548 E:7550 ||| ,
similar  ||| S:7550 E:7558 ||| JJ
to  ||| S:7558 E:7561 ||| TO
RAW  ||| S:7561 E:7565 ||| NNP
cells ||| S:7565 E:7570 ||| NNS
,  ||| S:7570 E:7572 ||| ,
although  ||| S:7572 E:7581 ||| IN
the  ||| S:7581 E:7595 ||| DT
foci  ||| S:7595 E:7600 ||| NN
did  ||| S:7600 E:7604 ||| VBD
not  ||| S:7604 E:7608 ||| RB
grow  ||| S:7608 E:7613 ||| VB
to  ||| S:7613 E:7616 ||| TO
as  ||| S:7616 E:7619 ||| RB
large  ||| S:7619 E:7625 ||| JJ
a  ||| S:7625 E:7627 ||| DT
size  ||| S:7627 E:7632 ||| NN
before  ||| S:7632 E:7639 ||| IN
detaching  ||| S:7639 E:7659 ||| NN
from  ||| S:7659 E:7664 ||| IN
the  ||| S:7664 E:7668 ||| DT
plate  ||| S:7668 E:7674 ||| NN
( ||| S:7674 E:7675 ||| -LRB-
Fig  ||| S:7675 E:7679 ||| NNP
2D ||| S:7679 E:7681 ||| NNP
, ||| S:7681 E:7682 ||| ,
E ||| S:7682 E:7683 ||| NNP
) ||| S:7683 E:7684 ||| -RRB-
.  ||| S:7684 E:7686 ||| .
The  ||| S:7686 E:7690 ||| DT
murine  ||| S:7690 E:7697 ||| JJ
monocytic  ||| S:7697 E:7707 ||| JJ
cell  ||| S:7707 E:7712 ||| NN
line  ||| S:7712 E:7727 ||| NN
P388  ||| S:7727 E:7732 ||| NN
was  ||| S:7732 E:7736 ||| VBD
also  ||| S:7736 E:7741 ||| RB
transfected  ||| S:7741 E:7753 ||| JJ
and  ||| S:7753 E:7757 ||| CC
expressed  ||| S:7757 E:7767 ||| VBD
IDO ||| S:7767 E:7770 ||| NNP
.  ||| S:7770 E:7772 ||| .
It  ||| S:7772 E:7775 ||| PRP
likewise  ||| S:7775 E:7794 ||| RB
exhibited  ||| S:7794 E:7804 ||| VBN
a  ||| S:7804 E:7806 ||| DT
change  ||| S:7806 E:7813 ||| NN
in  ||| S:7813 E:7816 ||| IN
morphology  ||| S:7816 E:7827 ||| JJ
similar  ||| S:7827 E:7835 ||| JJ
to  ||| S:7835 E:7838 ||| TO
that  ||| S:7838 E:7853 ||| WDT
described  ||| S:7853 E:7863 ||| VBD
above  ||| S:7863 E:7869 ||| IN
and  ||| S:7869 E:7873 ||| CC
clones  ||| S:7873 E:7880 ||| NNS
expressing  ||| S:7880 E:7891 ||| VBG
IDO  ||| S:7891 E:7895 ||| NNP
often  ||| S:7895 E:7901 ||| RB
changed  ||| S:7901 E:7919 ||| VBN
from  ||| S:7919 E:7924 ||| IN
non-attached  ||| S:7924 E:7937 ||| JJ
suspension  ||| S:7937 E:7948 ||| NN
cultures  ||| S:7948 E:7957 ||| NNS
to  ||| S:7957 E:7960 ||| TO
adherent  ||| S:7960 E:7979 ||| VB
cultures  ||| S:7979 E:7988 ||| NNS
which  ||| S:7988 E:7994 ||| WDT
resembled  ||| S:7994 E:8004 ||| VBZ
RAW  ||| S:8004 E:8008 ||| NNP
cells ||| S:8008 E:8013 ||| NNS
( ||| S:8013 E:8014 ||| -LRB-
not  ||| S:8014 E:8018 ||| RB
shown ||| S:8018 E:8023 ||| VBN
) ||| S:8023 E:8024 ||| -RRB-
.  ||| S:8024 E:8036 ||| .
IDO-expressing  ||| S:8036 E:8051 ||| JJ
clones  ||| S:8051 E:8058 ||| NNS
were  ||| S:8058 E:8063 ||| VBD
also  ||| S:8063 E:8068 ||| RB
slower  ||| S:8068 E:8075 ||| JJR
to  ||| S:8075 E:8078 ||| TO
re-attach  ||| S:8078 E:8088 ||| JJ
to  ||| S:8088 E:8101 ||| TO
tissue  ||| S:8101 E:8108 ||| NN
culture  ||| S:8108 E:8116 ||| NN
dishes  ||| S:8116 E:8123 ||| NNS
following  ||| S:8123 E:8133 ||| VBG
sub-culture  ||| S:8133 E:8145 ||| JJ
and  ||| S:8145 E:8149 ||| CC
could  ||| S:8149 E:8155 ||| MD
be  ||| S:8155 E:8168 ||| VB
seen  ||| S:8168 E:8173 ||| VBN
floating  ||| S:8173 E:8182 ||| VBG
as  ||| S:8182 E:8185 ||| IN
multicellular  ||| S:8185 E:8199 ||| JJ
aggregates ||| S:8199 E:8209 ||| NNS
.  ||| S:8209 E:8211 ||| .
To  ||| S:8211 E:8214 ||| TO
quantitate  ||| S:8214 E:8235 ||| VB
the  ||| S:8235 E:8239 ||| DT
change  ||| S:8239 E:8246 ||| NN
in  ||| S:8246 E:8249 ||| IN
cell  ||| S:8249 E:8254 ||| NN
adhesion  ||| S:8254 E:8263 ||| NN
in  ||| S:8263 E:8266 ||| IN
IDO-transfected  ||| S:8266 E:8282 ||| NNP
RAW  ||| S:8282 E:8286 ||| NNP
cells ||| S:8286 E:8291 ||| NNS
,  ||| S:8291 E:8303 ||| ,
we  ||| S:8303 E:8306 ||| PRP
performed  ||| S:8306 E:8316 ||| VBD
binding  ||| S:8316 E:8324 ||| JJ
studies  ||| S:8324 E:8332 ||| NNS
to  ||| S:8332 E:8335 ||| TO
tissue  ||| S:8335 E:8342 ||| NN
culture  ||| S:8342 E:8350 ||| NN
plates  ||| S:8350 E:8367 ||| VBZ
coated  ||| S:8367 E:8374 ||| VBN
with  ||| S:8374 E:8379 ||| IN
various  ||| S:8379 E:8387 ||| JJ
extra-cellular  ||| S:8387 E:8402 ||| JJ
matrices ||| S:8402 E:8410 ||| NN
,  ||| S:8410 E:8412 ||| ,
including  ||| S:8412 E:8432 ||| VBG
collagen ||| S:8432 E:8440 ||| NN
,  ||| S:8440 E:8442 ||| ,
laminin ||| S:8442 E:8449 ||| NN
,  ||| S:8449 E:8451 ||| ,
matrigel ||| S:8451 E:8459 ||| NN
,  ||| S:8459 E:8461 ||| ,
and  ||| S:8461 E:8465 ||| CC
fibronectin ||| S:8465 E:8476 ||| NN
.  ||| S:8476 E:8478 ||| .
Neither  ||| S:8478 E:8496 ||| DT
vector-only  ||| S:8496 E:8508 ||| JJ
controls  ||| S:8508 E:8517 ||| NNS
nor  ||| S:8517 E:8521 ||| CC
IDO-expressing  ||| S:8521 E:8536 ||| JJ
cells  ||| S:8536 E:8542 ||| NNS
adhered  ||| S:8542 E:8560 ||| VBP
significantly  ||| S:8560 E:8574 ||| RB
to  ||| S:8574 E:8577 ||| TO
laminin  ||| S:8577 E:8585 ||| VB
or  ||| S:8585 E:8588 ||| CC
matrigel  ||| S:8588 E:8597 ||| JJ
coated  ||| S:8597 E:8604 ||| JJ
plates  ||| S:8604 E:8611 ||| NN
in  ||| S:8611 E:8614 ||| IN
a  ||| S:8614 E:8626 ||| DT
45  ||| S:8626 E:8629 ||| CD
minute  ||| S:8629 E:8636 ||| NN
assay  ||| S:8636 E:8642 ||| NN
period  ||| S:8642 E:8649 ||| NN
( ||| S:8649 E:8650 ||| -LRB-
not  ||| S:8650 E:8654 ||| RB
shown ||| S:8654 E:8659 ||| VBN
)  ||| S:8659 E:8661 ||| -RRB-
and  ||| S:8661 E:8665 ||| CC
both  ||| S:8665 E:8670 ||| DT
controls  ||| S:8670 E:8679 ||| NNS
and  ||| S:8679 E:8693 ||| CC
IDO-expressing  ||| S:8693 E:8708 ||| JJ
cells  ||| S:8708 E:8714 ||| NNS
adhered  ||| S:8714 E:8722 ||| VBP
strongly  ||| S:8722 E:8731 ||| RB
and  ||| S:8731 E:8735 ||| CC
to  ||| S:8735 E:8738 ||| TO
similar  ||| S:8738 E:8756 ||| JJ
extents  ||| S:8756 E:8764 ||| NN
to  ||| S:8764 E:8767 ||| TO
fibronectin  ||| S:8767 E:8779 ||| VB
coated  ||| S:8779 E:8786 ||| JJ
plates  ||| S:8786 E:8793 ||| NNS
( ||| S:8793 E:8794 ||| -LRB-
Fig  ||| S:8794 E:8798 ||| NNP
3A ||| S:8798 E:8800 ||| NNP
) ||| S:8800 E:8801 ||| -RRB-
.  ||| S:8801 E:8803 ||| .
However ||| S:8803 E:8810 ||| RB
,  ||| S:8810 E:8822 ||| ,
there  ||| S:8822 E:8828 ||| EX
was  ||| S:8828 E:8832 ||| VBD
a  ||| S:8832 E:8834 ||| DT
substantial  ||| S:8834 E:8846 ||| JJ
difference  ||| S:8846 E:8857 ||| NN
in  ||| S:8857 E:8860 ||| IN
adhesion  ||| S:8860 E:8869 ||| VBG
to  ||| S:8869 E:8882 ||| TO
collagen-coated  ||| S:8882 E:8898 ||| JJ
plates ||| S:8898 E:8904 ||| NN
.  ||| S:8904 E:8906 ||| .
Although  ||| S:8906 E:8915 ||| IN
neither  ||| S:8915 E:8923 ||| DT
sample  ||| S:8923 E:8930 ||| NN
adhered  ||| S:8930 E:8948 ||| NN
to  ||| S:8948 E:8951 ||| TO
collagen  ||| S:8951 E:8960 ||| VB
to  ||| S:8960 E:8963 ||| TO
the  ||| S:8963 E:8967 ||| DT
same  ||| S:8967 E:8972 ||| JJ
extent  ||| S:8972 E:8979 ||| NN
as  ||| S:8979 E:8982 ||| IN
to  ||| S:8982 E:8985 ||| TO
fibronectin ||| S:8985 E:8996 ||| VB
,  ||| S:8996 E:8998 ||| ,
vector  ||| S:8998 E:9015 ||| VBD
only  ||| S:9015 E:9020 ||| RB
controls  ||| S:9020 E:9029 ||| VBZ
adhered  ||| S:9029 E:9037 ||| VBN
more  ||| S:9037 E:9042 ||| RBR
strongly  ||| S:9042 E:9051 ||| RB
than  ||| S:9051 E:9056 ||| IN
IDO-expressing  ||| S:9056 E:9081 ||| JJ
clone  ||| S:9081 E:9087 ||| NN
11  ||| S:9087 E:9090 ||| CD
( ||| S:9090 E:9091 ||| -LRB-
Fig  ||| S:9091 E:9095 ||| NNP
3B ||| S:9095 E:9097 ||| NNP
) ||| S:9097 E:9098 ||| -RRB-
.  ||| S:9098 E:9128 ||| .
IDO  ||| S:9128 E:9132 ||| NNP
expression  ||| S:9132 E:9143 ||| NN
is  ||| S:9143 E:9146 ||| VBZ
induced  ||| S:9146 E:9154 ||| VBN
during  ||| S:9154 E:9161 ||| IN
cell  ||| S:9161 E:9166 ||| NN
attachment  ||| S:9166 E:9177 ||| NN
to  ||| S:9177 E:9190 ||| TO
growth  ||| S:9190 E:9197 ||| NN
substrates  ||| S:9197 E:9218 ||| NN
To  ||| S:9218 E:9221 ||| TO
determine  ||| S:9221 E:9231 ||| VB
if  ||| S:9231 E:9234 ||| IN
IDO  ||| S:9234 E:9238 ||| NNP
normally  ||| S:9238 E:9247 ||| RB
plays  ||| S:9247 E:9253 ||| VBZ
a  ||| S:9253 E:9255 ||| DT
role  ||| S:9255 E:9260 ||| NN
during  ||| S:9260 E:9267 ||| IN
the  ||| S:9267 E:9281 ||| DT
course  ||| S:9281 E:9288 ||| NN
of  ||| S:9288 E:9291 ||| IN
cell  ||| S:9291 E:9296 ||| NN
adhesion ||| S:9296 E:9304 ||| NN
,  ||| S:9304 E:9306 ||| ,
we  ||| S:9306 E:9309 ||| PRP
detached  ||| S:9309 E:9318 ||| VBP
log  ||| S:9318 E:9322 ||| JJ
phase ||| S:9322 E:9327 ||| NN
,  ||| S:9327 E:9329 ||| ,
wild  ||| S:9329 E:9334 ||| JJ
type  ||| S:9334 E:9349 ||| NN
RAW  ||| S:9349 E:9353 ||| NN
cells  ||| S:9353 E:9359 ||| NNS
from  ||| S:9359 E:9364 ||| IN
their  ||| S:9364 E:9370 ||| PRP$
culture  ||| S:9370 E:9378 ||| NN
flasks  ||| S:9378 E:9385 ||| NN
by  ||| S:9385 E:9388 ||| IN
scraping ||| S:9388 E:9396 ||| NN
,  ||| S:9396 E:9398 ||| ,
reseeded  ||| S:9398 E:9417 ||| VBD
them  ||| S:9417 E:9422 ||| PRP
into  ||| S:9422 E:9427 ||| IN
fresh  ||| S:9427 E:9433 ||| JJ
medium  ||| S:9433 E:9440 ||| NN
and  ||| S:9440 E:9444 ||| CC
assayed  ||| S:9444 E:9452 ||| NN
for  ||| S:9452 E:9456 ||| IN
IDO  ||| S:9456 E:9460 ||| NNP
expression  ||| S:9460 E:9471 ||| NN
at  ||| S:9471 E:9484 ||| IN
subsequent  ||| S:9484 E:9495 ||| JJ
time  ||| S:9495 E:9500 ||| NN
points ||| S:9500 E:9506 ||| NNS
.  ||| S:9506 E:9508 ||| .
Log  ||| S:9508 E:9512 ||| JJ
phase  ||| S:9512 E:9518 ||| NN
cells  ||| S:9518 E:9524 ||| NNS
do  ||| S:9524 E:9527 ||| VBP
not  ||| S:9527 E:9531 ||| RB
express  ||| S:9531 E:9549 ||| VB
IDO  ||| S:9549 E:9553 ||| NNP
at  ||| S:9553 E:9556 ||| IN
levels  ||| S:9556 E:9563 ||| NNS
detectable  ||| S:9563 E:9574 ||| VBN
by  ||| S:9574 E:9577 ||| IN
standard  ||| S:9577 E:9586 ||| JJ
RT-PCR  ||| S:9586 E:9593 ||| JJ
methods ||| S:9593 E:9600 ||| NNS
.  ||| S:9600 E:9612 ||| .
However ||| S:9612 E:9619 ||| RB
,  ||| S:9619 E:9621 ||| ,
in  ||| S:9621 E:9624 ||| IN
cells  ||| S:9624 E:9630 ||| NNS
detached  ||| S:9630 E:9639 ||| VBN
from  ||| S:9639 E:9644 ||| IN
their  ||| S:9644 E:9650 ||| PRP$
normal  ||| S:9650 E:9657 ||| JJ
growth  ||| S:9657 E:9674 ||| NN
substrate ||| S:9674 E:9683 ||| NN
,  ||| S:9683 E:9685 ||| ,
IDO  ||| S:9685 E:9689 ||| NNP
expression  ||| S:9689 E:9700 ||| NN
was  ||| S:9700 E:9704 ||| VBD
already  ||| S:9704 E:9712 ||| RB
induced  ||| S:9712 E:9720 ||| VBN
by  ||| S:9720 E:9723 ||| IN
5  ||| S:9723 E:9725 ||| CD
hours  ||| S:9725 E:9741 ||| NNS
following  ||| S:9741 E:9751 ||| VBG
reseeding  ||| S:9751 E:9761 ||| NN
into  ||| S:9761 E:9766 ||| IN
fresh  ||| S:9766 E:9772 ||| JJ
tissue  ||| S:9772 E:9779 ||| NN
culture  ||| S:9779 E:9787 ||| NN
dishes  ||| S:9787 E:9794 ||| NNS
and  ||| S:9794 E:9808 ||| CC
expression  ||| S:9808 E:9819 ||| NN
was  ||| S:9819 E:9823 ||| VBD
detected  ||| S:9823 E:9832 ||| VBN
until  ||| S:9832 E:9838 ||| IN
48  ||| S:9838 E:9841 ||| CD
hours  ||| S:9841 E:9847 ||| NNS
( ||| S:9847 E:9848 ||| -LRB-
Fig  ||| S:9848 E:9852 ||| NNP
4A ||| S:9852 E:9854 ||| NNP
) ||| S:9854 E:9855 ||| -RRB-
.  ||| S:9855 E:9857 ||| .
Onset  ||| S:9857 E:9863 ||| NN
of  ||| S:9863 E:9876 ||| IN
expression  ||| S:9876 E:9887 ||| NN
coincided  ||| S:9887 E:9897 ||| NN
with  ||| S:9897 E:9902 ||| IN
the  ||| S:9902 E:9906 ||| DT
time  ||| S:9906 E:9911 ||| NN
when  ||| S:9911 E:9916 ||| WRB
the  ||| S:9916 E:9920 ||| DT
majority  ||| S:9920 E:9929 ||| NN
of  ||| S:9929 E:9942 ||| IN
cells  ||| S:9942 E:9948 ||| NNS
had  ||| S:9948 E:9952 ||| VBD
begun  ||| S:9952 E:9958 ||| VBN
to  ||| S:9958 E:9961 ||| TO
adhere  ||| S:9961 E:9968 ||| VB
to  ||| S:9968 E:9971 ||| TO
the  ||| S:9971 E:9975 ||| DT
plate ||| S:9975 E:9980 ||| NN
.  ||| S:9980 E:9992 ||| .
To  ||| S:9992 E:9995 ||| TO
determine  ||| S:9995 E:10005 ||| VB
if  ||| S:10005 E:10008 ||| IN
IDO  ||| S:10008 E:10012 ||| NNP
expression  ||| S:10012 E:10023 ||| NN
was  ||| S:10023 E:10027 ||| VBD
restricted  ||| S:10027 E:10038 ||| VBN
to  ||| S:10038 E:10041 ||| TO
cell  ||| S:10041 E:10056 ||| NN
interactions  ||| S:10056 E:10069 ||| NNS
with  ||| S:10069 E:10074 ||| IN
standard  ||| S:10074 E:10083 ||| JJ
tissue  ||| S:10083 E:10090 ||| NN
culture  ||| S:10090 E:10098 ||| NN
substrates  ||| S:10098 E:10109 ||| NNS
and  ||| S:10109 E:10123 ||| CC
to  ||| S:10123 E:10126 ||| TO
further  ||| S:10126 E:10134 ||| RB
explore  ||| S:10134 E:10142 ||| VB
the  ||| S:10142 E:10146 ||| DT
possibility  ||| S:10146 E:10158 ||| NN
that  ||| S:10158 E:10163 ||| IN
IDO  ||| S:10163 E:10167 ||| NNP
altered  ||| S:10167 E:10185 ||| VBD
inter-cellular  ||| S:10185 E:10200 ||| JJ
adhesiveness ||| S:10200 E:10212 ||| NN
,  ||| S:10212 E:10214 ||| ,
we  ||| S:10214 E:10217 ||| PRP
studied  ||| S:10217 E:10225 ||| VBD
the  ||| S:10225 E:10229 ||| DT
murine  ||| S:10229 E:10246 ||| JJ
embryonic  ||| S:10246 E:10256 ||| JJ
carcinoma  ||| S:10256 E:10266 ||| JJ
cell  ||| S:10266 E:10271 ||| NN
line  ||| S:10271 E:10276 ||| NN
P19 ||| S:10276 E:10279 ||| NN
.  ||| S:10279 E:10281 ||| .
This  ||| S:10281 E:10286 ||| DT
cell  ||| S:10286 E:10291 ||| NN
has  ||| S:10291 E:10295 ||| VBZ
been  ||| S:10295 E:10310 ||| VBN
characterized  ||| S:10310 E:10324 ||| VBN
extensively  ||| S:10324 E:10336 ||| NNS
and  ||| S:10336 E:10340 ||| CC
differentiates  ||| S:10340 E:10355 ||| NN
into  ||| S:10355 E:10370 ||| IN
skeletal  ||| S:10370 E:10379 ||| NN
and  ||| S:10379 E:10383 ||| CC
cardiac  ||| S:10383 E:10391 ||| JJ
muscle  ||| S:10391 E:10398 ||| NN
or  ||| S:10398 E:10401 ||| CC
neuronal  ||| S:10401 E:10410 ||| JJ
cells ||| S:10410 E:10415 ||| NNS
,  ||| S:10415 E:10417 ||| ,
depending  ||| S:10417 E:10437 ||| VBG
on  ||| S:10437 E:10440 ||| RP
whether  ||| S:10440 E:10448 ||| IN
it  ||| S:10448 E:10451 ||| PRP
is  ||| S:10451 E:10454 ||| VBZ
treated  ||| S:10454 E:10462 ||| VBN
with  ||| S:10462 E:10467 ||| IN
DMSO  ||| S:10467 E:10472 ||| NNP
or  ||| S:10472 E:10475 ||| CC
retinoic  ||| S:10475 E:10484 ||| JJ
acid  ||| S:10484 E:10489 ||| NN
( ||| S:10489 E:10490 ||| -LRB-
RA ||| S:10490 E:10492 ||| NNP
)  ||| S:10492 E:10504 ||| -RRB-
respectively  ||| S:10504 E:10517 ||| RB
[  ||| S:10517 E:10519 ||| -LRB-
23 ||| S:10519 E:10521 ||| CD
,  ||| S:10521 E:10523 ||| ,
24 ||| S:10523 E:10525 ||| CD
,  ||| S:10525 E:10527 ||| ,
25 ||| S:10527 E:10529 ||| CD
] ||| S:10529 E:10530 ||| -RRB-
.  ||| S:10530 E:10532 ||| .
Differentiation  ||| S:10532 E:10548 ||| NNP
is  ||| S:10548 E:10551 ||| VBZ
dependent  ||| S:10551 E:10571 ||| JJ
on  ||| S:10571 E:10574 ||| IN
an  ||| S:10574 E:10577 ||| DT
initial ||| S:10577 E:10584 ||| JJ
,  ||| S:10584 E:10586 ||| ,
3-5  ||| S:10586 E:10590 ||| CD
day  ||| S:10590 E:10594 ||| NN
incubation  ||| S:10594 E:10605 ||| NN
as  ||| S:10605 E:10608 ||| IN
multicellular  ||| S:10608 E:10632 ||| JJ
aggregates  ||| S:10632 E:10643 ||| NNS
in  ||| S:10643 E:10646 ||| IN
suspension  ||| S:10646 E:10657 ||| NN
culture ||| S:10657 E:10664 ||| NN
,  ||| S:10664 E:10666 ||| ,
in  ||| S:10666 E:10669 ||| IN
the  ||| S:10669 E:10673 ||| DT
presence  ||| S:10673 E:10682 ||| NN
of  ||| S:10682 E:10695 ||| IN
drug ||| S:10695 E:10699 ||| NN
,  ||| S:10699 E:10701 ||| ,
followed  ||| S:10701 E:10710 ||| VBN
by  ||| S:10710 E:10713 ||| IN
a  ||| S:10713 E:10715 ||| DT
similar  ||| S:10715 E:10723 ||| JJ
period  ||| S:10723 E:10730 ||| NN
growing  ||| S:10730 E:10738 ||| VBG
as  ||| S:10738 E:10741 ||| IN
monolayer  ||| S:10741 E:10761 ||| JJ
adherent  ||| S:10761 E:10770 ||| JJ
cells  ||| S:10770 E:10776 ||| NNS
in  ||| S:10776 E:10779 ||| IN
the  ||| S:10779 E:10783 ||| DT
absence  ||| S:10783 E:10791 ||| NN
of  ||| S:10791 E:10794 ||| IN
drug ||| S:10794 E:10798 ||| NN
.  ||| S:10798 E:10800 ||| .
Mature  ||| S:10800 E:10817 ||| JJ
differentiated  ||| S:10817 E:10832 ||| JJ
cells  ||| S:10832 E:10838 ||| NNS
begin  ||| S:10838 E:10844 ||| VBP
to  ||| S:10844 E:10847 ||| TO
appear  ||| S:10847 E:10854 ||| VB
during  ||| S:10854 E:10861 ||| IN
this  ||| S:10861 E:10876 ||| DT
subsequent  ||| S:10876 E:10887 ||| JJ
growth  ||| S:10887 E:10894 ||| NN
period  ||| S:10894 E:10901 ||| NN
in  ||| S:10901 E:10904 ||| IN
the  ||| S:10904 E:10908 ||| DT
absence  ||| S:10908 E:10916 ||| NN
of  ||| S:10916 E:10919 ||| IN
drug ||| S:10919 E:10923 ||| NN
.  ||| S:10923 E:10935 ||| .
IDO  ||| S:10935 E:10939 ||| NNP
expression  ||| S:10939 E:10950 ||| NN
was  ||| S:10950 E:10954 ||| VBD
detected  ||| S:10954 E:10963 ||| VBN
when  ||| S:10963 E:10968 ||| WRB
P19  ||| S:10968 E:10972 ||| JJ
cells  ||| S:10972 E:10978 ||| NNS
were  ||| S:10978 E:10993 ||| VBD
reseeded  ||| S:10993 E:11002 ||| VBN
into  ||| S:11002 E:11007 ||| IN
bacterial  ||| S:11007 E:11017 ||| JJ
petri  ||| S:11017 E:11023 ||| JJ
dishes  ||| S:11023 E:11030 ||| NNS
as  ||| S:11030 E:11033 ||| IN
suspension  ||| S:11033 E:11054 ||| NN
cultures  ||| S:11054 E:11063 ||| NNS
and  ||| S:11063 E:11067 ||| CC
allowed  ||| S:11067 E:11075 ||| VBN
to  ||| S:11075 E:11078 ||| TO
form  ||| S:11078 E:11083 ||| VB
aggregates ||| S:11083 E:11093 ||| NNS
.  ||| S:11093 E:11095 ||| .
IDO  ||| S:11095 E:11099 ||| NNP
expression  ||| S:11099 E:11120 ||| NN
was  ||| S:11120 E:11124 ||| VBD
observed  ||| S:11124 E:11133 ||| VBN
within  ||| S:11133 E:11140 ||| IN
12  ||| S:11140 E:11143 ||| CD
hours  ||| S:11143 E:11149 ||| NNS
of  ||| S:11149 E:11152 ||| IN
seeding  ||| S:11152 E:11160 ||| NN
into  ||| S:11160 E:11165 ||| IN
suspension  ||| S:11165 E:11186 ||| NN
with  ||| S:11186 E:11191 ||| IN
DMSO  ||| S:11191 E:11196 ||| NNP
and  ||| S:11196 E:11200 ||| CC
peaked  ||| S:11200 E:11207 ||| VBN
around  ||| S:11207 E:11214 ||| IN
48-54  ||| S:11214 E:11220 ||| CD
hours ||| S:11220 E:11225 ||| NNS
.  ||| S:11225 E:11227 ||| .
( ||| S:11227 E:11228 ||| -LRB-
Fig  ||| S:11228 E:11232 ||| NNP
4B ||| S:11232 E:11234 ||| NNP
) ||| S:11234 E:11235 ||| -RRB-
.  ||| S:11235 E:11237 ||| .
Thus ||| S:11237 E:11241 ||| RB
,  ||| S:11241 E:11253 ||| ,
removing  ||| S:11253 E:11262 ||| VBG
cells  ||| S:11262 E:11268 ||| NNS
from  ||| S:11268 E:11273 ||| IN
their  ||| S:11273 E:11279 ||| PRP$
normal  ||| S:11279 E:11286 ||| JJ
growth  ||| S:11286 E:11293 ||| NN
substrate  ||| S:11293 E:11303 ||| NNS
and  ||| S:11303 E:11317 ||| CC
reseeding  ||| S:11317 E:11327 ||| NN
into  ||| S:11327 E:11332 ||| IN
fresh  ||| S:11332 E:11338 ||| JJ
medium  ||| S:11338 E:11345 ||| NN
induced  ||| S:11345 E:11353 ||| VBD
a  ||| S:11353 E:11355 ||| DT
burst  ||| S:11355 E:11361 ||| NN
of  ||| S:11361 E:11364 ||| IN
IDO  ||| S:11364 E:11378 ||| NNP
expression  ||| S:11378 E:11389 ||| NN
irrespective  ||| S:11389 E:11402 ||| NN
of  ||| S:11402 E:11405 ||| IN
whether  ||| S:11405 E:11413 ||| IN
cells  ||| S:11413 E:11419 ||| NNS
reassociated  ||| S:11419 E:11442 ||| VBN
with  ||| S:11442 E:11447 ||| IN
tissue  ||| S:11447 E:11454 ||| NN
culture  ||| S:11454 E:11462 ||| NN
substrate  ||| S:11462 E:11472 ||| NNS
or  ||| S:11472 E:11475 ||| CC
other  ||| S:11475 E:11481 ||| JJ
cells ||| S:11481 E:11486 ||| NNS
.  ||| S:11486 E:11488 ||| .
Aggregating  ||| S:11488 E:11510 ||| JJ
cells  ||| S:11510 E:11516 ||| NNS
in  ||| S:11516 E:11519 ||| IN
the  ||| S:11519 E:11523 ||| DT
presence  ||| S:11523 E:11532 ||| NN
of  ||| S:11532 E:11535 ||| IN
10  ||| S:11535 E:11538 ||| CD
-6M  ||| S:11538 E:11542 ||| CD
RA ||| S:11542 E:11544 ||| NNP
,  ||| S:11544 E:11546 ||| ,
which  ||| S:11546 E:11552 ||| WDT
induces  ||| S:11552 E:11570 ||| VBZ
neuronal  ||| S:11570 E:11579 ||| JJ
differentiation  ||| S:11579 E:11595 ||| NNS
also  ||| S:11595 E:11600 ||| RB
induced  ||| S:11600 E:11608 ||| VBN
a  ||| S:11608 E:11610 ||| DT
transient  ||| S:11610 E:11620 ||| JJ
burst  ||| S:11620 E:11636 ||| NN
of  ||| S:11636 E:11639 ||| IN
IDO  ||| S:11639 E:11643 ||| NNP
transcription  ||| S:11643 E:11657 ||| NN
but  ||| S:11657 E:11661 ||| CC
the  ||| S:11661 E:11665 ||| DT
period  ||| S:11665 E:11672 ||| NN
was  ||| S:11672 E:11676 ||| VBD
shorter  ||| S:11676 E:11684 ||| JJR
and  ||| S:11684 E:11688 ||| CC
the  ||| S:11688 E:11702 ||| DT
peak  ||| S:11702 E:11707 ||| NN
level  ||| S:11707 E:11713 ||| NN
observed  ||| S:11713 E:11722 ||| NNS
was  ||| S:11722 E:11726 ||| VBD
lower  ||| S:11726 E:11732 ||| JJR
than  ||| S:11732 E:11737 ||| IN
that  ||| S:11737 E:11742 ||| WDT
observed  ||| S:11742 E:11751 ||| VBD
with  ||| S:11751 E:11766 ||| IN
DMSO ||| S:11766 E:11770 ||| NNP
.  ||| S:11770 E:11782 ||| .
To  ||| S:11782 E:11785 ||| TO
determine  ||| S:11785 E:11795 ||| VB
if  ||| S:11795 E:11798 ||| IN
IDO  ||| S:11798 E:11802 ||| NNP
expression  ||| S:11802 E:11813 ||| NN
was  ||| S:11813 E:11817 ||| VBD
related  ||| S:11817 E:11825 ||| VBN
to  ||| S:11825 E:11828 ||| TO
the  ||| S:11828 E:11842 ||| DT
removal  ||| S:11842 E:11850 ||| NN
of  ||| S:11850 E:11853 ||| IN
cells  ||| S:11853 E:11859 ||| NNS
from  ||| S:11859 E:11864 ||| IN
their  ||| S:11864 E:11870 ||| PRP$
normal  ||| S:11870 E:11877 ||| JJ
growth  ||| S:11877 E:11884 ||| NN
substrate  ||| S:11884 E:11894 ||| NNS
or  ||| S:11894 E:11907 ||| CC
the  ||| S:11907 E:11911 ||| DT
process  ||| S:11911 E:11919 ||| NN
of  ||| S:11919 E:11922 ||| IN
reattachment  ||| S:11922 E:11935 ||| VBG
to  ||| S:11935 E:11938 ||| TO
new  ||| S:11938 E:11942 ||| JJ
substrate ||| S:11942 E:11951 ||| NN
,  ||| S:11951 E:11953 ||| ,
we  ||| S:11953 E:11966 ||| PRP
trypsinized  ||| S:11966 E:11978 ||| VBD
P19  ||| S:11978 E:11982 ||| CD
cells  ||| S:11982 E:11988 ||| NNS
and  ||| S:11988 E:11992 ||| CC
reseeded  ||| S:11992 E:12001 ||| VBD
them  ||| S:12001 E:12006 ||| PRP
as  ||| S:12006 E:12009 ||| IN
aggregates  ||| S:12009 E:12020 ||| NNS
in  ||| S:12020 E:12033 ||| IN
suspension  ||| S:12033 E:12044 ||| NN
in  ||| S:12044 E:12047 ||| IN
the  ||| S:12047 E:12051 ||| DT
presence  ||| S:12051 E:12060 ||| NN
of  ||| S:12060 E:12063 ||| IN
various  ||| S:12063 E:12071 ||| JJ
concentrations  ||| S:12071 E:12086 ||| NNS
of  ||| S:12086 E:12099 ||| IN
EGTA ||| S:12099 E:12103 ||| NNP
.  ||| S:12103 E:12105 ||| .
EGTA  ||| S:12105 E:12110 ||| NNP
chelates  ||| S:12110 E:12119 ||| VBD
essential  ||| S:12119 E:12129 ||| JJ
Ca  ||| S:12129 E:12132 ||| JJ
2+required  ||| S:12132 E:12143 ||| NN
by  ||| S:12143 E:12146 ||| IN
cadherin  ||| S:12146 E:12165 ||| JJ
molecules  ||| S:12165 E:12175 ||| NNS
and  ||| S:12175 E:12179 ||| CC
inhibits  ||| S:12179 E:12188 ||| JJ
cell  ||| S:12188 E:12193 ||| NN
adhesion ||| S:12193 E:12201 ||| NN
.  ||| S:12201 E:12203 ||| .
We  ||| S:12203 E:12206 ||| PRP
observed  ||| S:12206 E:12215 ||| VBD
a  ||| S:12215 E:12227 ||| DT
concentration  ||| S:12227 E:12241 ||| NN
dependent  ||| S:12241 E:12251 ||| JJ
decrease  ||| S:12251 E:12260 ||| NN
in  ||| S:12260 E:12263 ||| IN
IDO  ||| S:12263 E:12267 ||| NNP
expression  ||| S:12267 E:12278 ||| NN
in  ||| S:12278 E:12291 ||| IN
EGTA  ||| S:12291 E:12296 ||| NNP
treated  ||| S:12296 E:12304 ||| VBD
samples  ||| S:12304 E:12312 ||| CD
24  ||| S:12312 E:12315 ||| CD
hours  ||| S:12315 E:12321 ||| NNS
after  ||| S:12321 E:12327 ||| IN
seeding ||| S:12327 E:12334 ||| NN
,  ||| S:12334 E:12336 ||| ,
which  ||| S:12336 E:12352 ||| WDT
paralleled  ||| S:12352 E:12363 ||| VBZ
a  ||| S:12363 E:12365 ||| DT
corresponding  ||| S:12365 E:12379 ||| JJ
decrease  ||| S:12379 E:12388 ||| NN
in  ||| S:12388 E:12391 ||| IN
cell  ||| S:12391 E:12396 ||| NN
aggregation  ||| S:12396 E:12418 ||| NNS
( ||| S:12418 E:12419 ||| -LRB-
Fig  ||| S:12419 E:12423 ||| NNP
4C ||| S:12423 E:12425 ||| NNP
) ||| S:12425 E:12426 ||| -RRB-
.  ||| S:12426 E:12428 ||| .
Therefore ||| S:12428 E:12437 ||| RB
,  ||| S:12437 E:12439 ||| ,
IDO  ||| S:12439 E:12443 ||| NNP
expression  ||| S:12443 E:12454 ||| NN
appeared  ||| S:12454 E:12463 ||| VBD
to  ||| S:12463 E:12466 ||| TO
be  ||| S:12466 E:12479 ||| VB
induced  ||| S:12479 E:12487 ||| VBN
by  ||| S:12487 E:12490 ||| IN
reattachment ||| S:12490 E:12502 ||| NN
,  ||| S:12502 E:12504 ||| ,
rather  ||| S:12504 E:12511 ||| RB
than  ||| S:12511 E:12516 ||| IN
detachment  ||| S:12516 E:12527 ||| NN
from  ||| S:12527 E:12532 ||| IN
a  ||| S:12532 E:12544 ||| DT
previous  ||| S:12544 E:12553 ||| JJ
substrate ||| S:12553 E:12562 ||| NN
.  ||| S:12562 E:12564 ||| .
Thus ||| S:12564 E:12568 ||| RB
,  ||| S:12568 E:12570 ||| ,
IDO  ||| S:12570 E:12574 ||| NNP
is  ||| S:12574 E:12577 ||| VBZ
thus  ||| S:12577 E:12582 ||| RB
expressed  ||| S:12582 E:12602 ||| VBD
endogenously  ||| S:12602 E:12615 ||| VBN
in  ||| S:12615 E:12618 ||| IN
various  ||| S:12618 E:12626 ||| JJ
cell  ||| S:12626 E:12631 ||| NN
types  ||| S:12631 E:12637 ||| NNS
and  ||| S:12637 E:12641 ||| CC
is  ||| S:12641 E:12644 ||| VBZ
induced  ||| S:12644 E:12652 ||| VBN
during  ||| S:12652 E:12669 ||| IN
cell  ||| S:12669 E:12674 ||| NN
attachment  ||| S:12674 E:12685 ||| NN
to  ||| S:12685 E:12688 ||| TO
growth  ||| S:12688 E:12695 ||| NN
substrates ||| S:12695 E:12705 ||| NN
.  ||| S:12705 E:12735 ||| .
Inhibition  ||| S:12735 E:12746 ||| NNP
of  ||| S:12746 E:12749 ||| IN
endogenous  ||| S:12749 E:12760 ||| FW
IDO  ||| S:12760 E:12764 ||| FW
expression  ||| S:12764 E:12775 ||| FW
disrupts  ||| S:12775 E:12794 ||| FW
P19  ||| S:12794 E:12798 ||| FW
cell  ||| S:12798 E:12803 ||| FW
adhesion  ||| S:12803 E:12822 ||| FW
To  ||| S:12822 E:12825 ||| TO
examine  ||| S:12825 E:12833 ||| VB
the  ||| S:12833 E:12837 ||| DT
role  ||| S:12837 E:12842 ||| NN
of  ||| S:12842 E:12845 ||| IN
IDO  ||| S:12845 E:12849 ||| NNP
expression  ||| S:12849 E:12860 ||| NN
in  ||| S:12860 E:12863 ||| IN
P19  ||| S:12863 E:12867 ||| CD
cells ||| S:12867 E:12872 ||| NNS
,  ||| S:12872 E:12874 ||| ,
we  ||| S:12874 E:12887 ||| PRP
transfected  ||| S:12887 E:12899 ||| VBD
P19  ||| S:12899 E:12903 ||| CD
cells  ||| S:12903 E:12909 ||| NNS
with  ||| S:12909 E:12914 ||| IN
a  ||| S:12914 E:12916 ||| DT
DNA  ||| S:12916 E:12920 ||| NN
construct  ||| S:12920 E:12930 ||| NNS
which  ||| S:12930 E:12946 ||| WDT
contained  ||| S:12946 E:12956 ||| VBD
a  ||| S:12956 E:12958 ||| DT
740  ||| S:12958 E:12962 ||| CD
bp  ||| S:12962 E:12965 ||| JJ
fragment  ||| S:12965 E:12974 ||| NN
of  ||| S:12974 E:12977 ||| IN
murine  ||| S:12977 E:12984 ||| JJ
IDO  ||| S:12984 E:12988 ||| NNP
cDNA  ||| S:12988 E:12993 ||| NNP
in  ||| S:12993 E:12996 ||| IN
the  ||| S:12996 E:13010 ||| DT
antisense  ||| S:13010 E:13020 ||| JJ
orientation ||| S:13020 E:13031 ||| NN
,  ||| S:13031 E:13033 ||| ,
under  ||| S:13033 E:13039 ||| IN
the  ||| S:13039 E:13043 ||| DT
control  ||| S:13043 E:13051 ||| NN
of  ||| S:13051 E:13054 ||| IN
the  ||| S:13054 E:13068 ||| DT
constitutively  ||| S:13068 E:13083 ||| JJ
active  ||| S:13083 E:13090 ||| JJ
CMV  ||| S:13090 E:13094 ||| NNP
promoter  ||| S:13094 E:13103 ||| NN
in  ||| S:13103 E:13106 ||| IN
the  ||| S:13106 E:13110 ||| DT
pcDNA-3  ||| S:13110 E:13128 ||| JJ
mammalian  ||| S:13128 E:13138 ||| JJ
expression  ||| S:13138 E:13149 ||| NN
vector ||| S:13149 E:13155 ||| NN
.  ||| S:13155 E:13157 ||| .
As  ||| S:13157 E:13160 ||| IN
control ||| S:13160 E:13167 ||| NN
,  ||| S:13167 E:13169 ||| ,
the  ||| S:13169 E:13173 ||| DT
IDO  ||| S:13173 E:13177 ||| NNP
gene  ||| S:13177 E:13192 ||| NN
fragment  ||| S:13192 E:13201 ||| NN
was  ||| S:13201 E:13205 ||| VBD
cloned  ||| S:13205 E:13212 ||| VBN
in  ||| S:13212 E:13215 ||| IN
a  ||| S:13215 E:13217 ||| DT
sense  ||| S:13217 E:13223 ||| NN
orientation ||| S:13223 E:13234 ||| NN
.  ||| S:13234 E:13236 ||| .
To  ||| S:13236 E:13239 ||| TO
confirm  ||| S:13239 E:13257 ||| VB
that  ||| S:13257 E:13262 ||| DT
transfected ||| S:13262 E:13273 ||| NN
,  ||| S:13273 E:13275 ||| ,
G418  ||| S:13275 E:13280 ||| FW
resistant  ||| S:13280 E:13290 ||| FW
P19  ||| S:13290 E:13294 ||| FW
cells  ||| S:13294 E:13300 ||| FW
expressed  ||| S:13300 E:13310 ||| FW
IDO  ||| S:13310 E:13324 ||| FW
antisense  ||| S:13324 E:13334 ||| FW
transcripts ||| S:13334 E:13345 ||| FW
,  ||| S:13345 E:13347 ||| ,
we  ||| S:13347 E:13350 ||| PRP
isolated  ||| S:13350 E:13359 ||| VBD
total  ||| S:13359 E:13365 ||| JJ
RNA  ||| S:13365 E:13369 ||| NNP
from  ||| S:13369 E:13374 ||| IN
G418  ||| S:13374 E:13389 ||| CD
resistant  ||| S:13389 E:13399 ||| JJ
clones ||| S:13399 E:13405 ||| NNS
,  ||| S:13405 E:13407 ||| ,
reverse  ||| S:13407 E:13415 ||| RB
transcribed  ||| S:13415 E:13427 ||| VB
it  ||| S:13427 E:13430 ||| PRP
into  ||| S:13430 E:13435 ||| IN
cDNA  ||| S:13435 E:13440 ||| JJ
using  ||| S:13440 E:13456 ||| VBG
a  ||| S:13456 E:13458 ||| DT
sense  ||| S:13458 E:13464 ||| NN
primer  ||| S:13464 E:13471 ||| VBZ
then  ||| S:13471 E:13476 ||| RB
PCR  ||| S:13476 E:13480 ||| VBP
amplified  ||| S:13480 E:13490 ||| VBN
the  ||| S:13490 E:13494 ||| DT
cDNA ||| S:13494 E:13498 ||| JJ
.  ||| S:13498 E:13500 ||| .
Three  ||| S:13500 E:13516 ||| CD
antisense-transfected  ||| S:13516 E:13538 ||| JJ
clones ||| S:13538 E:13544 ||| NNS
,  ||| S:13544 E:13546 ||| ,
which  ||| S:13546 E:13552 ||| WDT
expressed  ||| S:13552 E:13572 ||| VBD
progressively  ||| S:13572 E:13586 ||| RB
greater  ||| S:13586 E:13594 ||| JJR
amounts  ||| S:13594 E:13602 ||| NNS
of  ||| S:13602 E:13605 ||| IN
IDO  ||| S:13605 E:13609 ||| NNP
antisense  ||| S:13609 E:13619 ||| VBD
RNA  ||| S:13619 E:13623 ||| NNP
were  ||| S:13623 E:13638 ||| VBD
selected  ||| S:13638 E:13647 ||| VBN
for  ||| S:13647 E:13651 ||| IN
further  ||| S:13651 E:13659 ||| JJ
analysis  ||| S:13659 E:13668 ||| NN
together  ||| S:13668 E:13677 ||| RB
with  ||| S:13677 E:13682 ||| IN
a  ||| S:13682 E:13684 ||| DT
sense  ||| S:13684 E:13700 ||| NN
control  ||| S:13700 E:13708 ||| NN
( ||| S:13708 E:13709 ||| -LRB-
Fig  ||| S:13709 E:13713 ||| NNP
4D ||| S:13713 E:13715 ||| NNP
) ||| S:13715 E:13716 ||| -RRB-
.  ||| S:13716 E:13718 ||| .
The  ||| S:13718 E:13722 ||| DT
ability  ||| S:13722 E:13730 ||| NN
of  ||| S:13730 E:13733 ||| IN
the  ||| S:13733 E:13737 ||| DT
sense  ||| S:13737 E:13743 ||| NN
and  ||| S:13743 E:13747 ||| CC
antisense  ||| S:13747 E:13767 ||| JJ
transfectants  ||| S:13767 E:13781 ||| NN
to  ||| S:13781 E:13784 ||| TO
deplete  ||| S:13784 E:13792 ||| VB
tryptophan  ||| S:13792 E:13803 ||| VBN
from  ||| S:13803 E:13808 ||| IN
culture  ||| S:13808 E:13816 ||| NN
medium  ||| S:13816 E:13833 ||| NN
was  ||| S:13833 E:13837 ||| VBD
determined  ||| S:13837 E:13848 ||| VBN
following  ||| S:13848 E:13858 ||| VBG
48  ||| S:13858 E:13861 ||| CD
hours  ||| S:13861 E:13867 ||| NNS
in  ||| S:13867 E:13870 ||| IN
culture ||| S:13870 E:13877 ||| NN
.  ||| S:13877 E:13879 ||| .
IDO  ||| S:13879 E:13883 ||| NNP
sense  ||| S:13883 E:13899 ||| NN
transfected  ||| S:13899 E:13911 ||| VBD
P19  ||| S:13911 E:13915 ||| CD
cells  ||| S:13915 E:13921 ||| NNS
depleted  ||| S:13921 E:13930 ||| VBD
10 ||| S:13930 E:13932 ||| CD
%  ||| S:13932 E:13934 ||| NN
of  ||| S:13934 E:13937 ||| IN
available  ||| S:13937 E:13947 ||| JJ
culture  ||| S:13947 E:13965 ||| NN
tryptophan  ||| S:13965 E:13976 ||| NNS
( ||| S:13976 E:13977 ||| -LRB-
not  ||| S:13977 E:13981 ||| RB
shown ||| S:13981 E:13986 ||| VBN
)  ||| S:13986 E:13988 ||| -RRB-
while  ||| S:13988 E:13994 ||| IN
IDO  ||| S:13994 E:13998 ||| NNP
antisense  ||| S:13998 E:14008 ||| FW
transfected  ||| S:14008 E:14030 ||| FW
P19  ||| S:14030 E:14034 ||| FW
clones  ||| S:14034 E:14041 ||| NNS
which  ||| S:14041 E:14047 ||| WDT
expressed  ||| S:14047 E:14057 ||| VBD
high  ||| S:14057 E:14062 ||| JJ
levels  ||| S:14062 E:14069 ||| NNS
of  ||| S:14069 E:14072 ||| IN
antisense  ||| S:14072 E:14092 ||| NNS
( ||| S:14092 E:14093 ||| -LRB-
clones  ||| S:14093 E:14100 ||| FW
D3  ||| S:14100 E:14103 ||| FW
and  ||| S:14103 E:14107 ||| CC
E6 ||| S:14107 E:14109 ||| CD
)  ||| S:14109 E:14111 ||| -RRB-
depleted  ||| S:14111 E:14120 ||| VBD
essentially  ||| S:14120 E:14132 ||| RB
no  ||| S:14132 E:14135 ||| DT
tryptophan  ||| S:14135 E:14156 ||| NN
from  ||| S:14156 E:14161 ||| IN
the  ||| S:14161 E:14165 ||| DT
medium ||| S:14165 E:14171 ||| NN
.  ||| S:14171 E:14173 ||| .
Clone  ||| S:14173 E:14179 ||| NNP
C2 ||| S:14179 E:14181 ||| NNP
,  ||| S:14181 E:14183 ||| ,
which  ||| S:14183 E:14189 ||| WDT
expressed  ||| S:14189 E:14199 ||| VBD
low  ||| S:14199 E:14203 ||| JJ
levels  ||| S:14203 E:14210 ||| NNS
of  ||| S:14210 E:14223 ||| IN
IDO  ||| S:14223 E:14227 ||| NNP
antisense ||| S:14227 E:14236 ||| NN
,  ||| S:14236 E:14238 ||| ,
depleted  ||| S:14238 E:14247 ||| VBN
similar  ||| S:14247 E:14255 ||| JJ
levels  ||| S:14255 E:14262 ||| NNS
of  ||| S:14262 E:14265 ||| IN
tryptophan  ||| S:14265 E:14276 ||| VBG
to  ||| S:14276 E:14289 ||| TO
the  ||| S:14289 E:14293 ||| DT
sense  ||| S:14293 E:14299 ||| NN
control ||| S:14299 E:14306 ||| NN
.  ||| S:14306 E:14308 ||| .
Therefore ||| S:14308 E:14317 ||| RB
,  ||| S:14317 E:14319 ||| ,
the  ||| S:14319 E:14323 ||| DT
burst  ||| S:14323 E:14329 ||| NN
of  ||| S:14329 E:14332 ||| IN
IDO  ||| S:14332 E:14346 ||| NNP
expression ||| S:14346 E:14356 ||| NN
,  ||| S:14356 E:14358 ||| ,
which  ||| S:14358 E:14364 ||| WDT
takes  ||| S:14364 E:14370 ||| VBZ
place  ||| S:14370 E:14376 ||| NN
in  ||| S:14376 E:14379 ||| IN
cells  ||| S:14379 E:14385 ||| NNS
during  ||| S:14385 E:14402 ||| IN
reattachment  ||| S:14402 E:14415 ||| NN
does  ||| S:14415 E:14420 ||| VBZ
not  ||| S:14420 E:14424 ||| RB
result  ||| S:14424 E:14431 ||| VB
in  ||| S:14431 E:14434 ||| IN
substantial  ||| S:14434 E:14446 ||| JJ
tryptophan  ||| S:14446 E:14467 ||| JJ
depletion  ||| S:14467 E:14477 ||| NN
from  ||| S:14477 E:14482 ||| IN
culture  ||| S:14482 E:14490 ||| FW
medium  ||| S:14490 E:14507 ||| FW
IDO  ||| S:14507 E:14511 ||| FW
antisense-transfected  ||| S:14511 E:14533 ||| FW
clones  ||| S:14533 E:14540 ||| FW
D3  ||| S:14540 E:14543 ||| FW
and  ||| S:14543 E:14547 ||| CC
E6  ||| S:14547 E:14550 ||| NNP
exhibited  ||| S:14550 E:14560 ||| VBD
a  ||| S:14560 E:14572 ||| DT
different  ||| S:14572 E:14582 ||| JJ
phenotype  ||| S:14582 E:14592 ||| NNS
compared  ||| S:14592 E:14601 ||| VBN
to  ||| S:14601 E:14604 ||| TO
untransfected  ||| S:14604 E:14618 ||| VB
and  ||| S:14618 E:14622 ||| CC
sense  ||| S:14622 E:14638 ||| NN
transfected  ||| S:14638 E:14650 ||| VBD
P19  ||| S:14650 E:14654 ||| CD
cells  ||| S:14654 E:14660 ||| NNS
( ||| S:14660 E:14661 ||| -LRB-
Fig  ||| S:14661 E:14665 ||| NNP
5A ||| S:14665 E:14667 ||| NNP
, ||| S:14667 E:14668 ||| ,
B ||| S:14668 E:14669 ||| NNP
, ||| S:14669 E:14670 ||| ,
C ||| S:14670 E:14671 ||| NNP
) ||| S:14671 E:14672 ||| -RRB-
.  ||| S:14672 E:14674 ||| .
IDO  ||| S:14674 E:14678 ||| NNP
antisense  ||| S:14678 E:14698 ||| VBZ
expressing  ||| S:14698 E:14709 ||| VBG
clones  ||| S:14709 E:14716 ||| NNS
developed  ||| S:14716 E:14726 ||| VBD
a  ||| S:14726 E:14728 ||| DT
rounded  ||| S:14728 E:14736 ||| JJ
appearance  ||| S:14736 E:14747 ||| NN
with  ||| S:14747 E:14752 ||| IN
a  ||| S:14752 E:14764 ||| DT
more  ||| S:14764 E:14769 ||| RBR
scattered  ||| S:14769 E:14779 ||| JJ
morphology  ||| S:14779 E:14790 ||| NN
and  ||| S:14790 E:14794 ||| CC
apparent  ||| S:14794 E:14803 ||| JJ
loss  ||| S:14803 E:14808 ||| NN
of  ||| S:14808 E:14811 ||| IN
cell  ||| S:14811 E:14826 ||| NN
interaction  ||| S:14826 E:14838 ||| VBZ
instead  ||| S:14838 E:14846 ||| RB
of  ||| S:14846 E:14849 ||| IN
the  ||| S:14849 E:14853 ||| DT
usual ||| S:14853 E:14858 ||| JJ
,  ||| S:14858 E:14860 ||| ,
adherent  ||| S:14860 E:14869 ||| FW
P19  ||| S:14869 E:14873 ||| FW
phenotype ||| S:14873 E:14882 ||| FW
.  ||| S:14882 E:14894 ||| .
The  ||| S:14894 E:14898 ||| DT
degree  ||| S:14898 E:14905 ||| NN
to  ||| S:14905 E:14908 ||| TO
which  ||| S:14908 E:14914 ||| WDT
this  ||| S:14914 E:14919 ||| DT
phenotype  ||| S:14919 E:14929 ||| JJ
manifested ||| S:14929 E:14939 ||| NN
,  ||| S:14939 E:14941 ||| ,
correlated  ||| S:14941 E:14962 ||| VBG
with  ||| S:14962 E:14967 ||| IN
the  ||| S:14967 E:14971 ||| DT
extent  ||| S:14971 E:14978 ||| NN
of  ||| S:14978 E:14981 ||| IN
IDO  ||| S:14981 E:14985 ||| NNP
antisense  ||| S:14985 E:14995 ||| JJ
expression ||| S:14995 E:15005 ||| NN
,  ||| S:15005 E:15007 ||| ,
i.e.  ||| S:15007 E:15012 ||| VBZ
it  ||| S:15012 E:15015 ||| PRP
was  ||| S:15015 E:15029 ||| VBD
prominent  ||| S:15029 E:15039 ||| JJ
in  ||| S:15039 E:15042 ||| IN
clone  ||| S:15042 E:15048 ||| JJ
E6  ||| S:15048 E:15051 ||| NN
and  ||| S:15051 E:15055 ||| CC
D3  ||| S:15055 E:15058 ||| CD
while  ||| S:15058 E:15064 ||| IN
clone  ||| S:15064 E:15070 ||| JJ
C2  ||| S:15070 E:15073 ||| NN
was  ||| S:15073 E:15087 ||| VBD
indistinguishable  ||| S:15087 E:15105 ||| VBN
from  ||| S:15105 E:15110 ||| IN
sense-transfected  ||| S:15110 E:15128 ||| JJ
controls ||| S:15128 E:15136 ||| NNS
.  ||| S:15136 E:15148 ||| .
However  ||| S:15148 E:15156 ||| RB
growth  ||| S:15156 E:15163 ||| NN
rates  ||| S:15163 E:15169 ||| NNS
were  ||| S:15169 E:15174 ||| VBD
largely  ||| S:15174 E:15182 ||| RB
unaltered ||| S:15182 E:15191 ||| JJ
.  ||| S:15191 E:15203 ||| .
IDO-antisense  ||| S:15203 E:15217 ||| NNP
and  ||| S:15217 E:15221 ||| CC
sense  ||| S:15221 E:15227 ||| NN
transfectants  ||| S:15227 E:15241 ||| NNS
were  ||| S:15241 E:15246 ||| VBD
aggregated  ||| S:15246 E:15257 ||| VBN
in  ||| S:15257 E:15270 ||| IN
1 ||| S:15270 E:15271 ||| CD
%  ||| S:15271 E:15273 ||| NN
DMSO  ||| S:15273 E:15278 ||| NNP
and  ||| S:15278 E:15282 ||| CC
cell  ||| S:15282 E:15287 ||| NN
aggregates  ||| S:15287 E:15298 ||| NNS
were  ||| S:15298 E:15303 ||| VBD
visualized  ||| S:15303 E:15314 ||| VBN
by  ||| S:15314 E:15317 ||| IN
phase  ||| S:15317 E:15333 ||| NN
contrast  ||| S:15333 E:15342 ||| NN
microscopy ||| S:15342 E:15352 ||| NN
.  ||| S:15352 E:15354 ||| .
Sense  ||| S:15354 E:15360 ||| NN
or  ||| S:15360 E:15363 ||| CC
untransfected  ||| S:15363 E:15377 ||| CD
P19  ||| S:15377 E:15381 ||| CD
cells  ||| S:15381 E:15397 ||| NNS
aggregated  ||| S:15397 E:15408 ||| VBP
normally  ||| S:15408 E:15417 ||| RB
as  ||| S:15417 E:15420 ||| RB
tightly  ||| S:15420 E:15428 ||| RB
packed  ||| S:15428 E:15435 ||| VBN
spheroid  ||| S:15435 E:15444 ||| JJ
bodies ||| S:15444 E:15450 ||| NNS
.  ||| S:15450 E:15452 ||| .
In  ||| S:15452 E:15465 ||| IN
contrast ||| S:15465 E:15473 ||| NN
,  ||| S:15473 E:15475 ||| ,
antisense  ||| S:15475 E:15485 ||| NNS
transfectants  ||| S:15485 E:15499 ||| VBP
formed  ||| S:15499 E:15506 ||| VBN
aggregates ||| S:15506 E:15516 ||| NNS
,  ||| S:15516 E:15528 ||| ,
which  ||| S:15528 E:15534 ||| WDT
exhibited  ||| S:15534 E:15544 ||| VBP
markedly  ||| S:15544 E:15553 ||| RB
different  ||| S:15553 E:15563 ||| JJ
morphologies  ||| S:15563 E:15576 ||| NN
and  ||| S:15576 E:15590 ||| CC
differed  ||| S:15590 E:15599 ||| NN
from  ||| S:15599 E:15604 ||| IN
sense-transfected  ||| S:15604 E:15622 ||| JJ
aggregates  ||| S:15622 E:15633 ||| NNS
in  ||| S:15633 E:15636 ||| IN
two  ||| S:15636 E:15650 ||| CD
principal  ||| S:15650 E:15660 ||| JJ
respects ||| S:15660 E:15668 ||| NNS
;  ||| S:15668 E:15670 ||| :
shape  ||| S:15670 E:15676 ||| NN
and  ||| S:15676 E:15680 ||| CC
size  ||| S:15680 E:15685 ||| NN
( ||| S:15685 E:15686 ||| -LRB-
Fig  ||| S:15686 E:15690 ||| NNP
5D ||| S:15690 E:15692 ||| NNP
, ||| S:15692 E:15693 ||| ,
E ||| S:15693 E:15694 ||| NNP
, ||| S:15694 E:15695 ||| ,
F ||| S:15695 E:15696 ||| NNP
) ||| S:15696 E:15697 ||| -RRB-
.  ||| S:15697 E:15699 ||| .
At  ||| S:15699 E:15702 ||| IN
30  ||| S:15702 E:15715 ||| CD
hours  ||| S:15715 E:15721 ||| NNS
after  ||| S:15721 E:15727 ||| IN
seeding  ||| S:15727 E:15735 ||| JJ
suspension  ||| S:15735 E:15746 ||| NN
cultures ||| S:15746 E:15754 ||| NNS
,  ||| S:15754 E:15756 ||| ,
cells  ||| S:15756 E:15762 ||| NNS
formed  ||| S:15762 E:15779 ||| VBD
irregular  ||| S:15779 E:15789 ||| JJ
shaped ||| S:15789 E:15795 ||| NN
,  ||| S:15795 E:15797 ||| ,
non-spherical  ||| S:15797 E:15811 ||| JJ
aggregates  ||| S:15811 E:15822 ||| NNS
that  ||| S:15822 E:15827 ||| WDT
were  ||| S:15827 E:15832 ||| VBD
less  ||| S:15832 E:15847 ||| RBR
tightly  ||| S:15847 E:15855 ||| RB
packed  ||| S:15855 E:15862 ||| VBN
than  ||| S:15862 E:15867 ||| IN
control  ||| S:15867 E:15875 ||| NN
aggregates ||| S:15875 E:15885 ||| NNS
.  ||| S:15885 E:15887 ||| .
Antisense  ||| S:15887 E:15897 ||| FW
clone  ||| S:15897 E:15913 ||| FW
E6  ||| S:15913 E:15916 ||| FW
( ||| S:15916 E:15917 ||| -LRB-
shown  ||| S:15917 E:15923 ||| VBN
in  ||| S:15923 E:15926 ||| IN
Fig.  ||| S:15926 E:15931 ||| CD
5F ||| S:15931 E:15933 ||| CD
)  ||| S:15933 E:15935 ||| -RRB-
produced  ||| S:15935 E:15944 ||| VBD
aggregates  ||| S:15944 E:15955 ||| NNS
which  ||| S:15955 E:15961 ||| WDT
were  ||| S:15961 E:15966 ||| VBD
only  ||| S:15966 E:15981 ||| RB
loosely  ||| S:15981 E:15989 ||| RB
packed  ||| S:15989 E:15996 ||| VBN
and  ||| S:15996 E:16000 ||| CC
a  ||| S:16000 E:16002 ||| DT
substantial  ||| S:16002 E:16014 ||| JJ
number  ||| S:16014 E:16021 ||| NN
of  ||| S:16021 E:16024 ||| IN
cells  ||| S:16024 E:16030 ||| NNS
which  ||| S:16030 E:16046 ||| WDT
did  ||| S:16046 E:16050 ||| VBD
not  ||| S:16050 E:16054 ||| RB
package  ||| S:16054 E:16062 ||| NN
into  ||| S:16062 E:16067 ||| IN
any  ||| S:16067 E:16071 ||| DT
form  ||| S:16071 E:16076 ||| NN
of  ||| S:16076 E:16079 ||| IN
aggregate  ||| S:16079 E:16089 ||| NN
while  ||| S:16089 E:16105 ||| IN
antisense  ||| S:16105 E:16115 ||| JJ
clone  ||| S:16115 E:16121 ||| NNS
D3  ||| S:16121 E:16124 ||| VBP
formed  ||| S:16124 E:16131 ||| VBN
aggregates  ||| S:16131 E:16142 ||| NNS
more  ||| S:16142 E:16147 ||| RBR
diverse  ||| S:16147 E:16155 ||| JJ
in  ||| S:16155 E:16168 ||| IN
shape  ||| S:16168 E:16174 ||| NN
than  ||| S:16174 E:16179 ||| IN
the  ||| S:16179 E:16183 ||| DT
uniformly  ||| S:16183 E:16193 ||| JJ
spherical  ||| S:16193 E:16203 ||| JJ
controls  ||| S:16203 E:16212 ||| NNS
but  ||| S:16212 E:16216 ||| CC
less  ||| S:16216 E:16231 ||| RBR
diverse  ||| S:16231 E:16239 ||| JJ
than  ||| S:16239 E:16244 ||| IN
clone  ||| S:16244 E:16250 ||| CD
E6 ||| S:16250 E:16252 ||| CD
.  ||| S:16252 E:16254 ||| .
Clone  ||| S:16254 E:16260 ||| NNP
C2  ||| S:16260 E:16263 ||| NNP
produced  ||| S:16263 E:16272 ||| VBD
aggregates  ||| S:16272 E:16293 ||| JJ
similar  ||| S:16293 E:16301 ||| JJ
to  ||| S:16301 E:16304 ||| TO
sense  ||| S:16304 E:16310 ||| VB
transfected  ||| S:16310 E:16322 ||| JJ
controls  ||| S:16322 E:16331 ||| NNS
( ||| S:16331 E:16332 ||| -LRB-
not  ||| S:16332 E:16336 ||| RB
shown ||| S:16336 E:16341 ||| VBN
) ||| S:16341 E:16342 ||| -RRB-
.  ||| S:16342 E:16354 ||| .
To  ||| S:16354 E:16357 ||| TO
quantitate  ||| S:16357 E:16368 ||| VB
and  ||| S:16368 E:16372 ||| CC
compare  ||| S:16372 E:16380 ||| VB
the  ||| S:16380 E:16384 ||| DT
size  ||| S:16384 E:16389 ||| NN
difference  ||| S:16389 E:16400 ||| NN
between  ||| S:16400 E:16418 ||| IN
sense  ||| S:16418 E:16424 ||| NN
and  ||| S:16424 E:16428 ||| CC
antisense-transfected  ||| S:16428 E:16450 ||| JJ
aggregates  ||| S:16450 E:16461 ||| NNS
we  ||| S:16461 E:16474 ||| PRP
photographed  ||| S:16474 E:16487 ||| JJ
sense  ||| S:16487 E:16493 ||| NN
and  ||| S:16493 E:16497 ||| CC
antisense  ||| S:16497 E:16507 ||| CD
clone  ||| S:16507 E:16513 ||| CD
5  ||| S:16513 E:16515 ||| CD
aggregates  ||| S:16515 E:16526 ||| NNS
and  ||| S:16526 E:16540 ||| CC
calculated  ||| S:16540 E:16551 ||| VBN
the  ||| S:16551 E:16555 ||| DT
area  ||| S:16555 E:16560 ||| NN
of  ||| S:16560 E:16563 ||| IN
each  ||| S:16563 E:16568 ||| DT
aggregate  ||| S:16568 E:16578 ||| JJ
individually  ||| S:16578 E:16591 ||| NNS
( ||| S:16591 E:16592 ||| -LRB-
Fig.  ||| S:16592 E:16607 ||| NNP
5G ||| S:16607 E:16609 ||| NNP
) ||| S:16609 E:16610 ||| -RRB-
.  ||| S:16610 E:16612 ||| .
Antisense  ||| S:16612 E:16622 ||| JJ
aggregates  ||| S:16622 E:16633 ||| NNS
were  ||| S:16633 E:16638 ||| VBD
small ||| S:16638 E:16643 ||| JJ
,  ||| S:16643 E:16645 ||| ,
predominantly  ||| S:16645 E:16659 ||| RB
in  ||| S:16659 E:16672 ||| IN
the  ||| S:16672 E:16676 ||| DT
0.2-0.4  ||| S:16676 E:16684 ||| CD
sq.  ||| S:16684 E:16688 ||| CD
inch  ||| S:16688 E:16693 ||| NN
size  ||| S:16693 E:16698 ||| NN
range ||| S:16698 E:16703 ||| NN
,  ||| S:16703 E:16705 ||| ,
whereas  ||| S:16705 E:16713 ||| IN
control  ||| S:16713 E:16731 ||| NN
aggregate  ||| S:16731 E:16741 ||| NN
sizes  ||| S:16741 E:16747 ||| NNS
were  ||| S:16747 E:16752 ||| VBD
spread  ||| S:16752 E:16759 ||| VBN
over  ||| S:16759 E:16764 ||| IN
a  ||| S:16764 E:16766 ||| DT
much  ||| S:16766 E:16771 ||| RB
broader  ||| S:16771 E:16779 ||| JJR
range ||| S:16779 E:16784 ||| NN
.  ||| S:16784 E:16796 ||| .
The  ||| S:16796 E:16800 ||| DT
mean  ||| S:16800 E:16805 ||| JJ
size  ||| S:16805 E:16810 ||| NN
of  ||| S:16810 E:16813 ||| IN
antisense-transfected  ||| S:16813 E:16835 ||| JJ
aggregates  ||| S:16835 E:16846 ||| NNS
was  ||| S:16846 E:16860 ||| VBD
0.31  ||| S:16860 E:16865 ||| CD
sq.  ||| S:16865 E:16869 ||| CD
inches ||| S:16869 E:16875 ||| NNS
,  ||| S:16875 E:16877 ||| ,
while  ||| S:16877 E:16883 ||| IN
sense  ||| S:16883 E:16889 ||| NN
transfected  ||| S:16889 E:16901 ||| NN
controls  ||| S:16901 E:16910 ||| NNS
had  ||| S:16910 E:16914 ||| VBD
a  ||| S:16914 E:16926 ||| DT
mean  ||| S:16926 E:16931 ||| NN
of  ||| S:16931 E:16934 ||| IN
0.69  ||| S:16934 E:16939 ||| CD
sq.  ||| S:16939 E:16943 ||| CD
inches  ||| S:16943 E:16950 ||| NNS
( ||| S:16950 E:16951 ||| -LRB-
p  ||| S:16951 E:16953 ||| FW
< ||| S:16953 E:16955 ||| SYM
0.0001 ||| S:16955 E:16961 ||| FW
) ||| S:16961 E:16962 ||| -RRB-
.  ||| S:16962 E:16964 ||| .
The  ||| S:16964 E:16968 ||| DT
effect  ||| S:16968 E:16975 ||| NN
of  ||| S:16975 E:16988 ||| IN
IDO  ||| S:16988 E:16992 ||| NNP
inhibition  ||| S:16992 E:17003 ||| NN
on  ||| S:17003 E:17006 ||| IN
cell  ||| S:17006 E:17011 ||| NN
adhesion  ||| S:17011 E:17020 ||| NNS
was  ||| S:17020 E:17024 ||| VBD
demonstrated  ||| S:17024 E:17037 ||| VBN
by  ||| S:17037 E:17050 ||| IN
performing  ||| S:17050 E:17061 ||| VBG
cell  ||| S:17061 E:17066 ||| NN
migration  ||| S:17066 E:17076 ||| NN
assays ||| S:17076 E:17082 ||| NN
.  ||| S:17082 E:17084 ||| .
P19  ||| S:17084 E:17088 ||| NNP
cells  ||| S:17088 E:17094 ||| NNS
were  ||| S:17094 E:17099 ||| VBD
seeded  ||| S:17099 E:17116 ||| VBN
into  ||| S:17116 E:17121 ||| IN
porous  ||| S:17121 E:17128 ||| JJ
tissue  ||| S:17128 E:17135 ||| NN
culture  ||| S:17135 E:17143 ||| NN
inserts  ||| S:17143 E:17151 ||| NNS
placed  ||| S:17151 E:17158 ||| VBN
in  ||| S:17158 E:17161 ||| IN
a  ||| S:17161 E:17163 ||| DT
24  ||| S:17163 E:17166 ||| CD
well  ||| S:17166 E:17181 ||| RB
tissue  ||| S:17181 E:17188 ||| JJ
culture  ||| S:17188 E:17196 ||| NN
plate  ||| S:17196 E:17202 ||| NN
and  ||| S:17202 E:17206 ||| CC
cell  ||| S:17206 E:17211 ||| NN
migration  ||| S:17211 E:17221 ||| NN
to  ||| S:17221 E:17224 ||| TO
the  ||| S:17224 E:17228 ||| DT
lower  ||| S:17228 E:17244 ||| JJR
chamber  ||| S:17244 E:17252 ||| NN
in  ||| S:17252 E:17255 ||| IN
the  ||| S:17255 E:17259 ||| DT
absence  ||| S:17259 E:17267 ||| NN
of  ||| S:17267 E:17270 ||| IN
any  ||| S:17270 E:17274 ||| DT
stimulus  ||| S:17274 E:17283 ||| NN
was  ||| S:17283 E:17287 ||| VBD
determined ||| S:17287 E:17297 ||| VBN
.  ||| S:17297 E:17309 ||| .
Approximately  ||| S:17309 E:17323 ||| RB
12 ||| S:17323 E:17325 ||| CD
%  ||| S:17325 E:17327 ||| NN
of  ||| S:17327 E:17330 ||| IN
clone  ||| S:17330 E:17336 ||| CD
E6  ||| S:17336 E:17339 ||| CD
cells  ||| S:17339 E:17345 ||| NNS
migrated  ||| S:17345 E:17354 ||| VBP
to  ||| S:17354 E:17357 ||| TO
the  ||| S:17357 E:17361 ||| DT
lower  ||| S:17361 E:17377 ||| JJR
chamber  ||| S:17377 E:17385 ||| NN
18  ||| S:17385 E:17388 ||| CD
hours  ||| S:17388 E:17394 ||| NNS
after  ||| S:17394 E:17400 ||| IN
seeding  ||| S:17400 E:17408 ||| NN
into  ||| S:17408 E:17413 ||| IN
the  ||| S:17413 E:17417 ||| DT
upper  ||| S:17417 E:17423 ||| JJ
chamber  ||| S:17423 E:17441 ||| NN
( ||| S:17441 E:17442 ||| -LRB-
Fig.  ||| S:17442 E:17447 ||| NNP
5H ||| S:17447 E:17449 ||| NNP
) ||| S:17449 E:17450 ||| -RRB-
.  ||| S:17450 E:17452 ||| .
In  ||| S:17452 E:17455 ||| IN
contrast ||| S:17455 E:17463 ||| NN
,  ||| S:17463 E:17465 ||| ,
less  ||| S:17465 E:17470 ||| CC
than1 ||| S:17470 E:17475 ||| CD
%  ||| S:17475 E:17477 ||| NN
of  ||| S:17477 E:17480 ||| IN
control  ||| S:17480 E:17488 ||| NN
cells  ||| S:17488 E:17494 ||| NNS
had  ||| S:17494 E:17508 ||| VBD
migrated  ||| S:17508 E:17517 ||| VBN
in  ||| S:17517 E:17520 ||| IN
the  ||| S:17520 E:17524 ||| DT
same  ||| S:17524 E:17529 ||| JJ
period ||| S:17529 E:17535 ||| NN
.  ||| S:17535 E:17537 ||| .
Clones  ||| S:17537 E:17544 ||| NNP
C2  ||| S:17544 E:17547 ||| NNP
and  ||| S:17547 E:17551 ||| CC
D3  ||| S:17551 E:17554 ||| NNP
produced  ||| S:17554 E:17573 ||| VBD
intermediate  ||| S:17573 E:17586 ||| JJ
levels  ||| S:17586 E:17593 ||| NNS
of  ||| S:17593 E:17596 ||| IN
migration ||| S:17596 E:17605 ||| NN
.  ||| S:17605 E:17607 ||| .
When  ||| S:17607 E:17612 ||| WRB
inserts  ||| S:17612 E:17620 ||| NNS
were  ||| S:17620 E:17635 ||| VBD
coated  ||| S:17635 E:17642 ||| VBN
with  ||| S:17642 E:17647 ||| IN
Matrigel ||| S:17647 E:17655 ||| NNP
,  ||| S:17655 E:17657 ||| ,
no  ||| S:17657 E:17660 ||| DT
significant  ||| S:17660 E:17672 ||| JJ
migration  ||| S:17672 E:17682 ||| NN
was  ||| S:17682 E:17686 ||| VBD
seen  ||| S:17686 E:17701 ||| VBN
in  ||| S:17701 E:17704 ||| IN
either  ||| S:17704 E:17711 ||| DT
antisense  ||| S:17711 E:17721 ||| NN
or  ||| S:17721 E:17724 ||| CC
sense  ||| S:17724 E:17730 ||| NN
transfectants ||| S:17730 E:17743 ||| NN
,  ||| S:17743 E:17745 ||| ,
indicating  ||| S:17745 E:17766 ||| VBG
that  ||| S:17766 E:17771 ||| DT
cell  ||| S:17771 E:17776 ||| NN
motility  ||| S:17776 E:17785 ||| NNS
could  ||| S:17785 E:17791 ||| MD
be  ||| S:17791 E:17794 ||| VB
inhibited  ||| S:17794 E:17804 ||| VBN
by  ||| S:17804 E:17807 ||| IN
supplying  ||| S:17807 E:17817 ||| VBG
an  ||| S:17817 E:17830 ||| DT
extracellular  ||| S:17830 E:17844 ||| JJ
matrix ||| S:17844 E:17850 ||| NN
.  ||| S:17850 E:17880 ||| .
IDO  ||| S:17880 E:17884 ||| NNP
axpression  ||| S:17884 E:17895 ||| FW
alters  ||| S:17895 E:17902 ||| FW
metalloproteinase  ||| S:17902 E:17930 ||| FW
expression  ||| S:17930 E:17951 ||| FW
The  ||| S:17951 E:17955 ||| DT
altered  ||| S:17955 E:17963 ||| JJ
adhesion  ||| S:17963 E:17972 ||| NN
of  ||| S:17972 E:17975 ||| IN
IDO-expressing  ||| S:17975 E:17990 ||| NNP
RAW  ||| S:17990 E:17994 ||| NNP
cells  ||| S:17994 E:18000 ||| NNS
to  ||| S:18000 E:18013 ||| TO
collagen  ||| S:18013 E:18022 ||| VB
suggested  ||| S:18022 E:18032 ||| VBN
that  ||| S:18032 E:18037 ||| IN
IDO  ||| S:18037 E:18041 ||| NNP
might  ||| S:18041 E:18047 ||| MD
induce  ||| S:18047 E:18054 ||| VB
alterations  ||| S:18054 E:18066 ||| VBN
in  ||| S:18066 E:18079 ||| IN
enzymes  ||| S:18079 E:18087 ||| VBG
involved  ||| S:18087 E:18096 ||| VBN
in  ||| S:18096 E:18099 ||| IN
modifying  ||| S:18099 E:18109 ||| VBG
the  ||| S:18109 E:18113 ||| DT
extracellular  ||| S:18113 E:18127 ||| JJ
matrix ||| S:18127 E:18133 ||| NN
.  ||| S:18133 E:18145 ||| .
Therefore ||| S:18145 E:18154 ||| RB
,  ||| S:18154 E:18156 ||| ,
we  ||| S:18156 E:18159 ||| PRP
investigated  ||| S:18159 E:18172 ||| VBD
whether  ||| S:18172 E:18180 ||| IN
inhibition  ||| S:18180 E:18191 ||| NN
of  ||| S:18191 E:18194 ||| IN
IDO  ||| S:18194 E:18208 ||| NNP
expression  ||| S:18208 E:18219 ||| NN
in  ||| S:18219 E:18222 ||| IN
the  ||| S:18222 E:18226 ||| DT
P19  ||| S:18226 E:18241 ||| NN
in  ||| S:18241 E:18244 ||| IN
vitro  ||| S:18244 E:18250 ||| JJ
aggregation  ||| S:18250 E:18262 ||| JJ
system  ||| S:18262 E:18269 ||| NN
and  ||| S:18269 E:18273 ||| CC
the  ||| S:18273 E:18287 ||| DT
constitutive  ||| S:18287 E:18300 ||| JJ
overexpression  ||| S:18300 E:18315 ||| NN
of  ||| S:18315 E:18318 ||| IN
IDO  ||| S:18318 E:18322 ||| NNP
in  ||| S:18322 E:18325 ||| IN
RAW  ||| S:18325 E:18329 ||| NNP
cells  ||| S:18329 E:18335 ||| NNS
had  ||| S:18335 E:18339 ||| VBD
any  ||| S:18339 E:18353 ||| DT
effect  ||| S:18353 E:18360 ||| NN
on  ||| S:18360 E:18363 ||| IN
MMP  ||| S:18363 E:18367 ||| NNP
expression ||| S:18367 E:18377 ||| NN
.  ||| S:18377 E:18379 ||| .
We  ||| S:18379 E:18382 ||| PRP
allowed  ||| S:18382 E:18390 ||| VBD
the  ||| S:18390 E:18394 ||| DT
sense  ||| S:18394 E:18400 ||| NN
and  ||| S:18400 E:18414 ||| CC
three-antisense  ||| S:18414 E:18430 ||| JJ
expressing  ||| S:18430 E:18441 ||| JJ
clones  ||| S:18441 E:18448 ||| NNS
of  ||| S:18448 E:18451 ||| IN
P19  ||| S:18451 E:18455 ||| CD
to  ||| S:18455 E:18458 ||| TO
aggregate  ||| S:18458 E:18468 ||| VB
in  ||| S:18468 E:18481 ||| IN
1 ||| S:18481 E:18482 ||| CD
% ||| S:18482 E:18483 ||| NN
.  ||| S:18483 E:18485 ||| .
DMSO  ||| S:18485 E:18490 ||| NNP
for  ||| S:18490 E:18494 ||| IN
24  ||| S:18494 E:18497 ||| CD
hours ||| S:18497 E:18502 ||| NNS
,  ||| S:18502 E:18504 ||| ,
before  ||| S:18504 E:18511 ||| IN
harvesting  ||| S:18511 E:18522 ||| JJ
total  ||| S:18522 E:18528 ||| JJ
RNA  ||| S:18528 E:18532 ||| NNP
and  ||| S:18532 E:18546 ||| CC
determining  ||| S:18546 E:18558 ||| VBG
expression  ||| S:18558 E:18569 ||| NN
of  ||| S:18569 E:18572 ||| IN
various  ||| S:18572 E:18580 ||| JJ
MMP  ||| S:18580 E:18584 ||| NN
genes ||| S:18584 E:18589 ||| NNS
,  ||| S:18589 E:18591 ||| ,
including  ||| S:18591 E:18612 ||| VBG
stromelysins  ||| S:18612 E:18625 ||| CD
1  ||| S:18625 E:18627 ||| CD
( ||| S:18627 E:18628 ||| -LRB-
MMP-3 ||| S:18628 E:18633 ||| NNP
) ||| S:18633 E:18634 ||| -RRB-
,  ||| S:18634 E:18647 ||| ,
2  ||| S:18647 E:18649 ||| CD
( ||| S:18649 E:18650 ||| -LRB-
MMP-10 ||| S:18650 E:18656 ||| NNP
)  ||| S:18656 E:18658 ||| -RRB-
and  ||| S:18658 E:18673 ||| CC
3  ||| S:18673 E:18675 ||| CD
( ||| S:18675 E:18676 ||| -LRB-
MMP-11 ||| S:18676 E:18682 ||| NNP
) ||| S:18682 E:18683 ||| -RRB-
,  ||| S:18683 E:18696 ||| ,
collagenases  ||| S:18696 E:18709 ||| VBD
I  ||| S:18709 E:18711 ||| PRP
( ||| S:18711 E:18712 ||| -LRB-
MMP-1 ||| S:18712 E:18717 ||| NNP
)  ||| S:18717 E:18719 ||| -RRB-
and  ||| S:18719 E:18734 ||| CC
IV  ||| S:18734 E:18737 ||| NNP
( ||| S:18737 E:18738 ||| -LRB-
MMP-2 ||| S:18738 E:18743 ||| NNP
)  ||| S:18743 E:18745 ||| -RRB-
and  ||| S:18745 E:18760 ||| CC
meltrins  ||| S:18760 E:18769 ||| JJ
α  ||| S:18769 E:18771 ||| NNS
( ||| S:18771 E:18772 ||| -LRB-
ADAM-12 ||| S:18772 E:18779 ||| NNP
)  ||| S:18779 E:18781 ||| -RRB-
and  ||| S:18781 E:18785 ||| CC
β  ||| S:18785 E:18797 ||| NNS
( ||| S:18797 E:18798 ||| -LRB-
ADAM-19 ||| S:18798 E:18805 ||| NNP
) ||| S:18805 E:18806 ||| -RRB-
.  ||| S:18806 E:18819 ||| .
Meltrin  ||| S:18819 E:18827 ||| JJ
α  ||| S:18827 E:18829 ||| NN
is  ||| S:18829 E:18832 ||| VBZ
expressed  ||| S:18832 E:18853 ||| VBN
in  ||| S:18853 E:18856 ||| IN
vivo  ||| S:18856 E:18861 ||| NN
during  ||| S:18861 E:18868 ||| IN
development  ||| S:18868 E:18880 ||| NN
in  ||| S:18880 E:18893 ||| IN
condensed  ||| S:18893 E:18903 ||| JJ
mesenchymal  ||| S:18903 E:18915 ||| JJ
cells  ||| S:18915 E:18921 ||| NNS
that  ||| S:18921 E:18926 ||| WDT
give  ||| S:18926 E:18931 ||| VBP
rise  ||| S:18931 E:18936 ||| NN
to  ||| S:18936 E:18939 ||| TO
skeletal  ||| S:18939 E:18958 ||| VB
muscle  ||| S:18958 E:18965 ||| NN
while  ||| S:18965 E:18971 ||| IN
meltrin  ||| S:18971 E:18979 ||| JJ
β  ||| S:18979 E:18981 ||| NN
is  ||| S:18981 E:18984 ||| VBZ
expressed  ||| S:18984 E:18994 ||| VBN
in  ||| S:18994 E:18997 ||| IN
craniofacial  ||| S:18997 E:19010 ||| NN
and  ||| S:19010 E:19024 ||| CC
dorsal  ||| S:19024 E:19031 ||| FW
root  ||| S:19031 E:19036 ||| FW
ganglia  ||| S:19036 E:19044 ||| FW
where  ||| S:19044 E:19050 ||| FW
neuronal  ||| S:19050 E:19059 ||| FW
lineages  ||| S:19059 E:19068 ||| FW
differentiate  ||| S:19068 E:19092 ||| FW
[  ||| S:19092 E:19094 ||| -LRB-
26 ||| S:19094 E:19096 ||| CD
] ||| S:19096 E:19097 ||| -RRB-
.  ||| S:19097 E:19099 ||| .
Expression  ||| S:19099 E:19110 ||| NN
of  ||| S:19110 E:19124 ||| IN
stromelysin  ||| S:19124 E:19136 ||| JJ
s-  ||| S:19136 E:19150 ||| JJ
1  ||| S:19150 E:19152 ||| CD
and  ||| S:19152 E:19167 ||| CC
3  ||| S:19167 E:19169 ||| CD
and  ||| S:19169 E:19184 ||| CC
meltrin  ||| S:19184 E:19192 ||| JJ
α  ||| S:19192 E:19194 ||| NN
,  ||| S:19194 E:19196 ||| ,
was  ||| S:19196 E:19200 ||| VBD
increased  ||| S:19200 E:19210 ||| VBN
in  ||| S:19210 E:19223 ||| IN
antisense-expressing  ||| S:19223 E:19244 ||| JJ
aggregates ||| S:19244 E:19254 ||| NNS
,  ||| S:19254 E:19256 ||| ,
relative  ||| S:19256 E:19265 ||| JJ
to  ||| S:19265 E:19268 ||| TO
the  ||| S:19268 E:19272 ||| DT
sense  ||| S:19272 E:19288 ||| NN
control  ||| S:19288 E:19296 ||| NN
( ||| S:19296 E:19297 ||| -LRB-
Fig  ||| S:19297 E:19301 ||| NNP
6A ||| S:19301 E:19303 ||| NNP
) ||| S:19303 E:19304 ||| -RRB-
.  ||| S:19304 E:19306 ||| .
Furthermore ||| S:19306 E:19317 ||| RB
,  ||| S:19317 E:19319 ||| ,
there  ||| S:19319 E:19325 ||| EX
was  ||| S:19325 E:19329 ||| VBD
a  ||| S:19329 E:19331 ||| DT
progressive  ||| S:19331 E:19353 ||| JJ
increase  ||| S:19353 E:19362 ||| NN
in  ||| S:19362 E:19365 ||| IN
the  ||| S:19365 E:19369 ||| DT
expression  ||| S:19369 E:19380 ||| NN
level  ||| S:19380 E:19386 ||| NN
of  ||| S:19386 E:19389 ||| IN
these  ||| S:19389 E:19395 ||| DT
three  ||| S:19395 E:19401 ||| CD
protease  ||| S:19401 E:19420 ||| CD
genes ||| S:19420 E:19425 ||| NNS
,  ||| S:19425 E:19427 ||| ,
which  ||| S:19427 E:19433 ||| WDT
correlated  ||| S:19433 E:19444 ||| VBZ
with  ||| S:19444 E:19449 ||| IN
the  ||| S:19449 E:19453 ||| DT
amount  ||| S:19453 E:19460 ||| NN
of  ||| S:19460 E:19463 ||| IN
IDO  ||| S:19463 E:19467 ||| NNP
antisense  ||| S:19467 E:19487 ||| JJ
expression ||| S:19487 E:19497 ||| NN
.  ||| S:19497 E:19499 ||| .
In  ||| S:19499 E:19502 ||| IN
contrast ||| S:19502 E:19510 ||| NN
,  ||| S:19510 E:19512 ||| ,
the  ||| S:19512 E:19516 ||| DT
expression  ||| S:19516 E:19527 ||| NN
of  ||| S:19527 E:19541 ||| IN
meltri  ||| S:19541 E:19548 ||| JJ
n-β  ||| S:19548 E:19552 ||| JJ
and  ||| S:19552 E:19567 ||| CC
stromelysi  ||| S:19567 E:19578 ||| JJ
n-  ||| S:19578 E:19592 ||| JJ
2  ||| S:19592 E:19594 ||| CD
was  ||| S:19594 E:19598 ||| VBD
similar  ||| S:19598 E:19606 ||| JJ
in  ||| S:19606 E:19609 ||| IN
all  ||| S:19609 E:19613 ||| DT
samples  ||| S:19613 E:19621 ||| NNS
and  ||| S:19621 E:19635 ||| CC
expression  ||| S:19635 E:19646 ||| NN
of  ||| S:19646 E:19660 ||| IN
collagenase  ||| S:19660 E:19672 ||| VBG
I  ||| S:19672 E:19674 ||| PRP
or  ||| S:19674 E:19688 ||| CC
IV  ||| S:19688 E:19691 ||| NNP
was  ||| S:19691 E:19695 ||| VBD
undetectable  ||| S:19695 E:19708 ||| VBN
in  ||| S:19708 E:19711 ||| IN
either  ||| S:19711 E:19718 ||| DT
sense  ||| S:19718 E:19734 ||| NN
or  ||| S:19734 E:19737 ||| CC
antisense-expressing  ||| S:19737 E:19758 ||| JJ
aggregates  ||| S:19758 E:19769 ||| NNS
( ||| S:19769 E:19770 ||| -LRB-
not  ||| S:19770 E:19774 ||| RB
shown ||| S:19774 E:19779 ||| VBN
) ||| S:19779 E:19780 ||| -RRB-
.  ||| S:19780 E:19782 ||| .
Thus ||| S:19782 E:19786 ||| RB
,  ||| S:19786 E:19798 ||| ,
inhibition  ||| S:19798 E:19809 ||| VBG
of  ||| S:19809 E:19812 ||| IN
IDO  ||| S:19812 E:19816 ||| NNP
gene  ||| S:19816 E:19821 ||| NN
expression  ||| S:19821 E:19832 ||| NN
correlated  ||| S:19832 E:19843 ||| NN
with  ||| S:19843 E:19858 ||| IN
increased  ||| S:19858 E:19868 ||| JJ
expression  ||| S:19868 E:19879 ||| NN
of  ||| S:19879 E:19882 ||| IN
some  ||| S:19882 E:19887 ||| DT
but  ||| S:19887 E:19891 ||| CC
not  ||| S:19891 E:19895 ||| RB
all  ||| S:19895 E:19899 ||| DT
MMP  ||| S:19899 E:19903 ||| NNP
genes  ||| S:19903 E:19909 ||| NNS
in  ||| S:19909 E:19912 ||| IN
P19  ||| S:19912 E:19926 ||| CD
cells  ||| S:19926 E:19932 ||| NNS
undergoing  ||| S:19932 E:19943 ||| VBG
aggregation ||| S:19943 E:19954 ||| NNS
.  ||| S:19954 E:19956 ||| .
Furthermore ||| S:19956 E:19967 ||| RB
,  ||| S:19967 E:19969 ||| ,
increased  ||| S:19969 E:19979 ||| VBD
MMP  ||| S:19979 E:19993 ||| NNP
expression  ||| S:19993 E:20004 ||| NN
coincided  ||| S:20004 E:20014 ||| NN
with  ||| S:20014 E:20019 ||| IN
decreased  ||| S:20019 E:20029 ||| JJ
ability  ||| S:20029 E:20037 ||| NN
of  ||| S:20037 E:20040 ||| IN
P19  ||| S:20040 E:20044 ||| CD
cells  ||| S:20044 E:20060 ||| NNS
to  ||| S:20060 E:20063 ||| TO
aggregate  ||| S:20063 E:20073 ||| VB
in  ||| S:20073 E:20076 ||| IN
suspension  ||| S:20076 E:20087 ||| NN
culture ||| S:20087 E:20094 ||| NN
.  ||| S:20094 E:20096 ||| .
To  ||| S:20096 E:20099 ||| TO
determine  ||| S:20099 E:20109 ||| VB
whether  ||| S:20109 E:20127 ||| IN
IDO-expressing  ||| S:20127 E:20142 ||| NNP
RAW  ||| S:20142 E:20146 ||| NNP
cells  ||| S:20146 E:20152 ||| NNS
also  ||| S:20152 E:20157 ||| RB
showed  ||| S:20157 E:20164 ||| VBD
unusual  ||| S:20164 E:20172 ||| JJ
MMP  ||| S:20172 E:20186 ||| NNP
expression  ||| S:20186 E:20197 ||| NN
we  ||| S:20197 E:20200 ||| PRP
tested  ||| S:20200 E:20207 ||| VBD
the  ||| S:20207 E:20211 ||| DT
IDO-expressing  ||| S:20211 E:20226 ||| JJ
RAW  ||| S:20226 E:20230 ||| NNP
cell  ||| S:20230 E:20235 ||| NN
clones  ||| S:20235 E:20252 ||| NNS
for  ||| S:20252 E:20256 ||| IN
the  ||| S:20256 E:20260 ||| DT
same  ||| S:20260 E:20265 ||| JJ
group  ||| S:20265 E:20271 ||| NN
of  ||| S:20271 E:20274 ||| IN
MMPs  ||| S:20274 E:20279 ||| JJ
as  ||| S:20279 E:20282 ||| IN
P19  ||| S:20282 E:20286 ||| CD
cells ||| S:20286 E:20291 ||| NNS
.  ||| S:20291 E:20293 ||| .
Expression  ||| S:20293 E:20304 ||| NN
of  ||| S:20304 E:20317 ||| IN
all  ||| S:20317 E:20321 ||| DT
MMPs  ||| S:20321 E:20326 ||| NN
was  ||| S:20326 E:20330 ||| VBD
undetectable  ||| S:20330 E:20343 ||| VBN
except  ||| S:20343 E:20350 ||| IN
for  ||| S:20350 E:20354 ||| IN
collagenase  ||| S:20354 E:20366 ||| JJ
I.  ||| S:20366 E:20369 ||| NNP
This  ||| S:20369 E:20384 ||| NNP
showed  ||| S:20384 E:20391 ||| VBD
significant  ||| S:20391 E:20403 ||| JJ
expression  ||| S:20403 E:20414 ||| NN
in  ||| S:20414 E:20417 ||| IN
vector-only  ||| S:20417 E:20429 ||| JJ
controls  ||| S:20429 E:20438 ||| NNS
but  ||| S:20438 E:20452 ||| CC
little  ||| S:20452 E:20459 ||| JJ
or  ||| S:20459 E:20462 ||| CC
no  ||| S:20462 E:20465 ||| DT
expression  ||| S:20465 E:20476 ||| NN
in  ||| S:20476 E:20479 ||| IN
IDO-expressing  ||| S:20479 E:20494 ||| JJ
clones ||| S:20494 E:20500 ||| NNS
.  ||| S:20500 E:20502 ||| .
All  ||| S:20502 E:20516 ||| DT
IDO-expressing  ||| S:20516 E:20531 ||| JJ
clones  ||| S:20531 E:20538 ||| NNS
demonstrated  ||| S:20538 E:20551 ||| VBD
reduced  ||| S:20551 E:20559 ||| VBN
expression  ||| S:20559 E:20580 ||| NN
with  ||| S:20580 E:20585 ||| IN
no  ||| S:20585 E:20588 ||| DT
correlation  ||| S:20588 E:20600 ||| NN
to  ||| S:20600 E:20603 ||| TO
the  ||| S:20603 E:20607 ||| DT
level  ||| S:20607 E:20613 ||| NN
of  ||| S:20613 E:20616 ||| IN
IDO  ||| S:20616 E:20620 ||| NNP
expression  ||| S:20620 E:20631 ||| NN
( ||| S:20631 E:20632 ||| -LRB-
Fig  ||| S:20632 E:20646 ||| NNP
6B ||| S:20646 E:20648 ||| NNP
) ||| S:20648 E:20649 ||| -RRB-
.  ||| S:20649 E:20651 ||| .
Pharmacological  ||| S:20651 E:20667 ||| JJ
inhibition  ||| S:20667 E:20678 ||| NN
of  ||| S:20678 E:20681 ||| IN
MMP  ||| S:20681 E:20685 ||| NNP
activity  ||| S:20685 E:20694 ||| NN
in  ||| S:20694 E:20697 ||| IN
P19  ||| S:20697 E:20711 ||| CD
cells  ||| S:20711 E:20717 ||| NNS
using  ||| S:20717 E:20723 ||| VBG
the  ||| S:20723 E:20727 ||| DT
broad  ||| S:20727 E:20733 ||| JJ
spectrum ||| S:20733 E:20741 ||| NN
,  ||| S:20741 E:20743 ||| ,
hydroxamic  ||| S:20743 E:20754 ||| FW
acid-based  ||| S:20754 E:20765 ||| FW
MMP  ||| S:20765 E:20779 ||| FW
inhibitor  ||| S:20779 E:20789 ||| FW
GM  ||| S:20789 E:20792 ||| NNP
6001  ||| S:20792 E:20797 ||| CD
at  ||| S:20797 E:20800 ||| IN
concentrations  ||| S:20800 E:20815 ||| NNS
ranging  ||| S:20815 E:20823 ||| VBG
from  ||| S:20823 E:20828 ||| IN
1-30  ||| S:20828 E:20833 ||| NNP
μM ||| S:20833 E:20835 ||| NNP
,  ||| S:20835 E:20847 ||| ,
resulted  ||| S:20847 E:20856 ||| VBD
in  ||| S:20856 E:20859 ||| IN
partial  ||| S:20859 E:20867 ||| JJ
reversal  ||| S:20867 E:20876 ||| NN
of  ||| S:20876 E:20879 ||| IN
the  ||| S:20879 E:20883 ||| DT
poor  ||| S:20883 E:20888 ||| JJ
aggregation  ||| S:20888 E:20910 ||| NNS
shown  ||| S:20910 E:20916 ||| VBN
by  ||| S:20916 E:20919 ||| IN
IDO-AS  ||| S:20919 E:20926 ||| JJ
expressing  ||| S:20926 E:20937 ||| JJ
cells ||| S:20937 E:20942 ||| NNS
,  ||| S:20942 E:20944 ||| ,
with  ||| S:20944 E:20949 ||| IN
a  ||| S:20949 E:20951 ||| DT
maximal  ||| S:20951 E:20959 ||| JJ
effect  ||| S:20959 E:20976 ||| NN
shown  ||| S:20976 E:20982 ||| VBN
at  ||| S:20982 E:20985 ||| IN
20  ||| S:20985 E:20988 ||| CD
μM ||| S:20988 E:20990 ||| NN
,  ||| S:20990 E:20992 ||| ,
indicating  ||| S:20992 E:21003 ||| VBG
that  ||| S:21003 E:21008 ||| IN
changes  ||| S:21008 E:21016 ||| NNS
in  ||| S:21016 E:21019 ||| IN
MMP  ||| S:21019 E:21023 ||| NNP
expression  ||| S:21023 E:21044 ||| NN
were  ||| S:21044 E:21049 ||| VBD
responsible ||| S:21049 E:21060 ||| JJ
,  ||| S:21060 E:21062 ||| ,
at  ||| S:21062 E:21065 ||| IN
least  ||| S:21065 E:21071 ||| JJS
in  ||| S:21071 E:21074 ||| IN
part  ||| S:21074 E:21079 ||| NN
for  ||| S:21079 E:21083 ||| IN
altered  ||| S:21083 E:21091 ||| JJ
cell  ||| S:21091 E:21106 ||| NN
adhesion ||| S:21106 E:21114 ||| NN
.  ||| S:21114 E:21144 ||| .
IDO  ||| S:21144 E:21148 ||| NNP
regulates  ||| S:21148 E:21158 ||| VBZ
prostaglandin  ||| S:21158 E:21172 ||| JJ
synthesis  ||| S:21172 E:21192 ||| NN
To  ||| S:21192 E:21195 ||| TO
understand  ||| S:21195 E:21206 ||| VB
the  ||| S:21206 E:21210 ||| DT
mechanism  ||| S:21210 E:21220 ||| NN
of  ||| S:21220 E:21223 ||| IN
IDO  ||| S:21223 E:21227 ||| NNP
induced  ||| S:21227 E:21235 ||| VBD
alterations  ||| S:21235 E:21257 ||| VBN
in  ||| S:21257 E:21260 ||| IN
cell  ||| S:21260 E:21265 ||| NN
adhesion  ||| S:21265 E:21274 ||| NNS
and  ||| S:21274 E:21278 ||| CC
MMP  ||| S:21278 E:21282 ||| NNP
expression ||| S:21282 E:21292 ||| NN
,  ||| S:21292 E:21294 ||| ,
we  ||| S:21294 E:21297 ||| PRP
attempted  ||| S:21297 E:21307 ||| VBD
to  ||| S:21307 E:21320 ||| TO
reverse  ||| S:21320 E:21328 ||| VB
IDO  ||| S:21328 E:21332 ||| JJ
effects  ||| S:21332 E:21340 ||| NNS
on  ||| S:21340 E:21343 ||| IN
cell  ||| S:21343 E:21348 ||| NN
adhesion ||| S:21348 E:21356 ||| NN
.  ||| S:21356 E:21358 ||| .
As  ||| S:21358 E:21361 ||| RB
previously  ||| S:21361 E:21382 ||| RB
mentioned ||| S:21382 E:21391 ||| VBN
,  ||| S:21391 E:21393 ||| ,
tryptophan  ||| S:21393 E:21404 ||| NN
is  ||| S:21404 E:21407 ||| VBZ
not  ||| S:21407 E:21411 ||| RB
significantly  ||| S:21411 E:21425 ||| RB
depleted  ||| S:21425 E:21434 ||| VBN
in  ||| S:21434 E:21447 ||| IN
culture  ||| S:21447 E:21455 ||| NN
medium  ||| S:21455 E:21462 ||| NN
of  ||| S:21462 E:21465 ||| IN
RAW  ||| S:21465 E:21469 ||| NNP
cells  ||| S:21469 E:21475 ||| NNS
overexpressing  ||| S:21475 E:21490 ||| VBD
IDO ||| S:21490 E:21493 ||| NNP
,  ||| S:21493 E:21505 ||| ,
suggesting  ||| S:21505 E:21516 ||| VBG
that  ||| S:21516 E:21521 ||| IN
tryptophan  ||| S:21521 E:21532 ||| JJ
deprivation  ||| S:21532 E:21544 ||| NN
is  ||| S:21544 E:21547 ||| VBZ
not  ||| S:21547 E:21551 ||| RB
the  ||| S:21551 E:21555 ||| DT
cause  ||| S:21555 E:21571 ||| NN
of  ||| S:21571 E:21574 ||| IN
the  ||| S:21574 E:21578 ||| DT
IDO  ||| S:21578 E:21582 ||| NNP
effect ||| S:21582 E:21588 ||| NN
.  ||| S:21588 E:21590 ||| .
Consistent  ||| S:21590 E:21601 ||| JJ
with  ||| S:21601 E:21606 ||| IN
this ||| S:21606 E:21610 ||| DT
,  ||| S:21610 E:21612 ||| ,
adding  ||| S:21612 E:21619 ||| VBG
back  ||| S:21619 E:21634 ||| RB
tryptophan  ||| S:21634 E:21645 ||| VBN
to  ||| S:21645 E:21648 ||| TO
IDO-expressing  ||| S:21648 E:21663 ||| NNP
RAW  ||| S:21663 E:21667 ||| NNP
cells  ||| S:21667 E:21673 ||| NNS
did  ||| S:21673 E:21677 ||| VBD
not  ||| S:21677 E:21681 ||| RB
reverse  ||| S:21681 E:21699 ||| VB
the  ||| S:21699 E:21703 ||| DT
growth  ||| S:21703 E:21710 ||| NN
of  ||| S:21710 E:21713 ||| IN
macroscopic  ||| S:21713 E:21725 ||| JJ
foci ||| S:21725 E:21729 ||| NN
.  ||| S:21729 E:21731 ||| .
As  ||| S:21731 E:21734 ||| IN
tryptophan  ||| S:21734 E:21745 ||| NN
is  ||| S:21745 E:21748 ||| VBZ
not  ||| S:21748 E:21752 ||| RB
the  ||| S:21752 E:21766 ||| DT
only  ||| S:21766 E:21771 ||| JJ
substrate  ||| S:21771 E:21781 ||| NN
for  ||| S:21781 E:21785 ||| IN
IDO ||| S:21785 E:21788 ||| NNP
,  ||| S:21788 E:21790 ||| ,
we  ||| S:21790 E:21793 ||| PRP
also  ||| S:21793 E:21798 ||| RB
investigated  ||| S:21798 E:21811 ||| VBN
whether  ||| S:21811 E:21829 ||| IN
adding  ||| S:21829 E:21836 ||| VBG
serotonin  ||| S:21836 E:21846 ||| NNS
would  ||| S:21846 E:21852 ||| MD
overcome  ||| S:21852 E:21861 ||| VB
the  ||| S:21861 E:21865 ||| DT
effects  ||| S:21865 E:21873 ||| NNS
of  ||| S:21873 E:21876 ||| IN
IDO  ||| S:21876 E:21890 ||| NNP
expression ||| S:21890 E:21900 ||| NN
.  ||| S:21900 E:21902 ||| .
There  ||| S:21902 E:21908 ||| EX
was  ||| S:21908 E:21912 ||| VBD
a  ||| S:21912 E:21914 ||| DT
similar  ||| S:21914 E:21922 ||| JJ
lack  ||| S:21922 E:21927 ||| NN
of  ||| S:21927 E:21930 ||| IN
effect  ||| S:21930 E:21937 ||| NN
of  ||| S:21937 E:21940 ||| IN
this  ||| S:21940 E:21955 ||| DT
compound ||| S:21955 E:21963 ||| NN
.  ||| S:21963 E:21965 ||| .
This  ||| S:21965 E:21970 ||| DT
suggested  ||| S:21970 E:21980 ||| VBN
that  ||| S:21980 E:21985 ||| IN
depletion  ||| S:21985 E:21995 ||| NN
or  ||| S:21995 E:21998 ||| CC
reduction  ||| S:21998 E:22008 ||| NN
of  ||| S:22008 E:22021 ||| IN
an  ||| S:22021 E:22024 ||| DT
IDO  ||| S:22024 E:22028 ||| NNP
substrate  ||| S:22028 E:22038 ||| NN
was  ||| S:22038 E:22042 ||| VBD
probably  ||| S:22042 E:22051 ||| RB
not  ||| S:22051 E:22055 ||| RB
responsible  ||| S:22055 E:22067 ||| JJ
for  ||| S:22067 E:22071 ||| IN
the  ||| S:22071 E:22085 ||| DT
effects  ||| S:22085 E:22093 ||| NNS
described  ||| S:22093 E:22103 ||| VBD
here ||| S:22103 E:22107 ||| RB
.  ||| S:22107 E:22109 ||| .
An  ||| S:22109 E:22112 ||| DT
alternative  ||| S:22112 E:22124 ||| JJ
possibility  ||| S:22124 E:22136 ||| NN
was  ||| S:22136 E:22150 ||| VBD
that  ||| S:22150 E:22155 ||| IN
a  ||| S:22155 E:22157 ||| DT
biologically  ||| S:22157 E:22170 ||| JJ
active  ||| S:22170 E:22177 ||| JJ
downstream  ||| S:22177 E:22188 ||| JJ
catabolite  ||| S:22188 E:22199 ||| NN
of  ||| S:22199 E:22202 ||| IN
IDO  ||| S:22202 E:22216 ||| NNP
could  ||| S:22216 E:22222 ||| MD
be  ||| S:22222 E:22225 ||| VB
the  ||| S:22225 E:22229 ||| DT
cause ||| S:22229 E:22234 ||| NN
.  ||| S:22234 E:22236 ||| .
Therefore ||| S:22236 E:22245 ||| RB
,  ||| S:22245 E:22247 ||| ,
we  ||| S:22247 E:22250 ||| PRP
tested  ||| S:22250 E:22257 ||| VBD
the  ||| S:22257 E:22261 ||| DT
tryptophan  ||| S:22261 E:22282 ||| JJ
catabolites ||| S:22282 E:22293 ||| NN
,  ||| S:22293 E:22295 ||| ,
picolinic  ||| S:22295 E:22305 ||| JJ
acid  ||| S:22305 E:22310 ||| NN
and  ||| S:22310 E:22314 ||| CC
quinolinic  ||| S:22314 E:22325 ||| JJ
acid  ||| S:22325 E:22330 ||| NN
to  ||| S:22330 E:22333 ||| TO
see  ||| S:22333 E:22337 ||| VB
if  ||| S:22337 E:22350 ||| IN
they  ||| S:22350 E:22355 ||| PRP
could  ||| S:22355 E:22361 ||| MD
reproduce  ||| S:22361 E:22371 ||| VB
the  ||| S:22371 E:22375 ||| DT
effects  ||| S:22375 E:22383 ||| NNS
of  ||| S:22383 E:22386 ||| IN
IDO  ||| S:22386 E:22390 ||| NNP
overexpression ||| S:22390 E:22404 ||| NN
.  ||| S:22404 E:22416 ||| .
Picolinic  ||| S:22416 E:22426 ||| JJ
acid  ||| S:22426 E:22431 ||| NN
( ||| S:22431 E:22432 ||| -LRB-
1-6  ||| S:22432 E:22436 ||| NNP
mM ||| S:22436 E:22438 ||| NNP
)  ||| S:22438 E:22440 ||| -RRB-
produced  ||| S:22440 E:22449 ||| VBD
morphological  ||| S:22449 E:22463 ||| JJ
changes  ||| S:22463 E:22471 ||| NNS
in  ||| S:22471 E:22484 ||| IN
both  ||| S:22484 E:22489 ||| DT
MC57  ||| S:22489 E:22494 ||| NNP
and  ||| S:22494 E:22498 ||| CC
RAW  ||| S:22498 E:22502 ||| NNP
cells  ||| S:22502 E:22508 ||| NNS
and  ||| S:22508 E:22512 ||| CC
also  ||| S:22512 E:22517 ||| RB
substantial  ||| S:22517 E:22529 ||| JJ
reductions  ||| S:22529 E:22550 ||| NNS
in  ||| S:22550 E:22553 ||| IN
growth  ||| S:22553 E:22560 ||| NN
rate  ||| S:22560 E:22565 ||| NN
but  ||| S:22565 E:22569 ||| CC
did  ||| S:22569 E:22573 ||| VBD
not  ||| S:22573 E:22577 ||| RB
mimic  ||| S:22577 E:22583 ||| VB
the  ||| S:22583 E:22587 ||| DT
effects  ||| S:22587 E:22595 ||| NNS
of  ||| S:22595 E:22598 ||| IN
IDO  ||| S:22598 E:22612 ||| NNP
expression ||| S:22612 E:22622 ||| NN
.  ||| S:22622 E:22624 ||| .
In  ||| S:22624 E:22627 ||| IN
particular ||| S:22627 E:22637 ||| JJ
,  ||| S:22637 E:22639 ||| ,
at  ||| S:22639 E:22642 ||| IN
a  ||| S:22642 E:22644 ||| DT
concentration  ||| S:22644 E:22658 ||| NN
of  ||| S:22658 E:22661 ||| IN
2  ||| S:22661 E:22663 ||| CD
mM ||| S:22663 E:22665 ||| NN
,  ||| S:22665 E:22677 ||| ,
picolinic  ||| S:22677 E:22687 ||| JJ
acid  ||| S:22687 E:22692 ||| NN
induced  ||| S:22692 E:22700 ||| VBD
a  ||| S:22700 E:22702 ||| DT
more  ||| S:22702 E:22707 ||| RBR
flattened  ||| S:22707 E:22717 ||| JJ
phenotype ||| S:22717 E:22726 ||| NN
.  ||| S:22726 E:22728 ||| .
At  ||| S:22728 E:22741 ||| IN
concentrations  ||| S:22741 E:22756 ||| NNS
above  ||| S:22756 E:22762 ||| IN
6  ||| S:22762 E:22764 ||| CD
mM ||| S:22764 E:22766 ||| NN
,  ||| S:22766 E:22768 ||| ,
picolinic  ||| S:22768 E:22778 ||| JJ
acid-induced  ||| S:22778 E:22801 ||| JJ
apoptosis  ||| S:22801 E:22811 ||| NN
was  ||| S:22811 E:22815 ||| VBD
observed ||| S:22815 E:22823 ||| VBN
.  ||| S:22823 E:22825 ||| .
Quinolinic  ||| S:22825 E:22836 ||| JJ
acid  ||| S:22836 E:22841 ||| NN
was  ||| S:22841 E:22845 ||| VBD
essentially  ||| S:22845 E:22867 ||| RB
without  ||| S:22867 E:22875 ||| IN
effect  ||| S:22875 E:22882 ||| NN
at  ||| S:22882 E:22885 ||| IN
concentrations  ||| S:22885 E:22900 ||| VBG
up  ||| S:22900 E:22903 ||| RP
to  ||| S:22903 E:22906 ||| TO
10  ||| S:22906 E:22909 ||| CD
mM ||| S:22909 E:22911 ||| NN
.  ||| S:22911 E:22913 ||| .
Therefore ||| S:22913 E:22922 ||| RB
,  ||| S:22922 E:22934 ||| ,
the  ||| S:22934 E:22938 ||| DT
exact  ||| S:22938 E:22944 ||| JJ
mode  ||| S:22944 E:22949 ||| NN
of  ||| S:22949 E:22952 ||| IN
action  ||| S:22952 E:22959 ||| NN
of  ||| S:22959 E:22962 ||| IN
IDO  ||| S:22962 E:22966 ||| NNP
therefore  ||| S:22966 E:22976 ||| RB
remains  ||| S:22976 E:22984 ||| VBZ
to  ||| S:22984 E:22987 ||| TO
be  ||| S:22987 E:23000 ||| VB
determined ||| S:23000 E:23010 ||| VBN
.  ||| S:23010 E:23022 ||| .
Despite  ||| S:23022 E:23030 ||| IN
the  ||| S:23030 E:23034 ||| DT
uncertainty  ||| S:23034 E:23046 ||| NN
about  ||| S:23046 E:23052 ||| IN
the  ||| S:23052 E:23056 ||| DT
proximal  ||| S:23056 E:23065 ||| JJ
mediator  ||| S:23065 E:23074 ||| NN
of  ||| S:23074 E:23087 ||| IN
IDO ||| S:23087 E:23090 ||| NNP
's  ||| S:23090 E:23093 ||| POS
effect ||| S:23093 E:23099 ||| NN
,  ||| S:23099 E:23101 ||| ,
it  ||| S:23101 E:23104 ||| PRP
is  ||| S:23104 E:23107 ||| VBZ
known  ||| S:23107 E:23113 ||| VBN
that  ||| S:23113 E:23118 ||| IN
alterations  ||| S:23118 E:23130 ||| NN
in  ||| S:23130 E:23133 ||| IN
cell  ||| S:23133 E:23148 ||| NN
adhesion  ||| S:23148 E:23157 ||| NNS
and  ||| S:23157 E:23161 ||| CC
metalloproteinase  ||| S:23161 E:23179 ||| JJ
activity  ||| S:23179 E:23188 ||| NN
are  ||| S:23188 E:23192 ||| VBP
often  ||| S:23192 E:23208 ||| RB
associated  ||| S:23208 E:23219 ||| VBN
with  ||| S:23219 E:23224 ||| IN
changes  ||| S:23224 E:23232 ||| NNS
in  ||| S:23232 E:23235 ||| IN
prostaglandin  ||| S:23235 E:23249 ||| JJ
synthesis  ||| S:23249 E:23259 ||| NNS
[  ||| S:23259 E:23261 ||| -LRB-
27 ||| S:23261 E:23263 ||| CD
,  ||| S:23263 E:23275 ||| ,
28 ||| S:23275 E:23277 ||| CD
,  ||| S:23277 E:23279 ||| ,
29 ||| S:23279 E:23281 ||| CD
,  ||| S:23281 E:23283 ||| ,
30 ||| S:23283 E:23285 ||| CD
] ||| S:23285 E:23286 ||| -RRB-
.  ||| S:23286 E:23288 ||| .
Therefore ||| S:23288 E:23297 ||| RB
,  ||| S:23297 E:23299 ||| ,
we  ||| S:23299 E:23302 ||| PRP
analyzed  ||| S:23302 E:23311 ||| VBD
the  ||| S:23311 E:23315 ||| DT
spectrum  ||| S:23315 E:23324 ||| NN
of  ||| S:23324 E:23327 ||| IN
PGs  ||| S:23327 E:23341 ||| JJ
produced  ||| S:23341 E:23350 ||| VBN
by  ||| S:23350 E:23353 ||| IN
IDO-expressing  ||| S:23353 E:23368 ||| NNP
RAW  ||| S:23368 E:23372 ||| NNP
cells  ||| S:23372 E:23378 ||| NNS
using  ||| S:23378 E:23384 ||| VBG
thin  ||| S:23384 E:23389 ||| JJ
layer  ||| S:23389 E:23405 ||| NN
chromatography ||| S:23405 E:23419 ||| NN
.  ||| S:23419 E:23421 ||| .
PG  ||| S:23421 E:23424 ||| NNP
D  ||| S:23424 E:23437 ||| NNP
2  ||| S:23437 E:23439 ||| CD
was  ||| S:23439 E:23443 ||| VBD
the  ||| S:23443 E:23447 ||| DT
major  ||| S:23447 E:23453 ||| JJ
product  ||| S:23453 E:23461 ||| NN
of  ||| S:23461 E:23464 ||| IN
both  ||| S:23464 E:23479 ||| DT
vector-only  ||| S:23479 E:23491 ||| JJ
controls  ||| S:23491 E:23500 ||| NNS
and  ||| S:23500 E:23504 ||| CC
IDO-expressing  ||| S:23504 E:23519 ||| JJ
clone  ||| S:23519 E:23525 ||| NN
11 ||| S:23525 E:23527 ||| CD
,  ||| S:23527 E:23539 ||| ,
consistent  ||| S:23539 E:23550 ||| JJ
with  ||| S:23550 E:23555 ||| IN
reports  ||| S:23555 E:23563 ||| NNS
that  ||| S:23563 E:23568 ||| IN
D  ||| S:23568 E:23581 ||| NNP
2  ||| S:23581 E:23583 ||| CD
production  ||| S:23583 E:23594 ||| NN
is  ||| S:23594 E:23597 ||| VBZ
typical  ||| S:23597 E:23605 ||| JJ
of  ||| S:23605 E:23618 ||| IN
antigen-presenting  ||| S:23618 E:23637 ||| JJ
cells  ||| S:23637 E:23643 ||| NNS
[  ||| S:23643 E:23645 ||| -LRB-
31 ||| S:23645 E:23647 ||| CD
] ||| S:23647 E:23648 ||| -RRB-
.  ||| S:23648 E:23650 ||| .
There  ||| S:23650 E:23656 ||| EX
was  ||| S:23656 E:23660 ||| VBD
a  ||| S:23660 E:23662 ||| DT
greater  ||| S:23662 E:23670 ||| JJR
than  ||| S:23670 E:23685 ||| IN
50 ||| S:23685 E:23687 ||| CD
%  ||| S:23687 E:23689 ||| NN
reduction  ||| S:23689 E:23699 ||| NN
in  ||| S:23699 E:23702 ||| IN
PG  ||| S:23702 E:23705 ||| NNP
D  ||| S:23705 E:23718 ||| NNP
2  ||| S:23718 E:23720 ||| CD
production  ||| S:23720 E:23731 ||| NN
in  ||| S:23731 E:23734 ||| IN
clone  ||| S:23734 E:23740 ||| CD
11  ||| S:23740 E:23743 ||| CD
compared  ||| S:23743 E:23752 ||| VBN
with  ||| S:23752 E:23767 ||| IN
the  ||| S:23767 E:23771 ||| DT
vector  ||| S:23771 E:23778 ||| JJ
only  ||| S:23778 E:23783 ||| JJ
control  ||| S:23783 E:23791 ||| NN
and  ||| S:23791 E:23795 ||| CC
a  ||| S:23795 E:23797 ||| DT
similar  ||| S:23797 E:23805 ||| JJ
decrease  ||| S:23805 E:23814 ||| NN
in  ||| S:23814 E:23817 ||| IN
levels  ||| S:23817 E:23834 ||| NNS
of  ||| S:23834 E:23837 ||| IN
PGs  ||| S:23837 E:23841 ||| NNP
F  ||| S:23841 E:23854 ||| NNP
2α  ||| S:23854 E:23857 ||| NNP
,  ||| S:23857 E:23859 ||| ,
6keto-F  ||| S:23859 E:23878 ||| NNP
1α  ||| S:23878 E:23881 ||| NNP
and  ||| S:23881 E:23885 ||| CC
thromboxane  ||| S:23885 E:23897 ||| JJ
B  ||| S:23897 E:23910 ||| NNP
2  ||| S:23910 E:23912 ||| CD
in  ||| S:23912 E:23915 ||| IN
this  ||| S:23915 E:23920 ||| DT
clone  ||| S:23920 E:23926 ||| NN
( ||| S:23926 E:23927 ||| -LRB-
Fig  ||| S:23927 E:23931 ||| NNP
7A ||| S:23931 E:23933 ||| NNP
) ||| S:23933 E:23934 ||| -RRB-
.  ||| S:23934 E:23936 ||| .
However ||| S:23936 E:23943 ||| RB
,  ||| S:23943 E:23945 ||| ,
PG  ||| S:23945 E:23958 ||| NNP
E  ||| S:23958 E:23971 ||| NNP
2  ||| S:23971 E:23973 ||| CD
production  ||| S:23973 E:23984 ||| NN
was  ||| S:23984 E:23988 ||| VBD
affected  ||| S:23988 E:23997 ||| VBN
relatively  ||| S:23997 E:24018 ||| RB
little  ||| S:24018 E:24025 ||| RB
compared  ||| S:24025 E:24034 ||| VBN
to  ||| S:24034 E:24037 ||| TO
the  ||| S:24037 E:24041 ||| DT
other  ||| S:24041 E:24047 ||| JJ
PGs ||| S:24047 E:24050 ||| NN
.  ||| S:24050 E:24052 ||| .
Thus  ||| S:24052 E:24057 ||| RB
IDO  ||| S:24057 E:24061 ||| JJ
overexpression  ||| S:24061 E:24086 ||| NN
resulted  ||| S:24086 E:24095 ||| VBD
in  ||| S:24095 E:24098 ||| IN
an  ||| S:24098 E:24101 ||| DT
increase  ||| S:24101 E:24110 ||| NN
in  ||| S:24110 E:24113 ||| IN
PG  ||| S:24113 E:24116 ||| NNP
E  ||| S:24116 E:24129 ||| NNP
2  ||| S:24129 E:24131 ||| CD
relative  ||| S:24131 E:24140 ||| JJ
to  ||| S:24140 E:24143 ||| TO
the  ||| S:24143 E:24147 ||| DT
other  ||| S:24147 E:24153 ||| JJ
PGs ||| S:24153 E:24156 ||| NN
.  ||| S:24156 E:24158 ||| .
However ||| S:24158 E:24165 ||| RB
,  ||| S:24165 E:24177 ||| ,
in  ||| S:24177 E:24180 ||| IN
MC57  ||| S:24180 E:24185 ||| CD
cells ||| S:24185 E:24190 ||| NNS
,  ||| S:24190 E:24192 ||| ,
the  ||| S:24192 E:24196 ||| DT
prostaglandin  ||| S:24196 E:24210 ||| JJ
profile  ||| S:24210 E:24218 ||| NN
was  ||| S:24218 E:24222 ||| VBD
quite  ||| S:24222 E:24238 ||| RB
different  ||| S:24238 E:24248 ||| JJ
from  ||| S:24248 E:24253 ||| IN
that  ||| S:24253 E:24258 ||| DT
seen  ||| S:24258 E:24263 ||| VBN
in  ||| S:24263 E:24266 ||| IN
RAW  ||| S:24266 E:24270 ||| NNP
cells ||| S:24270 E:24275 ||| NNS
.  ||| S:24275 E:24277 ||| .
PG  ||| S:24277 E:24280 ||| NNP
E  ||| S:24280 E:24293 ||| NNP
2  ||| S:24293 E:24295 ||| CD
was  ||| S:24295 E:24299 ||| VBD
the  ||| S:24299 E:24303 ||| DT
dominant  ||| S:24303 E:24312 ||| JJ
prostaglandin  ||| S:24312 E:24326 ||| NN
( ||| S:24326 E:24327 ||| -LRB-
Fig  ||| S:24327 E:24341 ||| NNP
7B ||| S:24341 E:24343 ||| NNP
)  ||| S:24343 E:24345 ||| -RRB-
and  ||| S:24345 E:24349 ||| CC
overexpression  ||| S:24349 E:24364 ||| NN
of  ||| S:24364 E:24367 ||| IN
IDO  ||| S:24367 E:24371 ||| NNP
resulted  ||| S:24371 E:24380 ||| VBD
in  ||| S:24380 E:24383 ||| IN
a  ||| S:24383 E:24385 ||| DT
relative  ||| S:24385 E:24404 ||| JJ
increase  ||| S:24404 E:24413 ||| NN
in  ||| S:24413 E:24416 ||| IN
the  ||| S:24416 E:24420 ||| DT
amount  ||| S:24420 E:24427 ||| NN
of  ||| S:24427 E:24430 ||| IN
PG  ||| S:24430 E:24433 ||| NNP
D  ||| S:24433 E:24446 ||| NNP
2  ||| S:24446 E:24448 ||| CD
and  ||| S:24448 E:24452 ||| CC
other  ||| S:24452 E:24458 ||| JJ
PGs ||| S:24458 E:24461 ||| NN
,  ||| S:24461 E:24463 ||| ,
relative  ||| S:24463 E:24472 ||| JJ
to  ||| S:24472 E:24475 ||| TO
E  ||| S:24475 E:24488 ||| NNP
2  ||| S:24488 E:24490 ||| CD
.  ||| S:24490 E:24502 ||| .
In  ||| S:24502 E:24505 ||| IN
IDO-expressing  ||| S:24505 E:24520 ||| NNP
RAW  ||| S:24520 E:24524 ||| NNP
cells ||| S:24524 E:24529 ||| NNS
,  ||| S:24529 E:24531 ||| ,
COX-1  ||| S:24531 E:24537 ||| CD
protein  ||| S:24537 E:24545 ||| NN
levels  ||| S:24545 E:24552 ||| NNS
were  ||| S:24552 E:24567 ||| VBD
unchanged  ||| S:24567 E:24577 ||| JJ
compared  ||| S:24577 E:24586 ||| VBN
to  ||| S:24586 E:24589 ||| TO
the  ||| S:24589 E:24593 ||| DT
vector-only  ||| S:24593 E:24605 ||| JJ
control  ||| S:24605 E:24613 ||| NN
( ||| S:24613 E:24614 ||| -LRB-
Fig  ||| S:24614 E:24618 ||| NNP
8A ||| S:24618 E:24620 ||| NNP
) ||| S:24620 E:24621 ||| -RRB-
.  ||| S:24621 E:24633 ||| .
In  ||| S:24633 E:24636 ||| IN
contrast ||| S:24636 E:24644 ||| NN
,  ||| S:24644 E:24646 ||| ,
COX-2  ||| S:24646 E:24652 ||| NNP
was  ||| S:24652 E:24656 ||| VBD
not  ||| S:24656 E:24660 ||| RB
expressed  ||| S:24660 E:24670 ||| VBN
by  ||| S:24670 E:24673 ||| IN
vector  ||| S:24673 E:24680 ||| JJ
only  ||| S:24680 E:24695 ||| JJ
controls  ||| S:24695 E:24704 ||| NNS
or  ||| S:24704 E:24707 ||| CC
RAW  ||| S:24707 E:24711 ||| NNP
clones  ||| S:24711 E:24718 ||| VBD
6 ||| S:24718 E:24719 ||| CD
,  ||| S:24719 E:24721 ||| ,
8  ||| S:24721 E:24723 ||| CD
and  ||| S:24723 E:24727 ||| CC
22  ||| S:24727 E:24730 ||| CD
but  ||| S:24730 E:24734 ||| CC
COX-2  ||| S:24734 E:24740 ||| NNP
mRNA  ||| S:24740 E:24745 ||| NNP
and  ||| S:24745 E:24759 ||| CC
protein  ||| S:24759 E:24767 ||| NN
was  ||| S:24767 E:24771 ||| VBD
induced  ||| S:24771 E:24779 ||| VBN
in  ||| S:24779 E:24782 ||| IN
the  ||| S:24782 E:24786 ||| DT
RAW  ||| S:24786 E:24790 ||| NNP
clone  ||| S:24790 E:24796 ||| VBZ
expressing  ||| S:24796 E:24807 ||| VBG
the  ||| S:24807 E:24821 ||| DT
greatest  ||| S:24821 E:24830 ||| JJS
amount  ||| S:24830 E:24837 ||| NN
of  ||| S:24837 E:24840 ||| IN
IDO  ||| S:24840 E:24844 ||| NNP
( ||| S:24844 E:24845 ||| -LRB-
clone  ||| S:24845 E:24851 ||| CD
11 ||| S:24851 E:24853 ||| CD
)  ||| S:24853 E:24855 ||| -RRB-
( ||| S:24855 E:24856 ||| -LRB-
Fig  ||| S:24856 E:24860 ||| NNP
8A ||| S:24860 E:24862 ||| NNP
) ||| S:24862 E:24863 ||| -RRB-
.  ||| S:24863 E:24865 ||| .
Although  ||| S:24865 E:24884 ||| IN
COX-2  ||| S:24884 E:24890 ||| NNP
is  ||| S:24890 E:24893 ||| VBZ
not  ||| S:24893 E:24897 ||| RB
usually  ||| S:24897 E:24905 ||| RB
expressed  ||| S:24905 E:24915 ||| VBN
in  ||| S:24915 E:24918 ||| IN
RAW  ||| S:24918 E:24922 ||| NNP
cells ||| S:24922 E:24927 ||| NNS
,  ||| S:24927 E:24929 ||| ,
it  ||| S:24929 E:24932 ||| PRP
can  ||| S:24932 E:24936 ||| MD
be  ||| S:24936 E:24949 ||| VB
strongly  ||| S:24949 E:24958 ||| RB
induced  ||| S:24958 E:24966 ||| VBN
with  ||| S:24966 E:24971 ||| IN
lipopolysaccharide  ||| S:24971 E:24990 ||| NNS
( ||| S:24990 E:24991 ||| -LRB-
LPS ||| S:24991 E:24994 ||| NNP
)  ||| S:24994 E:24996 ||| -RRB-
[  ||| S:24996 E:24998 ||| -LRB-
32 ||| S:24998 E:25000 ||| CD
,  ||| S:25000 E:25002 ||| ,
33 ||| S:25002 E:25004 ||| CD
] ||| S:25004 E:25005 ||| -RRB-
.  ||| S:25005 E:25017 ||| .
Therefore ||| S:25017 E:25026 ||| RB
,  ||| S:25026 E:25028 ||| ,
we  ||| S:25028 E:25031 ||| PRP
treated  ||| S:25031 E:25039 ||| VBD
IDO  ||| S:25039 E:25043 ||| NNP
transfected  ||| S:25043 E:25055 ||| VBD
RAW  ||| S:25055 E:25059 ||| NNP
cells  ||| S:25059 E:25065 ||| NNS
and  ||| S:25065 E:25079 ||| CC
controls  ||| S:25079 E:25088 ||| NNS
with  ||| S:25088 E:25093 ||| IN
LPS  ||| S:25093 E:25097 ||| NNP
and  ||| S:25097 E:25101 ||| CC
measured  ||| S:25101 E:25110 ||| VBD
COX-2  ||| S:25110 E:25116 ||| CD
expression  ||| S:25116 E:25127 ||| CD
24  ||| S:25127 E:25130 ||| CD
hours  ||| S:25130 E:25146 ||| NNS
later ||| S:25146 E:25151 ||| RB
.  ||| S:25151 E:25153 ||| .
COX-2  ||| S:25153 E:25159 ||| NNP
mRNA  ||| S:25159 E:25164 ||| NNP
was  ||| S:25164 E:25168 ||| VBD
most  ||| S:25168 E:25173 ||| RBS
strongly  ||| S:25173 E:25182 ||| RB
induced  ||| S:25182 E:25190 ||| VBN
in  ||| S:25190 E:25193 ||| IN
vector  ||| S:25193 E:25210 ||| NN
only  ||| S:25210 E:25215 ||| RB
or  ||| S:25215 E:25218 ||| CC
low  ||| S:25218 E:25222 ||| JJ
IDO-expressing  ||| S:25222 E:25237 ||| JJ
clones  ||| S:25237 E:25244 ||| NNS
( ||| S:25244 E:25245 ||| -LRB-
Fig  ||| S:25245 E:25249 ||| NNP
8B ||| S:25249 E:25251 ||| NNP
) ||| S:25251 E:25252 ||| -RRB-
.  ||| S:25252 E:25254 ||| .
Curiously ||| S:25254 E:25263 ||| NNP
,  ||| S:25263 E:25275 ||| ,
clones  ||| S:25275 E:25282 ||| NNS
expressing  ||| S:25282 E:25293 ||| VBG
higher  ||| S:25293 E:25300 ||| JJR
levels  ||| S:25300 E:25307 ||| NNS
of  ||| S:25307 E:25310 ||| IN
IDO  ||| S:25310 E:25314 ||| NNP
( ||| S:25314 E:25315 ||| -LRB-
clones  ||| S:25315 E:25322 ||| CD
22  ||| S:25322 E:25325 ||| CD
and  ||| S:25325 E:25329 ||| CC
11 ||| S:25329 E:25331 ||| CD
)  ||| S:25331 E:25343 ||| -RRB-
showed  ||| S:25343 E:25350 ||| VBD
lower  ||| S:25350 E:25356 ||| JJR
levels  ||| S:25356 E:25363 ||| NNS
of  ||| S:25363 E:25366 ||| IN
COX-2  ||| S:25366 E:25372 ||| CD
mRNA  ||| S:25372 E:25377 ||| JJ
induction ||| S:25377 E:25386 ||| NN
.  ||| S:25386 E:25388 ||| .
In  ||| S:25388 E:25391 ||| IN
contrast ||| S:25391 E:25399 ||| NN
,  ||| S:25399 E:25411 ||| ,
COX-2  ||| S:25411 E:25417 ||| CD
protein  ||| S:25417 E:25425 ||| NN
levels  ||| S:25425 E:25432 ||| NNS
were  ||| S:25432 E:25437 ||| VBD
higher  ||| S:25437 E:25444 ||| JJR
in  ||| S:25444 E:25447 ||| IN
clones  ||| S:25447 E:25454 ||| NNS
expressing  ||| S:25454 E:25475 ||| VBG
lower  ||| S:25475 E:25481 ||| JJR
amounts  ||| S:25481 E:25489 ||| NNS
of  ||| S:25489 E:25492 ||| IN
IDO  ||| S:25492 E:25496 ||| NNP
mRNA  ||| S:25496 E:25501 ||| NNP
and  ||| S:25501 E:25505 ||| CC
lower  ||| S:25505 E:25511 ||| JJR
in  ||| S:25511 E:25514 ||| IN
vector  ||| S:25514 E:25521 ||| JJ
only  ||| S:25521 E:25536 ||| JJ
controls ||| S:25536 E:25544 ||| NNS
,  ||| S:25544 E:25546 ||| ,
whereas  ||| S:25546 E:25554 ||| IN
COX-1  ||| S:25554 E:25560 ||| CD
protein  ||| S:25560 E:25568 ||| NN
levels  ||| S:25568 E:25575 ||| NNS
were  ||| S:25575 E:25580 ||| VBD
unchanged  ||| S:25580 E:25590 ||| JJ
by  ||| S:25590 E:25603 ||| IN
LPS  ||| S:25603 E:25607 ||| NNP
treatment ||| S:25607 E:25616 ||| NN
.  ||| S:25616 E:25618 ||| .
MC57  ||| S:25618 E:25623 ||| NNP
cells  ||| S:25623 E:25629 ||| NNS
expressed  ||| S:25629 E:25639 ||| VBD
COX-2  ||| S:25639 E:25645 ||| CD
constitutively ||| S:25645 E:25659 ||| NN
,  ||| S:25659 E:25671 ||| ,
consistent  ||| S:25671 E:25682 ||| JJ
with  ||| S:25682 E:25687 ||| IN
the  ||| S:25687 E:25691 ||| DT
domination  ||| S:25691 E:25702 ||| NN
of  ||| S:25702 E:25705 ||| IN
the  ||| S:25705 E:25709 ||| DT
PG  ||| S:25709 E:25712 ||| NNP
profile  ||| S:25712 E:25720 ||| NN
by  ||| S:25720 E:25723 ||| IN
PG  ||| S:25723 E:25726 ||| NNP
E  ||| S:25726 E:25739 ||| NNP
2  ||| S:25739 E:25741 ||| CD
.  ||| S:25741 E:25743 ||| .
However ||| S:25743 E:25750 ||| RB
,  ||| S:25750 E:25752 ||| ,
IDO  ||| S:25752 E:25756 ||| NNP
overexpressing  ||| S:25756 E:25771 ||| VBD
clone  ||| S:25771 E:25787 ||| CD
26  ||| S:25787 E:25790 ||| CD
showed  ||| S:25790 E:25797 ||| VBD
a  ||| S:25797 E:25799 ||| DT
reduced  ||| S:25799 E:25807 ||| JJ
amount  ||| S:25807 E:25814 ||| NN
of  ||| S:25814 E:25817 ||| IN
COX-2  ||| S:25817 E:25823 ||| CD
protein  ||| S:25823 E:25831 ||| NN
compared  ||| S:25831 E:25840 ||| VBN
to  ||| S:25840 E:25853 ||| TO
the  ||| S:25853 E:25857 ||| DT
vector  ||| S:25857 E:25864 ||| JJ
only  ||| S:25864 E:25869 ||| JJ
control  ||| S:25869 E:25877 ||| NN
( ||| S:25877 E:25878 ||| -LRB-
Fig  ||| S:25878 E:25882 ||| NNP
8C ||| S:25882 E:25884 ||| NNP
) ||| S:25884 E:25885 ||| -RRB-
.  ||| S:25885 E:25897 ||| .
If  ||| S:25897 E:25900 ||| IN
uniformly  ||| S:25900 E:25910 ||| RB
diminished  ||| S:25910 E:25921 ||| VBN
PG  ||| S:25921 E:25924 ||| NNP
synthesis  ||| S:25924 E:25934 ||| NN
by  ||| S:25934 E:25937 ||| IN
IDO  ||| S:25937 E:25941 ||| NNP
was  ||| S:25941 E:25955 ||| VBD
responsible  ||| S:25955 E:25967 ||| JJ
for  ||| S:25967 E:25971 ||| IN
growth  ||| S:25971 E:25978 ||| NN
of  ||| S:25978 E:25981 ||| IN
RAW  ||| S:25981 E:25985 ||| NNP
cell  ||| S:25985 E:25990 ||| NN
macroscopic  ||| S:25990 E:26002 ||| NN
foci ||| S:26002 E:26006 ||| NN
,  ||| S:26006 E:26018 ||| ,
inhibiting  ||| S:26018 E:26029 ||| VBG
PG  ||| S:26029 E:26032 ||| NNP
synthesis  ||| S:26032 E:26042 ||| NN
with  ||| S:26042 E:26047 ||| IN
a  ||| S:26047 E:26049 ||| DT
pharmacological  ||| S:26049 E:26065 ||| JJ
inhibitor  ||| S:26065 E:26085 ||| NN
of  ||| S:26085 E:26088 ||| IN
COX-1  ||| S:26088 E:26094 ||| NNP
and  ||| S:26094 E:26098 ||| CC
-2  ||| S:26098 E:26101 ||| NNP
ought  ||| S:26101 E:26107 ||| MD
to  ||| S:26107 E:26110 ||| TO
reproduce  ||| S:26110 E:26120 ||| VB
the  ||| S:26120 E:26124 ||| DT
effect  ||| S:26124 E:26131 ||| NN
of  ||| S:26131 E:26134 ||| IN
IDO  ||| S:26134 E:26148 ||| NNP
expression ||| S:26148 E:26158 ||| NN
.  ||| S:26158 E:26160 ||| .
Therefore  ||| S:26160 E:26170 ||| RB
we  ||| S:26170 E:26173 ||| PRP
treated  ||| S:26173 E:26181 ||| VBD
vector-only  ||| S:26181 E:26193 ||| JJ
transfected  ||| S:26193 E:26215 ||| JJ
RAW  ||| S:26215 E:26219 ||| NN
cells  ||| S:26219 E:26225 ||| NNS
with  ||| S:26225 E:26230 ||| IN
various  ||| S:26230 E:26238 ||| JJ
concentrations  ||| S:26238 E:26253 ||| NNS
of  ||| S:26253 E:26256 ||| IN
indomethacin  ||| S:26256 E:26279 ||| NNS
ranging  ||| S:26279 E:26287 ||| VBG
from  ||| S:26287 E:26292 ||| IN
0.1  ||| S:26292 E:26296 ||| CD
μM  ||| S:26296 E:26299 ||| JJ
to  ||| S:26299 E:26302 ||| TO
100  ||| S:26302 E:26306 ||| CD
mM ||| S:26306 E:26308 ||| NN
.  ||| S:26308 E:26310 ||| .
Although  ||| S:26310 E:26319 ||| IN
some  ||| S:26319 E:26324 ||| DT
effect  ||| S:26324 E:26331 ||| NN
of  ||| S:26331 E:26344 ||| IN
indomethacin  ||| S:26344 E:26357 ||| NN
on  ||| S:26357 E:26360 ||| IN
cell  ||| S:26360 E:26365 ||| NN
growth  ||| S:26365 E:26372 ||| NN
rate  ||| S:26372 E:26377 ||| NN
was  ||| S:26377 E:26381 ||| VBD
observed ||| S:26381 E:26389 ||| VBN
,  ||| S:26389 E:26391 ||| ,
there  ||| S:26391 E:26397 ||| EX
was  ||| S:26397 E:26411 ||| VBD
no  ||| S:26411 E:26414 ||| DT
sign  ||| S:26414 E:26419 ||| NN
of  ||| S:26419 E:26422 ||| IN
macroscopic  ||| S:26422 E:26434 ||| JJ
foci  ||| S:26434 E:26439 ||| NNS
( ||| S:26439 E:26440 ||| -LRB-
data  ||| S:26440 E:26445 ||| NNS
not  ||| S:26445 E:26449 ||| RB
shown ||| S:26449 E:26454 ||| VBN
) ||| S:26454 E:26455 ||| -RRB-
.  ||| S:26455 E:26457 ||| .
Thus  ||| S:26457 E:26462 ||| RB
IDO  ||| S:26462 E:26476 ||| JJ
expression  ||| S:26476 E:26487 ||| NN
does  ||| S:26487 E:26492 ||| VBZ
not  ||| S:26492 E:26496 ||| RB
mimic  ||| S:26496 E:26502 ||| VB
the  ||| S:26502 E:26506 ||| DT
effects  ||| S:26506 E:26514 ||| NNS
of  ||| S:26514 E:26517 ||| IN
a  ||| S:26517 E:26519 ||| DT
global  ||| S:26519 E:26526 ||| JJ
COX  ||| S:26526 E:26540 ||| NNP
inhibitor ||| S:26540 E:26549 ||| NN
.  ||| S:26549 E:26551 ||| .
To  ||| S:26551 E:26554 ||| TO
test  ||| S:26554 E:26559 ||| VB
the  ||| S:26559 E:26563 ||| DT
hypothesis  ||| S:26563 E:26574 ||| NN
that  ||| S:26574 E:26579 ||| IN
alterations  ||| S:26579 E:26591 ||| NN
in  ||| S:26591 E:26594 ||| IN
the  ||| S:26594 E:26608 ||| DT
relative  ||| S:26608 E:26617 ||| JJ
levels  ||| S:26617 E:26624 ||| NNS
of  ||| S:26624 E:26627 ||| IN
PGs  ||| S:26627 E:26631 ||| NNP
were  ||| S:26631 E:26636 ||| VBD
responsible  ||| S:26636 E:26648 ||| JJ
for  ||| S:26648 E:26652 ||| IN
the  ||| S:26652 E:26656 ||| DT
growth  ||| S:26656 E:26663 ||| NN
of  ||| S:26663 E:26676 ||| IN
macroscopic  ||| S:26676 E:26688 ||| JJ
foci ||| S:26688 E:26692 ||| NN
,  ||| S:26692 E:26694 ||| ,
we  ||| S:26694 E:26697 ||| PRP
added  ||| S:26697 E:26703 ||| VBD
PGs  ||| S:26703 E:26707 ||| JJ
directly  ||| S:26707 E:26716 ||| RB
to  ||| S:26716 E:26719 ||| TO
vector-only  ||| S:26719 E:26741 ||| JJ
transfected  ||| S:26741 E:26753 ||| JJ
RAW  ||| S:26753 E:26757 ||| NN
cells ||| S:26757 E:26762 ||| NNS
.  ||| S:26762 E:26764 ||| .
The  ||| S:26764 E:26768 ||| DT
phenotype  ||| S:26768 E:26778 ||| NN
produced  ||| S:26778 E:26787 ||| VBN
by  ||| S:26787 E:26790 ||| IN
IDO  ||| S:26790 E:26804 ||| NNP
expression  ||| S:26804 E:26815 ||| NN
could  ||| S:26815 E:26821 ||| MD
be  ||| S:26821 E:26824 ||| VB
reproduced  ||| S:26824 E:26835 ||| VBN
by  ||| S:26835 E:26838 ||| IN
adding  ||| S:26838 E:26845 ||| VBG
PG  ||| S:26845 E:26848 ||| NNP
E  ||| S:26848 E:26861 ||| NNP
2  ||| S:26861 E:26863 ||| CD
alone  ||| S:26863 E:26869 ||| RB
to  ||| S:26869 E:26872 ||| TO
the  ||| S:26872 E:26876 ||| DT
cultures ||| S:26876 E:26884 ||| NNS
.  ||| S:26884 E:26886 ||| .
PG  ||| S:26886 E:26889 ||| NNP
E  ||| S:26889 E:26902 ||| NNP
2  ||| S:26902 E:26904 ||| CD
addition  ||| S:26904 E:26913 ||| NN
resulted  ||| S:26913 E:26922 ||| VBD
in  ||| S:26922 E:26925 ||| IN
a  ||| S:26925 E:26937 ||| DT
dose-dependent  ||| S:26937 E:26952 ||| JJ
increase  ||| S:26952 E:26961 ||| NN
in  ||| S:26961 E:26964 ||| IN
the  ||| S:26964 E:26968 ||| DT
appearance  ||| S:26968 E:26979 ||| NN
of  ||| S:26979 E:26982 ||| IN
macroscopic  ||| S:26982 E:27004 ||| JJ
foci ||| S:27004 E:27008 ||| NN
,  ||| S:27008 E:27010 ||| ,
with  ||| S:27010 E:27015 ||| IN
visible  ||| S:27015 E:27023 ||| JJ
foci  ||| S:27023 E:27028 ||| NNS
appearing  ||| S:27028 E:27038 ||| VBG
at  ||| S:27038 E:27041 ||| IN
1  ||| S:27041 E:27043 ||| CD
ng ||| S:27043 E:27045 ||| CD
/ ||| S:27045 E:27046 ||| CD
ml  ||| S:27046 E:27049 ||| NNS
( ||| S:27049 E:27050 ||| -LRB-
3  ||| S:27050 E:27052 ||| CD
nM ||| S:27052 E:27054 ||| NN
)  ||| S:27054 E:27056 ||| -RRB-
and  ||| S:27056 E:27070 ||| CC
becoming  ||| S:27070 E:27079 ||| VBG
abundant  ||| S:27079 E:27088 ||| JJ
at  ||| S:27088 E:27091 ||| IN
10  ||| S:27091 E:27094 ||| CD
ng ||| S:27094 E:27096 ||| CD
/ ||| S:27096 E:27097 ||| CD
ml  ||| S:27097 E:27100 ||| NNS
( ||| S:27100 E:27101 ||| -LRB-
30  ||| S:27101 E:27104 ||| CD
nM ||| S:27104 E:27106 ||| NN
)  ||| S:27106 E:27108 ||| -RRB-
( ||| S:27108 E:27109 ||| -LRB-
Fig.  ||| S:27109 E:27114 ||| NNP
9A ||| S:27114 E:27116 ||| NNP
) ||| S:27116 E:27117 ||| -RRB-
.  ||| S:27117 E:27119 ||| .
Adding  ||| S:27119 E:27136 ||| VBG
PG  ||| S:27136 E:27139 ||| NNP
F  ||| S:27139 E:27152 ||| NNP
2α  ||| S:27152 E:27155 ||| NNP
at  ||| S:27155 E:27158 ||| IN
the  ||| S:27158 E:27162 ||| DT
same  ||| S:27162 E:27167 ||| JJ
time  ||| S:27167 E:27172 ||| NN
as  ||| S:27172 E:27175 ||| IN
E  ||| S:27175 E:27188 ||| NNP
2  ||| S:27188 E:27190 ||| CD
resulted  ||| S:27190 E:27199 ||| VBN
in  ||| S:27199 E:27202 ||| IN
a  ||| S:27202 E:27204 ||| DT
reduction  ||| S:27204 E:27214 ||| NN
of  ||| S:27214 E:27217 ||| IN
the  ||| S:27217 E:27231 ||| DT
number  ||| S:27231 E:27238 ||| NN
of  ||| S:27238 E:27241 ||| IN
foci ||| S:27241 E:27245 ||| NN
.  ||| S:27245 E:27247 ||| .
Surprisingly ||| S:27247 E:27259 ||| RB
,  ||| S:27259 E:27261 ||| ,
addition  ||| S:27261 E:27270 ||| NN
of  ||| S:27270 E:27273 ||| IN
PG  ||| S:27273 E:27276 ||| NNP
D  ||| S:27276 E:27289 ||| NNP
2  ||| S:27289 E:27291 ||| CD
also  ||| S:27291 E:27296 ||| RB
resulted  ||| S:27296 E:27305 ||| VBN
in  ||| S:27305 E:27308 ||| IN
a  ||| S:27308 E:27310 ||| DT
slight  ||| S:27310 E:27317 ||| JJ
increase  ||| S:27317 E:27336 ||| NN
in  ||| S:27336 E:27339 ||| IN
focus  ||| S:27339 E:27345 ||| NN
numbers  ||| S:27345 E:27353 ||| NNS
( ||| S:27353 E:27354 ||| -LRB-
not  ||| S:27354 E:27358 ||| RB
shown ||| S:27358 E:27363 ||| VBN
) ||| S:27363 E:27364 ||| -RRB-
.  ||| S:27364 E:27376 ||| .
We  ||| S:27376 E:27379 ||| PRP
next  ||| S:27379 E:27384 ||| RB
attempted  ||| S:27384 E:27394 ||| VBN
to  ||| S:27394 E:27397 ||| TO
reverse  ||| S:27397 E:27405 ||| VB
the  ||| S:27405 E:27409 ||| DT
phenotype  ||| S:27409 E:27419 ||| NN
seen  ||| S:27419 E:27424 ||| VBN
in  ||| S:27424 E:27437 ||| IN
clone  ||| S:27437 E:27443 ||| CD
11  ||| S:27443 E:27446 ||| CD
cells ||| S:27446 E:27451 ||| NNS
.  ||| S:27451 E:27453 ||| .
If  ||| S:27453 E:27456 ||| IN
increased  ||| S:27456 E:27466 ||| JJ
PG  ||| S:27466 E:27469 ||| NNP
E  ||| S:27469 E:27482 ||| NNP
2  ||| S:27482 E:27484 ||| CD
production  ||| S:27484 E:27495 ||| NN
relative  ||| S:27495 E:27504 ||| JJ
to  ||| S:27504 E:27507 ||| TO
other  ||| S:27507 E:27513 ||| JJ
PGs  ||| S:27513 E:27517 ||| NN
was  ||| S:27517 E:27531 ||| VBD
responsible  ||| S:27531 E:27543 ||| JJ
for  ||| S:27543 E:27547 ||| IN
the  ||| S:27547 E:27551 ||| DT
appearance  ||| S:27551 E:27562 ||| NN
of  ||| S:27562 E:27565 ||| IN
macroscopic  ||| S:27565 E:27577 ||| JJ
foci ||| S:27577 E:27581 ||| NN
,  ||| S:27581 E:27583 ||| ,
then  ||| S:27583 E:27598 ||| RB
adding  ||| S:27598 E:27605 ||| VBG
back  ||| S:27605 E:27610 ||| RP
increasing  ||| S:27610 E:27621 ||| VBG
amounts  ||| S:27621 E:27629 ||| NNS
of  ||| S:27629 E:27632 ||| IN
other  ||| S:27632 E:27638 ||| JJ
PGs  ||| S:27638 E:27642 ||| JJ
such  ||| S:27642 E:27647 ||| JJ
as  ||| S:27647 E:27650 ||| IN
D  ||| S:27650 E:27663 ||| NNP
2  ||| S:27663 E:27665 ||| CD
and  ||| S:27665 E:27669 ||| CC
F  ||| S:27669 E:27682 ||| NNP
2α  ||| S:27682 E:27685 ||| NNP
should  ||| S:27685 E:27692 ||| MD
restore  ||| S:27692 E:27700 ||| VB
the  ||| S:27700 E:27704 ||| DT
phenotype  ||| S:27704 E:27714 ||| NN
of  ||| S:27714 E:27727 ||| IN
clone  ||| S:27727 E:27733 ||| CD
11  ||| S:27733 E:27736 ||| CD
to  ||| S:27736 E:27739 ||| TO
that  ||| S:27739 E:27744 ||| DT
of  ||| S:27744 E:27747 ||| IN
vector  ||| S:27747 E:27754 ||| JJ
only  ||| S:27754 E:27759 ||| JJ
controls ||| S:27759 E:27767 ||| NNS
.  ||| S:27767 E:27769 ||| .
As  ||| S:27769 E:27772 ||| IN
PG  ||| S:27772 E:27775 ||| NNP
F  ||| S:27775 E:27788 ||| NNP
2α  ||| S:27788 E:27791 ||| NNP
attenuated  ||| S:27791 E:27802 ||| VBD
the  ||| S:27802 E:27806 ||| DT
focus  ||| S:27806 E:27812 ||| NN
forming  ||| S:27812 E:27830 ||| VBG
ability  ||| S:27830 E:27838 ||| NN
of  ||| S:27838 E:27841 ||| IN
PG  ||| S:27841 E:27844 ||| NNP
E  ||| S:27844 E:27857 ||| NNP
2  ||| S:27857 E:27859 ||| CD
in  ||| S:27859 E:27862 ||| IN
the  ||| S:27862 E:27866 ||| DT
experiment  ||| S:27866 E:27877 ||| NN
shown  ||| S:27877 E:27883 ||| VBN
in  ||| S:27883 E:27886 ||| IN
Fig.  ||| S:27886 E:27891 ||| CD
9A ||| S:27891 E:27893 ||| CD
,  ||| S:27893 E:27905 ||| ,
we  ||| S:27905 E:27908 ||| PRP
added  ||| S:27908 E:27914 ||| VBD
PG  ||| S:27914 E:27917 ||| NNP
F  ||| S:27917 E:27930 ||| NNP
2α  ||| S:27930 E:27933 ||| NNP
in  ||| S:27933 E:27936 ||| IN
various  ||| S:27936 E:27944 ||| JJ
concentrations  ||| S:27944 E:27959 ||| NNS
to  ||| S:27959 E:27962 ||| TO
clone  ||| S:27962 E:27978 ||| CD
11  ||| S:27978 E:27981 ||| CD
cells ||| S:27981 E:27986 ||| NNS
.  ||| S:27986 E:27988 ||| .
PG  ||| S:27988 E:27991 ||| NNP
F  ||| S:27991 E:28004 ||| NNP
2α  ||| S:28004 E:28007 ||| NNP
at  ||| S:28007 E:28010 ||| IN
10  ||| S:28010 E:28013 ||| CD
ng ||| S:28013 E:28015 ||| CD
/ ||| S:28015 E:28016 ||| CD
ml  ||| S:28016 E:28019 ||| NNS
( ||| S:28019 E:28020 ||| -LRB-
30  ||| S:28020 E:28023 ||| CD
nM ||| S:28023 E:28025 ||| NN
)  ||| S:28025 E:28027 ||| -RRB-
substantially  ||| S:28027 E:28051 ||| RB
reduced  ||| S:28051 E:28059 ||| VBN
the  ||| S:28059 E:28063 ||| DT
focus  ||| S:28063 E:28069 ||| NN
forming  ||| S:28069 E:28077 ||| VBG
ability  ||| S:28077 E:28085 ||| NN
of  ||| S:28085 E:28088 ||| IN
IDO  ||| S:28088 E:28092 ||| NNP
expressing  ||| S:28092 E:28103 ||| VBD
clone  ||| S:28103 E:28119 ||| CD
11  ||| S:28119 E:28122 ||| CD
( ||| S:28122 E:28123 ||| -LRB-
Fig  ||| S:28123 E:28127 ||| NNP
9B ||| S:28127 E:28129 ||| NNP
) ||| S:28129 E:28130 ||| -RRB-
.  ||| S:28130 E:28132 ||| .
Thus  ||| S:28132 E:28137 ||| RB
an  ||| S:28137 E:28140 ||| DT
alteration  ||| S:28140 E:28151 ||| NN
in  ||| S:28151 E:28154 ||| IN
the  ||| S:28154 E:28158 ||| DT
PG  ||| S:28158 E:28161 ||| NNP
E  ||| S:28161 E:28174 ||| NNP
2  ||| S:28174 E:28176 ||| CD
/ ||| S:28176 E:28177 ||| CD
F  ||| S:28177 E:28190 ||| NN
2α  ||| S:28190 E:28193 ||| CD
ratio  ||| S:28193 E:28199 ||| NN
plays  ||| S:28199 E:28205 ||| VBZ
an  ||| S:28205 E:28208 ||| DT
important  ||| S:28208 E:28218 ||| JJ
role  ||| S:28218 E:28223 ||| NN
in  ||| S:28223 E:28236 ||| IN
mediating  ||| S:28236 E:28246 ||| JJ
IDO ||| S:28246 E:28249 ||| NNP
's  ||| S:28249 E:28252 ||| POS
effects  ||| S:28252 E:28260 ||| NNS
on  ||| S:28260 E:28263 ||| IN
cell  ||| S:28263 E:28268 ||| NN
growth  ||| S:28268 E:28275 ||| NN
and  ||| S:28275 E:28289 ||| CC
morphology ||| S:28289 E:28299 ||| NN
.  ||| S:28299 E:28332 ||| .
Discussion  ||| S:28332 E:28351 ||| NNP
Tryptophan  ||| S:28351 E:28362 ||| NNP
catabolism  ||| S:28362 E:28373 ||| NN
by  ||| S:28373 E:28376 ||| IN
cells  ||| S:28376 E:28382 ||| NNS
expressing  ||| S:28382 E:28393 ||| VBG
IDO  ||| S:28393 E:28397 ||| NNP
is  ||| S:28397 E:28408 ||| VBZ
something  ||| S:28408 E:28418 ||| NN
of  ||| S:28418 E:28421 ||| IN
an  ||| S:28421 E:28424 ||| DT
enigma  ||| S:28424 E:28431 ||| NN
and  ||| S:28431 E:28435 ||| CC
has  ||| S:28435 E:28439 ||| VBZ
resulted  ||| S:28439 E:28448 ||| VBN
in  ||| S:28448 E:28451 ||| IN
speculation  ||| S:28451 E:28463 ||| NN
as  ||| S:28463 E:28474 ||| IN
to  ||| S:28474 E:28477 ||| TO
why  ||| S:28477 E:28481 ||| WRB
the  ||| S:28481 E:28485 ||| DT
body  ||| S:28485 E:28490 ||| NN
requires  ||| S:28490 E:28499 ||| VBZ
two  ||| S:28499 E:28503 ||| CD
enzymes  ||| S:28503 E:28511 ||| NN
with  ||| S:28511 E:28516 ||| IN
different  ||| S:28516 E:28526 ||| JJ
tissue  ||| S:28526 E:28541 ||| NN
specificities  ||| S:28541 E:28555 ||| NN
to  ||| S:28555 E:28558 ||| TO
degrade  ||| S:28558 E:28566 ||| VB
the  ||| S:28566 E:28570 ||| DT
rarest  ||| S:28570 E:28577 ||| JJ
essential  ||| S:28577 E:28587 ||| JJ
amino  ||| S:28587 E:28593 ||| JJ
acid  ||| S:28593 E:28598 ||| NN
[  ||| S:28598 E:28608 ||| -LRB-
5 ||| S:28608 E:28609 ||| CD
,  ||| S:28609 E:28611 ||| ,
34 ||| S:28611 E:28613 ||| CD
] ||| S:28613 E:28614 ||| -RRB-
.  ||| S:28614 E:28616 ||| .
The  ||| S:28616 E:28620 ||| DT
inability  ||| S:28620 E:28630 ||| NN
of  ||| S:28630 E:28633 ||| IN
IDO  ||| S:28633 E:28637 ||| NNP
to  ||| S:28637 E:28640 ||| TO
be  ||| S:28640 E:28643 ||| VB
induced  ||| S:28643 E:28651 ||| VBN
by  ||| S:28651 E:28654 ||| IN
its  ||| S:28654 E:28658 ||| PRP$
own  ||| S:28658 E:28670 ||| JJ
substrate  ||| S:28670 E:28680 ||| NN
exemplifies  ||| S:28680 E:28692 ||| VBZ
this  ||| S:28692 E:28697 ||| DT
puzzle ||| S:28697 E:28703 ||| NN
.  ||| S:28703 E:28705 ||| .
While  ||| S:28705 E:28711 ||| IN
IDO ||| S:28711 E:28714 ||| NNP
's  ||| S:28714 E:28717 ||| POS
role  ||| S:28717 E:28722 ||| NN
in  ||| S:28722 E:28733 ||| IN
controlling  ||| S:28733 E:28745 ||| VBG
intracellular  ||| S:28745 E:28759 ||| JJ
pathogens  ||| S:28759 E:28769 ||| NN
is  ||| S:28769 E:28772 ||| VBZ
well  ||| S:28772 E:28777 ||| RB
documented ||| S:28777 E:28787 ||| VBN
,  ||| S:28787 E:28797 ||| ,
there  ||| S:28797 E:28803 ||| EX
is  ||| S:28803 E:28806 ||| VBZ
little  ||| S:28806 E:28813 ||| JJ
understanding  ||| S:28813 E:28827 ||| NN
of  ||| S:28827 E:28830 ||| IN
the  ||| S:28830 E:28834 ||| DT
reasons  ||| S:28834 E:28842 ||| NNS
for  ||| S:28842 E:28846 ||| IN
IDO  ||| S:28846 E:28858 ||| NNP
expression  ||| S:28858 E:28869 ||| NN
at  ||| S:28869 E:28872 ||| IN
sites  ||| S:28872 E:28878 ||| NNS
in  ||| S:28878 E:28881 ||| IN
the  ||| S:28881 E:28885 ||| DT
body  ||| S:28885 E:28890 ||| NN
unlikely  ||| S:28890 E:28899 ||| JJ
to  ||| S:28899 E:28902 ||| TO
be  ||| S:28902 E:28905 ||| VB
related  ||| S:28905 E:28913 ||| VBN
to  ||| S:28913 E:28924 ||| TO
this  ||| S:28924 E:28929 ||| DT
function ||| S:28929 E:28937 ||| NN
,  ||| S:28937 E:28939 ||| ,
such  ||| S:28939 E:28944 ||| JJ
as  ||| S:28944 E:28947 ||| IN
the  ||| S:28947 E:28951 ||| DT
epididymis ||| S:28951 E:28961 ||| NN
.  ||| S:28961 E:28963 ||| .
The  ||| S:28963 E:28967 ||| DT
data  ||| S:28967 E:28972 ||| NNS
we  ||| S:28972 E:28975 ||| PRP
present  ||| S:28975 E:28991 ||| VBP
here  ||| S:28991 E:28996 ||| RB
reveal  ||| S:28996 E:29003 ||| VB
that  ||| S:29003 E:29008 ||| IN
IDO  ||| S:29008 E:29012 ||| NNP
expression  ||| S:29012 E:29023 ||| NN
is  ||| S:29023 E:29026 ||| VBZ
an  ||| S:29026 E:29029 ||| DT
important  ||| S:29029 E:29039 ||| JJ
determinant  ||| S:29039 E:29059 ||| NN
of  ||| S:29059 E:29062 ||| IN
the  ||| S:29062 E:29066 ||| DT
way  ||| S:29066 E:29070 ||| NN
in  ||| S:29070 E:29073 ||| IN
which  ||| S:29073 E:29079 ||| WDT
cells  ||| S:29079 E:29085 ||| NNS
interact  ||| S:29085 E:29094 ||| VBN
with  ||| S:29094 E:29099 ||| IN
their  ||| S:29099 E:29105 ||| PRP$
extracellular  ||| S:29105 E:29127 ||| JJ
environment  ||| S:29127 E:29148 ||| NN
in  ||| S:29148 E:29151 ||| IN
vitro  ||| S:29151 E:29157 ||| NN
.  ||| S:29157 E:29159 ||| .
In  ||| S:29159 E:29162 ||| IN
particular ||| S:29162 E:29172 ||| JJ
,  ||| S:29172 E:29174 ||| ,
cell  ||| S:29174 E:29187 ||| NN
adhesion  ||| S:29187 E:29196 ||| NN
is  ||| S:29196 E:29199 ||| VBZ
altered  ||| S:29199 E:29207 ||| VBN
dramatically  ||| S:29207 E:29220 ||| RB
by  ||| S:29220 E:29223 ||| IN
overexpressing  ||| S:29223 E:29238 ||| JJ
IDO  ||| S:29238 E:29242 ||| NN
in  ||| S:29242 E:29253 ||| IN
cells  ||| S:29253 E:29259 ||| NNS
which  ||| S:29259 E:29265 ||| WDT
do  ||| S:29265 E:29268 ||| VBP
not  ||| S:29268 E:29272 ||| RB
otherwise  ||| S:29272 E:29282 ||| RB
express  ||| S:29282 E:29290 ||| VB
it ||| S:29290 E:29292 ||| PRP
,  ||| S:29292 E:29294 ||| ,
or  ||| S:29294 E:29297 ||| CC
inhibiting  ||| S:29297 E:29308 ||| JJ
IDO  ||| S:29308 E:29320 ||| NNP
expression  ||| S:29320 E:29331 ||| NN
in  ||| S:29331 E:29334 ||| IN
cells  ||| S:29334 E:29340 ||| NNS
in  ||| S:29340 E:29343 ||| IN
which  ||| S:29343 E:29349 ||| WDT
it  ||| S:29349 E:29352 ||| PRP
is  ||| S:29352 E:29355 ||| VBZ
naturally  ||| S:29355 E:29365 ||| RB
induced  ||| S:29365 E:29381 ||| VBN
following  ||| S:29381 E:29391 ||| VBG
cell  ||| S:29391 E:29396 ||| NN
passage ||| S:29396 E:29403 ||| NN
.  ||| S:29403 E:29405 ||| .
Specifically ||| S:29405 E:29417 ||| RB
,  ||| S:29417 E:29419 ||| ,
overexpression  ||| S:29419 E:29434 ||| VBG
of  ||| S:29434 E:29437 ||| IN
IDO  ||| S:29437 E:29449 ||| NNP
in  ||| S:29449 E:29452 ||| IN
RAW  ||| S:29452 E:29456 ||| NNP
and  ||| S:29456 E:29460 ||| CC
MC57  ||| S:29460 E:29465 ||| CD
cells  ||| S:29465 E:29471 ||| NNS
resulted  ||| S:29471 E:29480 ||| VBD
in  ||| S:29480 E:29483 ||| IN
the  ||| S:29483 E:29487 ||| DT
growth  ||| S:29487 E:29494 ||| NN
of  ||| S:29494 E:29497 ||| IN
macroscopic  ||| S:29497 E:29517 ||| JJ
foci  ||| S:29517 E:29522 ||| NN
and  ||| S:29522 E:29526 ||| CC
other  ||| S:29526 E:29532 ||| JJ
phenotypic  ||| S:29532 E:29543 ||| JJ
alterations ||| S:29543 E:29554 ||| NN
.  ||| S:29554 E:29556 ||| .
The  ||| S:29556 E:29560 ||| DT
cell  ||| S:29560 E:29565 ||| NN
foci  ||| S:29565 E:29570 ||| NNS
were  ||| S:29570 E:29583 ||| VBD
multicellular  ||| S:29583 E:29597 ||| JJ
aggregates ||| S:29597 E:29607 ||| NNS
,  ||| S:29607 E:29609 ||| ,
which  ||| S:29609 E:29615 ||| WDT
grew  ||| S:29615 E:29620 ||| VBD
vertically  ||| S:29620 E:29631 ||| RB
as  ||| S:29631 E:29634 ||| RB
well  ||| S:29634 E:29639 ||| RB
as  ||| S:29639 E:29650 ||| IN
horizontally  ||| S:29650 E:29663 ||| NN
across  ||| S:29663 E:29670 ||| IN
the  ||| S:29670 E:29674 ||| DT
plate  ||| S:29674 E:29680 ||| NN
surface  ||| S:29680 E:29688 ||| NN
and  ||| S:29688 E:29692 ||| CC
contained  ||| S:29692 E:29710 ||| VBD
significant  ||| S:29710 E:29722 ||| JJ
numbers  ||| S:29722 E:29730 ||| NNS
of  ||| S:29730 E:29733 ||| IN
necrotic  ||| S:29733 E:29742 ||| JJ
cells  ||| S:29742 E:29748 ||| NNS
within  ||| S:29748 E:29755 ||| IN
their  ||| S:29755 E:29769 ||| PRP$
interior ||| S:29769 E:29777 ||| NN
,  ||| S:29777 E:29779 ||| ,
as  ||| S:29779 E:29782 ||| RB
judged  ||| S:29782 E:29789 ||| VBN
by  ||| S:29789 E:29792 ||| IN
trypan  ||| S:29792 E:29799 ||| JJ
blue  ||| S:29799 E:29804 ||| JJ
exclusion ||| S:29804 E:29813 ||| NN
.  ||| S:29813 E:29815 ||| .
Conversely ||| S:29815 E:29825 ||| RB
,  ||| S:29825 E:29835 ||| ,
in  ||| S:29835 E:29838 ||| IN
P19  ||| S:29838 E:29842 ||| CD
cell  ||| S:29842 E:29847 ||| NN
aggregates  ||| S:29847 E:29858 ||| NNS
in  ||| S:29858 E:29861 ||| IN
which  ||| S:29861 E:29867 ||| WDT
IDO  ||| S:29867 E:29871 ||| NNP
expression  ||| S:29871 E:29882 ||| NN
was  ||| S:29882 E:29894 ||| VBD
inhibited ||| S:29894 E:29903 ||| CD
,  ||| S:29903 E:29905 ||| ,
there  ||| S:29905 E:29911 ||| EX
was  ||| S:29911 E:29915 ||| VBD
a  ||| S:29915 E:29917 ||| DT
more  ||| S:29917 E:29922 ||| RBR
dispersed  ||| S:29922 E:29932 ||| JJ
phenotype  ||| S:29932 E:29942 ||| NN
with  ||| S:29942 E:29947 ||| IN
cells  ||| S:29947 E:29961 ||| NNS
losing  ||| S:29961 E:29968 ||| VBG
the  ||| S:29968 E:29972 ||| DT
ability  ||| S:29972 E:29980 ||| NN
to  ||| S:29980 E:29983 ||| TO
interact  ||| S:29983 E:29992 ||| VB
with  ||| S:29992 E:29997 ||| IN
each  ||| S:29997 E:30002 ||| DT
other ||| S:30002 E:30007 ||| JJ
.  ||| S:30007 E:30009 ||| .
We  ||| S:30009 E:30012 ||| PRP
have  ||| S:30012 E:30025 ||| VBP
recently  ||| S:30025 E:30034 ||| RB
confirmed  ||| S:30034 E:30044 ||| VBN
that  ||| S:30044 E:30049 ||| IN
IDO  ||| S:30049 E:30053 ||| NNP
expression  ||| S:30053 E:30064 ||| NN
in  ||| S:30064 E:30067 ||| IN
RAW  ||| S:30067 E:30071 ||| NNP
cells  ||| S:30071 E:30085 ||| NNS
following  ||| S:30085 E:30095 ||| VBG
cell  ||| S:30095 E:30100 ||| NN
passage  ||| S:30100 E:30108 ||| NN
is  ||| S:30108 E:30111 ||| VBZ
likewise  ||| S:30111 E:30120 ||| RB
important  ||| S:30120 E:30130 ||| JJ
for  ||| S:30130 E:30134 ||| IN
correct  ||| S:30134 E:30150 ||| JJ
cell  ||| S:30150 E:30155 ||| NN
adhesion  ||| S:30155 E:30164 ||| NNS
( ||| S:30164 E:30165 ||| -LRB-
results  ||| S:30165 E:30173 ||| NNS
not  ||| S:30173 E:30177 ||| RB
shown ||| S:30177 E:30182 ||| VBN
) ||| S:30182 E:30183 ||| -RRB-
.  ||| S:30183 E:30193 ||| .
Our  ||| S:30193 E:30197 ||| PRP$
data  ||| S:30197 E:30202 ||| NNS
support  ||| S:30202 E:30210 ||| VBP
the  ||| S:30210 E:30214 ||| DT
hypothesis  ||| S:30214 E:30225 ||| NN
that  ||| S:30225 E:30230 ||| IN
IDO-induced  ||| S:30230 E:30250 ||| JJ
alterations  ||| S:30250 E:30262 ||| NN
in  ||| S:30262 E:30265 ||| IN
PG  ||| S:30265 E:30268 ||| NNP
synthesis  ||| S:30268 E:30278 ||| NN
can  ||| S:30278 E:30282 ||| MD
modify  ||| S:30282 E:30289 ||| VB
cell  ||| S:30289 E:30294 ||| NN
adhesion ||| S:30294 E:30302 ||| NN
.  ||| S:30302 E:30304 ||| .
We  ||| S:30304 E:30315 ||| PRP
observed  ||| S:30315 E:30324 ||| VBD
changes  ||| S:30324 E:30332 ||| NNS
in  ||| S:30332 E:30335 ||| IN
the  ||| S:30335 E:30339 ||| DT
relative  ||| S:30339 E:30348 ||| JJ
amounts  ||| S:30348 E:30356 ||| NNS
of  ||| S:30356 E:30359 ||| IN
PGs  ||| S:30359 E:30363 ||| JJ
in  ||| S:30363 E:30374 ||| IN
IDO-transfected  ||| S:30374 E:30390 ||| NNP
RAW  ||| S:30390 E:30394 ||| NNP
cells  ||| S:30394 E:30400 ||| NNS
and  ||| S:30400 E:30404 ||| CC
reversal  ||| S:30404 E:30413 ||| NN
of  ||| S:30413 E:30416 ||| IN
the  ||| S:30416 E:30420 ||| DT
effects  ||| S:30420 E:30428 ||| NNS
of  ||| S:30428 E:30439 ||| IN
IDO-expression  ||| S:30439 E:30454 ||| JJ
by  ||| S:30454 E:30457 ||| IN
PG  ||| S:30457 E:30460 ||| NNP
F  ||| S:30460 E:30471 ||| NNP
2α  ||| S:30471 E:30474 ||| NNP
while  ||| S:30474 E:30480 ||| IN
PG  ||| S:30480 E:30483 ||| NNP
E  ||| S:30483 E:30494 ||| NNP
2  ||| S:30494 E:30496 ||| CD
stimulated  ||| S:30496 E:30507 ||| JJ
focus  ||| S:30507 E:30513 ||| NN
formation ||| S:30513 E:30522 ||| NN
.  ||| S:30522 E:30524 ||| .
COX-2  ||| S:30524 E:30530 ||| NNP
was  ||| S:30530 E:30542 ||| VBD
upregulated  ||| S:30542 E:30554 ||| VBN
in  ||| S:30554 E:30557 ||| IN
IDO-expressing  ||| S:30557 E:30572 ||| NNP
RAW  ||| S:30572 E:30576 ||| NNP
cells ||| S:30576 E:30581 ||| NNS
.  ||| S:30581 E:30583 ||| .
Similar  ||| S:30583 E:30591 ||| JJ
effects  ||| S:30591 E:30599 ||| NNS
of  ||| S:30599 E:30610 ||| IN
PG  ||| S:30610 E:30613 ||| NNP
E  ||| S:30613 E:30624 ||| NNP
2  ||| S:30624 E:30626 ||| CD
on  ||| S:30626 E:30629 ||| IN
cell  ||| S:30629 E:30634 ||| NN
morphology  ||| S:30634 E:30645 ||| NNS
have  ||| S:30645 E:30650 ||| VBP
recently  ||| S:30650 E:30659 ||| RB
been  ||| S:30659 E:30672 ||| VBN
reported  ||| S:30672 E:30681 ||| VBN
in  ||| S:30681 E:30684 ||| IN
the  ||| S:30684 E:30688 ||| DT
human  ||| S:30688 E:30694 ||| JJ
embryonic  ||| S:30694 E:30704 ||| JJ
kidney  ||| S:30704 E:30711 ||| NN
cell  ||| S:30711 E:30716 ||| NN
line  ||| S:30716 E:30721 ||| NN
HEK  ||| S:30721 E:30725 ||| NNP
293 ||| S:30725 E:30728 ||| CD
,  ||| S:30728 E:30738 ||| ,
which  ||| S:30738 E:30744 ||| WDT
overexpressed  ||| S:30744 E:30758 ||| VBZ
COX-2  ||| S:30758 E:30764 ||| NNP
and  ||| S:30764 E:30768 ||| CC
PG  ||| S:30768 E:30771 ||| NNP
E  ||| S:30771 E:30782 ||| NNP
2  ||| S:30782 E:30784 ||| CD
synthase  ||| S:30784 E:30793 ||| NNS
[  ||| S:30793 E:30795 ||| -LRB-
35 ||| S:30795 E:30797 ||| CD
] ||| S:30797 E:30798 ||| -RRB-
.  ||| S:30798 E:30800 ||| .
COX-2 ||| S:30800 E:30805 ||| NNP
/ ||| S:30805 E:30806 ||| NNP
PG  ||| S:30806 E:30809 ||| NNP
E  ||| S:30809 E:30820 ||| NNP
2  ||| S:30820 E:30822 ||| CD
synthase-expressing  ||| S:30822 E:30842 ||| JJ
cells  ||| S:30842 E:30848 ||| NNS
were  ||| S:30848 E:30853 ||| VBD
highly  ||| S:30853 E:30868 ||| RB
aggregated ||| S:30868 E:30878 ||| JJ
,  ||| S:30878 E:30880 ||| ,
piled  ||| S:30880 E:30886 ||| VBD
up  ||| S:30886 E:30889 ||| RP
and  ||| S:30889 E:30893 ||| CC
exhibited  ||| S:30893 E:30903 ||| JJ
round  ||| S:30903 E:30909 ||| NN
shape  ||| S:30909 E:30915 ||| NN
morphology  ||| S:30915 E:30934 ||| VBZ
similar  ||| S:30934 E:30942 ||| JJ
to  ||| S:30942 E:30945 ||| TO
the  ||| S:30945 E:30949 ||| DT
RAW  ||| S:30949 E:30953 ||| NNP
cells  ||| S:30953 E:30959 ||| NNS
described  ||| S:30959 E:30969 ||| VBD
here ||| S:30969 E:30973 ||| RB
.  ||| S:30973 E:30975 ||| .
MC57  ||| S:30975 E:30980 ||| NNP
cells ||| S:30980 E:30985 ||| NNS
,  ||| S:30985 E:30987 ||| ,
which  ||| S:30987 E:31001 ||| WDT
demonstrated  ||| S:31001 E:31014 ||| VBD
similar  ||| S:31014 E:31022 ||| JJ
changes  ||| S:31022 E:31030 ||| NNS
in  ||| S:31030 E:31033 ||| IN
cell  ||| S:31033 E:31038 ||| NN
adhesion  ||| S:31038 E:31047 ||| NN
to  ||| S:31047 E:31050 ||| TO
RAW  ||| S:31050 E:31054 ||| NNP
cells  ||| S:31054 E:31068 ||| NNS
following  ||| S:31068 E:31078 ||| VBG
IDO  ||| S:31078 E:31082 ||| NNP
expression ||| S:31082 E:31092 ||| NN
,  ||| S:31092 E:31094 ||| ,
exhibited  ||| S:31094 E:31104 ||| VBG
lower  ||| S:31104 E:31110 ||| JJR
levels  ||| S:31110 E:31117 ||| NNS
of  ||| S:31117 E:31120 ||| IN
COX-2  ||| S:31120 E:31134 ||| CD
synthesis  ||| S:31134 E:31144 ||| NN
upon  ||| S:31144 E:31149 ||| IN
IDO  ||| S:31149 E:31153 ||| NNP
expression  ||| S:31153 E:31164 ||| NN
and  ||| S:31164 E:31168 ||| CC
lower  ||| S:31168 E:31174 ||| JJR
levels  ||| S:31174 E:31181 ||| NNS
of  ||| S:31181 E:31184 ||| IN
PG  ||| S:31184 E:31187 ||| NNP
E  ||| S:31187 E:31198 ||| NNP
2  ||| S:31198 E:31200 ||| CD
relative  ||| S:31200 E:31209 ||| JJ
to  ||| S:31209 E:31212 ||| TO
other  ||| S:31212 E:31218 ||| JJ
PGs  ||| S:31218 E:31222 ||| JJ
such  ||| S:31222 E:31227 ||| JJ
as  ||| S:31227 E:31230 ||| IN
D  ||| S:31230 E:31241 ||| NNP
2  ||| S:31241 E:31243 ||| CD
.  ||| S:31243 E:31245 ||| .
Furthermore ||| S:31245 E:31256 ||| RB
,  ||| S:31256 E:31258 ||| ,
adding  ||| S:31258 E:31265 ||| VBG
back  ||| S:31265 E:31270 ||| RP
PGE  ||| S:31270 E:31283 ||| NNP
2  ||| S:31283 E:31285 ||| CD
to  ||| S:31285 E:31288 ||| TO
IDO-expressing  ||| S:31288 E:31303 ||| JJ
MC57  ||| S:31303 E:31308 ||| CD
cells  ||| S:31308 E:31314 ||| NNS
did  ||| S:31314 E:31318 ||| VBD
not  ||| S:31318 E:31330 ||| RB
reproduce  ||| S:31330 E:31340 ||| VB
the  ||| S:31340 E:31344 ||| DT
wild  ||| S:31344 E:31349 ||| JJ
type  ||| S:31349 E:31354 ||| NN
phenotype  ||| S:31354 E:31364 ||| NNS
( ||| S:31364 E:31365 ||| -LRB-
not  ||| S:31365 E:31369 ||| RB
shown ||| S:31369 E:31374 ||| VBN
) ||| S:31374 E:31375 ||| -RRB-
.  ||| S:31375 E:31377 ||| .
Thus ||| S:31377 E:31381 ||| RB
,  ||| S:31381 E:31391 ||| ,
similar  ||| S:31391 E:31399 ||| JJ
effects  ||| S:31399 E:31407 ||| NNS
on  ||| S:31407 E:31410 ||| IN
cell  ||| S:31410 E:31415 ||| NN
morphology  ||| S:31415 E:31426 ||| NNS
were  ||| S:31426 E:31431 ||| VBD
produced  ||| S:31431 E:31440 ||| VBN
by  ||| S:31440 E:31451 ||| IN
opposite  ||| S:31451 E:31460 ||| JJ
effects  ||| S:31460 E:31468 ||| NNS
on  ||| S:31468 E:31471 ||| IN
COX-2  ||| S:31471 E:31477 ||| CD
expression  ||| S:31477 E:31488 ||| NN
and  ||| S:31488 E:31492 ||| CC
PG  ||| S:31492 E:31495 ||| NNP
E  ||| S:31495 E:31506 ||| NNP
2  ||| S:31506 E:31508 ||| CD
production  ||| S:31508 E:31519 ||| NN
in  ||| S:31519 E:31522 ||| IN
these  ||| S:31522 E:31528 ||| DT
two  ||| S:31528 E:31532 ||| CD
cell  ||| S:31532 E:31537 ||| NN
lines ||| S:31537 E:31542 ||| NNS
.  ||| S:31542 E:31544 ||| .
We  ||| S:31544 E:31555 ||| PRP
are  ||| S:31555 E:31559 ||| VBP
presently  ||| S:31559 E:31569 ||| RB
attempting  ||| S:31569 E:31580 ||| VBG
to  ||| S:31580 E:31583 ||| TO
determine  ||| S:31583 E:31593 ||| VB
if  ||| S:31593 E:31596 ||| IN
products  ||| S:31596 E:31605 ||| NNS
of  ||| S:31605 E:31608 ||| IN
COX-2  ||| S:31608 E:31622 ||| CD
activity  ||| S:31622 E:31631 ||| NN
other  ||| S:31631 E:31637 ||| JJ
than  ||| S:31637 E:31642 ||| IN
E  ||| S:31642 E:31653 ||| NNP
2  ||| S:31653 E:31655 ||| CD
may  ||| S:31655 E:31659 ||| MD
be  ||| S:31659 E:31662 ||| VB
responsible  ||| S:31662 E:31674 ||| JJ
for  ||| S:31674 E:31678 ||| IN
IDO  ||| S:31678 E:31682 ||| NNP
effects  ||| S:31682 E:31690 ||| NNS
in  ||| S:31690 E:31701 ||| IN
this  ||| S:31701 E:31706 ||| DT
cell  ||| S:31706 E:31711 ||| NN
line ||| S:31711 E:31715 ||| NN
.  ||| S:31715 E:31725 ||| .
The  ||| S:31725 E:31729 ||| DT
mechanism  ||| S:31729 E:31739 ||| NN
of  ||| S:31739 E:31742 ||| IN
PG-induced  ||| S:31742 E:31753 ||| JJ
changes  ||| S:31753 E:31761 ||| NNS
in  ||| S:31761 E:31764 ||| IN
cell  ||| S:31764 E:31769 ||| NN
adhesion  ||| S:31769 E:31778 ||| NNS
and  ||| S:31778 E:31790 ||| CC
morphology  ||| S:31790 E:31801 ||| NNS
may  ||| S:31801 E:31805 ||| MD
involve  ||| S:31805 E:31813 ||| VB
MMP  ||| S:31813 E:31817 ||| JJ
activity ||| S:31817 E:31825 ||| NN
.  ||| S:31825 E:31827 ||| .
Synthesis  ||| S:31827 E:31837 ||| NNP
of  ||| S:31837 E:31840 ||| IN
MMPs  ||| S:31840 E:31845 ||| JJ
such  ||| S:31845 E:31858 ||| JJ
as  ||| S:31858 E:31861 ||| IN
collagenase  ||| S:31861 E:31873 ||| VBG
I  ||| S:31873 E:31875 ||| PRP
( ||| S:31875 E:31876 ||| -LRB-
MMP-1 ||| S:31876 E:31881 ||| NNP
) ||| S:31881 E:31882 ||| -RRB-
,  ||| S:31882 E:31884 ||| ,
gelatinase  ||| S:31884 E:31895 ||| VBG
B  ||| S:31895 E:31897 ||| NNP
( ||| S:31897 E:31898 ||| -LRB-
MMP-9 ||| S:31898 E:31903 ||| NNP
)  ||| S:31903 E:31905 ||| -RRB-
and  ||| S:31905 E:31917 ||| CC
matrilysin  ||| S:31917 E:31928 ||| NNS
( ||| S:31928 E:31929 ||| -LRB-
MMP-7 ||| S:31929 E:31934 ||| NNP
)  ||| S:31934 E:31936 ||| -RRB-
has  ||| S:31936 E:31940 ||| VBZ
been  ||| S:31940 E:31945 ||| VBN
shown  ||| S:31945 E:31951 ||| VBN
to  ||| S:31951 E:31954 ||| TO
be  ||| S:31954 E:31957 ||| VB
dependent  ||| S:31957 E:31967 ||| JJ
on  ||| S:31967 E:31970 ||| IN
the  ||| S:31970 E:31982 ||| DT
synthesis  ||| S:31982 E:31992 ||| NN
of  ||| S:31992 E:31995 ||| IN
PG  ||| S:31995 E:31998 ||| NNP
E  ||| S:31998 E:32009 ||| NNP
2  ||| S:32009 E:32011 ||| CD
,  ||| S:32011 E:32013 ||| ,
suggesting  ||| S:32013 E:32024 ||| VBG
that  ||| S:32024 E:32029 ||| DT
alterations  ||| S:32029 E:32041 ||| NN
in  ||| S:32041 E:32044 ||| IN
MMP  ||| S:32044 E:32056 ||| NNP
expression  ||| S:32056 E:32067 ||| NN
may  ||| S:32067 E:32071 ||| MD
be  ||| S:32071 E:32074 ||| VB
instigated  ||| S:32074 E:32085 ||| VBN
by  ||| S:32085 E:32088 ||| IN
alterations  ||| S:32088 E:32100 ||| NN
in  ||| S:32100 E:32103 ||| IN
PG  ||| S:32103 E:32106 ||| NNP
synthesis  ||| S:32106 E:32124 ||| NNS
[  ||| S:32124 E:32126 ||| -LRB-
27 ||| S:32126 E:32128 ||| CD
,  ||| S:32128 E:32130 ||| ,
28 ||| S:32130 E:32132 ||| CD
,  ||| S:32132 E:32134 ||| ,
29 ||| S:32134 E:32136 ||| CD
,  ||| S:32136 E:32138 ||| ,
30 ||| S:32138 E:32140 ||| CD
] ||| S:32140 E:32141 ||| -RRB-
.  ||| S:32141 E:32143 ||| .
Furthermore ||| S:32143 E:32154 ||| RB
,  ||| S:32154 E:32156 ||| ,
both  ||| S:32156 E:32161 ||| DT
COX-1  ||| S:32161 E:32167 ||| NNP
and  ||| S:32167 E:32171 ||| CC
COX-2  ||| S:32171 E:32177 ||| NNP
have  ||| S:32177 E:32190 ||| VBP
recently  ||| S:32190 E:32199 ||| RB
been  ||| S:32199 E:32204 ||| VBN
shown  ||| S:32204 E:32210 ||| VBN
to  ||| S:32210 E:32213 ||| TO
mediate  ||| S:32213 E:32221 ||| VB
adhesion  ||| S:32221 E:32230 ||| VBN
of  ||| S:32230 E:32233 ||| IN
various  ||| S:32233 E:32241 ||| JJ
cell  ||| S:32241 E:32254 ||| NN
types  ||| S:32254 E:32269 ||| NNS
in  ||| S:32269 E:32272 ||| IN
vivo  ||| S:32272 E:32277 ||| NN
and  ||| S:32277 E:32290 ||| CC
in  ||| S:32290 E:32293 ||| IN
vitro  ||| S:32293 E:32299 ||| NNS
[  ||| S:32299 E:32301 ||| -LRB-
36 ||| S:32301 E:32303 ||| CD
,  ||| S:32303 E:32305 ||| ,
37 ||| S:32305 E:32307 ||| CD
] ||| S:32307 E:32308 ||| -RRB-
.  ||| S:32308 E:32310 ||| .
Thus ||| S:32310 E:32314 ||| RB
,  ||| S:32314 E:32316 ||| ,
one  ||| S:32316 E:32328 ||| CD
possibility  ||| S:32328 E:32340 ||| NN
is  ||| S:32340 E:32343 ||| VBZ
that  ||| S:32343 E:32348 ||| DT
alterations  ||| S:32348 E:32360 ||| NN
in  ||| S:32360 E:32363 ||| IN
MMP  ||| S:32363 E:32367 ||| NNP
expression  ||| S:32367 E:32378 ||| NN
and  ||| S:32378 E:32390 ||| CC
activity  ||| S:32390 E:32399 ||| NN
could  ||| S:32399 E:32405 ||| MD
modify  ||| S:32405 E:32412 ||| VB
cellular  ||| S:32412 E:32421 ||| JJ
interactions  ||| S:32421 E:32434 ||| NNS
with  ||| S:32434 E:32439 ||| IN
the  ||| S:32439 E:32451 ||| DT
extracellular  ||| S:32451 E:32465 ||| JJ
matrix  ||| S:32465 E:32472 ||| NNS
following  ||| S:32472 E:32482 ||| VBG
IDO  ||| S:32482 E:32486 ||| NNP
expression ||| S:32486 E:32496 ||| NN
.  ||| S:32496 E:32498 ||| .
Consistent  ||| S:32498 E:32517 ||| JJ
with  ||| S:32517 E:32522 ||| IN
this  ||| S:32522 E:32527 ||| DT
possibility  ||| S:32527 E:32539 ||| NN
is  ||| S:32539 E:32542 ||| VBZ
the  ||| S:32542 E:32546 ||| DT
observation  ||| S:32546 E:32558 ||| NN
that  ||| S:32558 E:32563 ||| IN
MMP  ||| S:32563 E:32575 ||| NNP
expression  ||| S:32575 E:32586 ||| NN
in  ||| S:32586 E:32589 ||| IN
P19  ||| S:32589 E:32593 ||| CD
cells  ||| S:32593 E:32599 ||| NNS
was  ||| S:32599 E:32603 ||| VBD
correlated  ||| S:32603 E:32614 ||| VBN
with  ||| S:32614 E:32619 ||| IN
the  ||| S:32619 E:32623 ||| DT
degree  ||| S:32623 E:32630 ||| NN
of  ||| S:32630 E:32641 ||| IN
IDO-antisense  ||| S:32641 E:32655 ||| JJ
expression ||| S:32655 E:32665 ||| NN
.  ||| S:32665 E:32667 ||| .
RAW  ||| S:32667 E:32671 ||| JJ
transfectants  ||| S:32671 E:32685 ||| JJ
over-expressing  ||| S:32685 E:32709 ||| JJ
IDO  ||| S:32709 E:32713 ||| NNP
showed  ||| S:32713 E:32720 ||| VBD
reduced  ||| S:32720 E:32728 ||| VBN
expression  ||| S:32728 E:32739 ||| NN
of  ||| S:32739 E:32742 ||| IN
collagenase  ||| S:32742 E:32754 ||| VBG
I  ||| S:32754 E:32756 ||| PRP
( ||| S:32756 E:32757 ||| -LRB-
MMP-1 ||| S:32757 E:32762 ||| NNP
) ||| S:32762 E:32763 ||| -RRB-
,  ||| S:32763 E:32765 ||| ,
and  ||| S:32765 E:32777 ||| CC
also  ||| S:32777 E:32782 ||| RB
bound  ||| S:32782 E:32788 ||| VBN
less  ||| S:32788 E:32793 ||| RBR
well  ||| S:32793 E:32798 ||| RB
to  ||| S:32798 E:32801 ||| TO
collagen-coated  ||| S:32801 E:32817 ||| JJ
plates  ||| S:32817 E:32824 ||| NN
than  ||| S:32824 E:32837 ||| IN
controls ||| S:32837 E:32845 ||| NNS
.  ||| S:32845 E:32847 ||| .
Collagen  ||| S:32847 E:32856 ||| NNP
is  ||| S:32856 E:32859 ||| VBZ
one  ||| S:32859 E:32863 ||| CD
of  ||| S:32863 E:32866 ||| IN
the  ||| S:32866 E:32870 ||| DT
principal  ||| S:32870 E:32880 ||| JJ
components  ||| S:32880 E:32891 ||| NNS
of  ||| S:32891 E:32902 ||| IN
the  ||| S:32902 E:32906 ||| DT
extracellular  ||| S:32906 E:32920 ||| JJ
matrix  ||| S:32920 E:32927 ||| NN
and  ||| S:32927 E:32931 ||| CC
RAW  ||| S:32931 E:32935 ||| NNP
cells  ||| S:32935 E:32941 ||| NNS
bind  ||| S:32941 E:32946 ||| VBP
poorly  ||| S:32946 E:32953 ||| RB
to  ||| S:32953 E:32964 ||| TO
fibrillar  ||| S:32964 E:32974 ||| VB
type  ||| S:32974 E:32979 ||| NN
I  ||| S:32979 E:32981 ||| PRP
collagen  ||| S:32981 E:32990 ||| VBD
unless  ||| S:32990 E:32997 ||| IN
it  ||| S:32997 E:33000 ||| PRP
is  ||| S:33000 E:33003 ||| VBZ
denatured  ||| S:33003 E:33013 ||| VBN
or  ||| S:33013 E:33024 ||| CC
activated  ||| S:33024 E:33034 ||| VBN
by  ||| S:33034 E:33037 ||| IN
collagenase  ||| S:33037 E:33049 ||| NNS
[  ||| S:33049 E:33051 ||| -LRB-
38 ||| S:33051 E:33053 ||| CD
] ||| S:33053 E:33054 ||| -RRB-
.  ||| S:33054 E:33056 ||| .
Thus ||| S:33056 E:33060 ||| RB
,  ||| S:33060 E:33062 ||| ,
the  ||| S:33062 E:33066 ||| DT
diminished  ||| S:33066 E:33085 ||| JJ
expression  ||| S:33085 E:33096 ||| NN
of  ||| S:33096 E:33099 ||| IN
MMP-1  ||| S:33099 E:33105 ||| CD
in  ||| S:33105 E:33108 ||| IN
IDO  ||| S:33108 E:33112 ||| NNP
transfectants  ||| S:33112 E:33126 ||| NN
could  ||| S:33126 E:33132 ||| MD
explain  ||| S:33132 E:33148 ||| VB
their  ||| S:33148 E:33154 ||| PRP$
weaker  ||| S:33154 E:33161 ||| JJR
binding  ||| S:33161 E:33169 ||| NN
to  ||| S:33169 E:33172 ||| TO
this  ||| S:33172 E:33177 ||| DT
substrate ||| S:33177 E:33186 ||| NN
.  ||| S:33186 E:33188 ||| .
The  ||| S:33188 E:33192 ||| DT
mechanism  ||| S:33192 E:33202 ||| NN
by  ||| S:33202 E:33213 ||| IN
which  ||| S:33213 E:33219 ||| WDT
IDO  ||| S:33219 E:33223 ||| NNP
regulates  ||| S:33223 E:33233 ||| VBZ
prostaglandin  ||| S:33233 E:33247 ||| JJ
synthesis  ||| S:33247 E:33257 ||| NN
is  ||| S:33257 E:33260 ||| VBZ
yet  ||| S:33260 E:33264 ||| RB
to  ||| S:33264 E:33267 ||| TO
be  ||| S:33267 E:33278 ||| VB
determined ||| S:33278 E:33288 ||| VBN
.  ||| S:33288 E:33290 ||| .
Tryptophan  ||| S:33290 E:33301 ||| NNP
is  ||| S:33301 E:33304 ||| VBZ
a  ||| S:33304 E:33306 ||| DT
stimulatory  ||| S:33306 E:33318 ||| JJ
co-factor  ||| S:33318 E:33328 ||| NN
for  ||| S:33328 E:33332 ||| IN
COX  ||| S:33332 E:33344 ||| NNP
and  ||| S:33344 E:33348 ||| CC
degradation  ||| S:33348 E:33360 ||| NN
of  ||| S:33360 E:33363 ||| IN
tryptophan  ||| S:33363 E:33374 ||| NN
in  ||| S:33374 E:33377 ||| IN
the  ||| S:33377 E:33381 ||| DT
intracellular  ||| S:33381 E:33403 ||| JJ
environment  ||| S:33403 E:33415 ||| NN
could  ||| S:33415 E:33421 ||| MD
alter  ||| S:33421 E:33427 ||| VB
COX  ||| S:33427 E:33431 ||| JJ
activity ||| S:33431 E:33439 ||| NN
.  ||| S:33439 E:33441 ||| .
Alternatively ||| S:33441 E:33454 ||| RB
,  ||| S:33454 E:33456 ||| ,
IDO  ||| S:33456 E:33468 ||| NNP
might  ||| S:33468 E:33474 ||| MD
influence  ||| S:33474 E:33484 ||| VB
COX  ||| S:33484 E:33488 ||| JJ
activity  ||| S:33488 E:33497 ||| NN
and  ||| S:33497 E:33501 ||| CC
expression  ||| S:33501 E:33512 ||| NN
through  ||| S:33512 E:33528 ||| IN
competition  ||| S:33528 E:33540 ||| NN
for  ||| S:33540 E:33544 ||| IN
or  ||| S:33544 E:33547 ||| CC
release  ||| S:33547 E:33555 ||| NN
of  ||| S:33555 E:33558 ||| IN
heme ||| S:33558 E:33562 ||| NN
,  ||| S:33562 E:33564 ||| ,
which  ||| S:33564 E:33570 ||| WDT
both  ||| S:33570 E:33575 ||| DT
enzymes  ||| S:33575 E:33591 ||| NNS
require ||| S:33591 E:33598 ||| VBP
.  ||| S:33598 E:33609 ||| .
In  ||| S:33609 E:33612 ||| IN
vitro  ||| S:33612 E:33618 ||| NN
,  ||| S:33618 E:33620 ||| ,
arachidonic  ||| S:33620 E:33632 ||| JJ
acid  ||| S:33632 E:33645 ||| NN
stimulates  ||| S:33645 E:33656 ||| VBD
the  ||| S:33656 E:33660 ||| DT
dissociation  ||| S:33660 E:33673 ||| NN
of  ||| S:33673 E:33676 ||| IN
heme  ||| S:33676 E:33681 ||| NN
from  ||| S:33681 E:33686 ||| IN
IDO  ||| S:33686 E:33690 ||| NNP
and  ||| S:33690 E:33694 ||| CC
this  ||| S:33694 E:33707 ||| DT
correlates  ||| S:33707 E:33718 ||| NN
with  ||| S:33718 E:33723 ||| IN
IDO  ||| S:33723 E:33727 ||| NNP
stimulatory  ||| S:33727 E:33739 ||| NN
effects  ||| S:33739 E:33747 ||| NNS
on  ||| S:33747 E:33750 ||| IN
COX  ||| S:33750 E:33754 ||| NNP
[  ||| S:33754 E:33756 ||| -LRB-
39 ||| S:33756 E:33758 ||| CD
] ||| S:33758 E:33759 ||| -RRB-
,  ||| S:33759 E:33769 ||| ,
providing  ||| S:33769 E:33779 ||| VBG
circumstantial  ||| S:33779 E:33794 ||| JJ
support  ||| S:33794 E:33802 ||| NN
for  ||| S:33802 E:33806 ||| IN
the  ||| S:33806 E:33810 ||| DT
latter  ||| S:33810 E:33825 ||| JJ
possibility ||| S:33825 E:33836 ||| NN
.  ||| S:33836 E:33846 ||| .
The  ||| S:33846 E:33850 ||| DT
alterations  ||| S:33850 E:33862 ||| NN
in  ||| S:33862 E:33865 ||| IN
COX-2  ||| S:33865 E:33871 ||| CD
expression  ||| S:33871 E:33882 ||| NN
observed  ||| S:33882 E:33891 ||| VBD
in  ||| S:33891 E:33902 ||| IN
IDO-expressing  ||| S:33902 E:33917 ||| NNP
RAW  ||| S:33917 E:33921 ||| NNP
and  ||| S:33921 E:33925 ||| CC
MC57  ||| S:33925 E:33930 ||| CD
cells  ||| S:33930 E:33936 ||| NNS
are  ||| S:33936 E:33940 ||| VBP
a  ||| S:33940 E:33942 ||| DT
particularly  ||| S:33942 E:33963 ||| RB
interesting  ||| S:33963 E:33975 ||| JJ
feature  ||| S:33975 E:33983 ||| NN
of  ||| S:33983 E:33986 ||| IN
our  ||| S:33986 E:33990 ||| PRP$
results ||| S:33990 E:33997 ||| NNS
.  ||| S:33997 E:33999 ||| .
COX-2  ||| S:33999 E:34005 ||| NNP
is  ||| S:34005 E:34008 ||| VBZ
inducible  ||| S:34008 E:34018 ||| VBN
by  ||| S:34018 E:34021 ||| IN
a  ||| S:34021 E:34031 ||| DT
number  ||| S:34031 E:34038 ||| NN
of  ||| S:34038 E:34041 ||| IN
inflammatory  ||| S:34041 E:34054 ||| JJ
mediators  ||| S:34054 E:34064 ||| NNS
including  ||| S:34064 E:34074 ||| VBG
IFN-γ  ||| S:34074 E:34080 ||| JJ
[  ||| S:34080 E:34082 ||| -LRB-
40 ||| S:34082 E:34084 ||| CD
]  ||| S:34084 E:34086 ||| -RRB-
and  ||| S:34086 E:34098 ||| CC
LPS  ||| S:34098 E:34102 ||| NNP
[  ||| S:34102 E:34104 ||| -LRB-
32 ||| S:34104 E:34106 ||| CD
] ||| S:34106 E:34107 ||| -RRB-
.  ||| S:34107 E:34109 ||| .
These  ||| S:34109 E:34115 ||| DT
also  ||| S:34115 E:34120 ||| RB
induce  ||| S:34120 E:34127 ||| VB
IDO ||| S:34127 E:34130 ||| NNP
.  ||| S:34130 E:34132 ||| .
Treatment  ||| S:34132 E:34142 ||| NN
of  ||| S:34142 E:34153 ||| IN
IDO-expressing  ||| S:34153 E:34168 ||| NNP
RAW  ||| S:34168 E:34172 ||| NNP
clones  ||| S:34172 E:34179 ||| NNS
with  ||| S:34179 E:34184 ||| IN
a  ||| S:34184 E:34186 ||| DT
known  ||| S:34186 E:34192 ||| JJ
inducer  ||| S:34192 E:34200 ||| NN
of  ||| S:34200 E:34203 ||| IN
COX-2  ||| S:34203 E:34217 ||| NNP
( ||| S:34217 E:34218 ||| -LRB-
LPS ||| S:34218 E:34221 ||| NNP
) ||| S:34221 E:34222 ||| -RRB-
,  ||| S:34222 E:34224 ||| ,
revealed  ||| S:34224 E:34233 ||| VBD
a  ||| S:34233 E:34235 ||| DT
lack  ||| S:34235 E:34240 ||| NN
of  ||| S:34240 E:34243 ||| IN
correlation  ||| S:34243 E:34255 ||| NN
between  ||| S:34255 E:34263 ||| IN
COX-2  ||| S:34263 E:34269 ||| NNP
RNA  ||| S:34269 E:34273 ||| NNP
and  ||| S:34273 E:34285 ||| CC
protein  ||| S:34285 E:34293 ||| NN
levels ||| S:34293 E:34299 ||| NNS
.  ||| S:34299 E:34301 ||| .
Clones  ||| S:34301 E:34308 ||| NNP
11  ||| S:34308 E:34311 ||| CD
and  ||| S:34311 E:34315 ||| CC
22  ||| S:34315 E:34318 ||| CD
showed  ||| S:34318 E:34325 ||| VBD
low  ||| S:34325 E:34329 ||| JJ
levels  ||| S:34329 E:34336 ||| NNS
of  ||| S:34336 E:34339 ||| IN
COX-2  ||| S:34339 E:34353 ||| CD
message  ||| S:34353 E:34361 ||| NN
but  ||| S:34361 E:34365 ||| CC
high  ||| S:34365 E:34370 ||| JJ
levels  ||| S:34370 E:34377 ||| NNS
of  ||| S:34377 E:34380 ||| IN
protein  ||| S:34380 E:34388 ||| NN
following  ||| S:34388 E:34398 ||| VBG
LPS  ||| S:34398 E:34402 ||| NNP
treatment ||| S:34402 E:34411 ||| NN
.  ||| S:34411 E:34421 ||| .
This  ||| S:34421 E:34426 ||| DT
suggests  ||| S:34426 E:34435 ||| VBZ
that  ||| S:34435 E:34440 ||| IN
COX-2  ||| S:34440 E:34446 ||| NNP
RNA  ||| S:34446 E:34450 ||| NNP
and ||| S:34450 E:34453 ||| CC
/ ||| S:34453 E:34454 ||| NNP
or  ||| S:34454 E:34457 ||| CC
protein  ||| S:34457 E:34465 ||| NN
turnover  ||| S:34465 E:34474 ||| NN
may  ||| S:34474 E:34478 ||| MD
be  ||| S:34478 E:34489 ||| VB
affected  ||| S:34489 E:34498 ||| VBN
by  ||| S:34498 E:34501 ||| IN
IDO  ||| S:34501 E:34505 ||| NNP
expression ||| S:34505 E:34515 ||| NN
.  ||| S:34515 E:34517 ||| .
Other  ||| S:34517 E:34523 ||| JJ
workers  ||| S:34523 E:34531 ||| NNS
have  ||| S:34531 E:34536 ||| VBP
noted  ||| S:34536 E:34542 ||| VBN
that  ||| S:34542 E:34555 ||| IN
non-steroidal  ||| S:34555 E:34569 ||| JJ
anti-inflammatory  ||| S:34569 E:34587 ||| JJ
drugs ||| S:34587 E:34592 ||| NNS
,  ||| S:34592 E:34594 ||| ,
which  ||| S:34594 E:34600 ||| WDT
inhibit  ||| S:34600 E:34608 ||| VBP
COX  ||| S:34608 E:34620 ||| JJ
activity  ||| S:34620 E:34629 ||| NN
result  ||| S:34629 E:34636 ||| NN
in  ||| S:34636 E:34639 ||| IN
increased  ||| S:34639 E:34649 ||| JJ
COX  ||| S:34649 E:34653 ||| NNP
protein  ||| S:34653 E:34661 ||| NN
expression  ||| S:34661 E:34672 ||| NN
[  ||| S:34672 E:34674 ||| -LRB-
41 ||| S:34674 E:34676 ||| CD
] ||| S:34676 E:34677 ||| -RRB-
,  ||| S:34677 E:34687 ||| ,
while  ||| S:34687 E:34693 ||| IN
differences  ||| S:34693 E:34705 ||| NNS
between  ||| S:34705 E:34713 ||| IN
COX  ||| S:34713 E:34717 ||| NNP
protein  ||| S:34717 E:34725 ||| NN
expression  ||| S:34725 E:34736 ||| NN
and  ||| S:34736 E:34748 ||| CC
activity  ||| S:34748 E:34757 ||| NN
have  ||| S:34757 E:34762 ||| VBP
been  ||| S:34762 E:34767 ||| VBN
reported  ||| S:34767 E:34776 ||| VBN
to  ||| S:34776 E:34779 ||| TO
be  ||| S:34779 E:34782 ||| VB
produced  ||| S:34782 E:34791 ||| VBN
by  ||| S:34791 E:34794 ||| IN
some  ||| S:34794 E:34807 ||| DT
cytokines ||| S:34807 E:34816 ||| NN
,  ||| S:34816 E:34818 ||| ,
including  ||| S:34818 E:34828 ||| VBG
tumor  ||| S:34828 E:34834 ||| NN
necrosis  ||| S:34834 E:34843 ||| NN
factor-α ||| S:34843 E:34851 ||| NN
,  ||| S:34851 E:34853 ||| ,
and  ||| S:34853 E:34857 ||| CC
also  ||| S:34857 E:34870 ||| RB
nitric  ||| S:34870 E:34877 ||| JJ
oxide  ||| S:34877 E:34883 ||| NN
donors  ||| S:34883 E:34890 ||| NNS
[  ||| S:34890 E:34892 ||| -LRB-
42 ||| S:34892 E:34894 ||| CD
,  ||| S:34894 E:34896 ||| ,
43 ||| S:34896 E:34898 ||| CD
] ||| S:34898 E:34899 ||| -RRB-
.  ||| S:34899 E:34901 ||| .
Although  ||| S:34901 E:34910 ||| IN
not  ||| S:34910 E:34914 ||| RB
well  ||| S:34914 E:34927 ||| RB
understood ||| S:34927 E:34937 ||| VBN
,  ||| S:34937 E:34939 ||| ,
evidence  ||| S:34939 E:34948 ||| NN
for  ||| S:34948 E:34952 ||| IN
regulation  ||| S:34952 E:34963 ||| NN
of  ||| S:34963 E:34966 ||| IN
COX  ||| S:34966 E:34970 ||| NNP
expression  ||| S:34970 E:34981 ||| NN
at  ||| S:34981 E:34992 ||| IN
the  ||| S:34992 E:34996 ||| DT
post-transcriptional  ||| S:34996 E:35017 ||| JJ
level  ||| S:35017 E:35023 ||| NN
is  ||| S:35023 E:35026 ||| VBZ
increasing  ||| S:35026 E:35037 ||| VBG
[  ||| S:35037 E:35039 ||| -LRB-
44 ||| S:35039 E:35041 ||| CD
,  ||| S:35041 E:35043 ||| ,
45 ||| S:35043 E:35045 ||| CD
] ||| S:35045 E:35046 ||| -RRB-
.  ||| S:35046 E:35048 ||| .
The  ||| S:35048 E:35060 ||| DT
down  ||| S:35060 E:35065 ||| JJ
regulation  ||| S:35065 E:35076 ||| NN
of  ||| S:35076 E:35079 ||| IN
COX-2  ||| S:35079 E:35085 ||| CD
transcripts  ||| S:35085 E:35097 ||| NNS
in  ||| S:35097 E:35100 ||| IN
LPS-treated ||| S:35100 E:35111 ||| NNP
,  ||| S:35111 E:35121 ||| ,
IDO-expressing  ||| S:35121 E:35136 ||| NNP
RAW  ||| S:35136 E:35140 ||| NNP
cells  ||| S:35140 E:35146 ||| NNS
is  ||| S:35146 E:35149 ||| VBZ
reminiscent  ||| S:35149 E:35161 ||| VBN
of  ||| S:35161 E:35164 ||| IN
the  ||| S:35164 E:35168 ||| DT
endotoxin  ||| S:35168 E:35186 ||| JJ
tolerance  ||| S:35186 E:35196 ||| NN
effect  ||| S:35196 E:35203 ||| NN
observed  ||| S:35203 E:35212 ||| VBD
in  ||| S:35212 E:35215 ||| IN
human  ||| S:35215 E:35221 ||| JJ
THP-1  ||| S:35221 E:35227 ||| CD
promonocytic  ||| S:35227 E:35248 ||| CD
cells ||| S:35248 E:35253 ||| NNS
.  ||| S:35253 E:35255 ||| .
Cells  ||| S:35255 E:35261 ||| NNS
pretreated  ||| S:35261 E:35272 ||| VBN
with  ||| S:35272 E:35277 ||| IN
LPS  ||| S:35277 E:35281 ||| NNP
and  ||| S:35281 E:35285 ||| CC
thus  ||| S:35285 E:35290 ||| RB
expressing  ||| S:35290 E:35301 ||| VBG
COX-2  ||| S:35301 E:35315 ||| NNP
showed  ||| S:35315 E:35322 ||| VBD
down  ||| S:35322 E:35327 ||| RP
regulation  ||| S:35327 E:35338 ||| NN
of  ||| S:35338 E:35341 ||| IN
COX-2  ||| S:35341 E:35347 ||| CD
mRNA  ||| S:35347 E:35352 ||| NN
when  ||| S:35352 E:35357 ||| WRB
subjected  ||| S:35357 E:35367 ||| VBN
to  ||| S:35367 E:35370 ||| TO
a  ||| S:35370 E:35380 ||| DT
second  ||| S:35380 E:35387 ||| JJ
LPS  ||| S:35387 E:35391 ||| NNP
exposure  ||| S:35391 E:35400 ||| NN
[  ||| S:35400 E:35402 ||| -LRB-
46 ||| S:35402 E:35404 ||| CD
] ||| S:35404 E:35405 ||| -RRB-
.  ||| S:35405 E:35407 ||| .
In  ||| S:35407 E:35410 ||| IN
addition ||| S:35410 E:35418 ||| NN
,  ||| S:35418 E:35420 ||| ,
the  ||| S:35420 E:35424 ||| DT
COX-2  ||| S:35424 E:35430 ||| FW
inhibitor  ||| S:35430 E:35448 ||| FW
flufenamic  ||| S:35448 E:35459 ||| FW
acid  ||| S:35459 E:35464 ||| FW
induced  ||| S:35464 E:35472 ||| FW
COX-2  ||| S:35472 E:35478 ||| FW
expression  ||| S:35478 E:35489 ||| NN
in  ||| S:35489 E:35492 ||| IN
RAW  ||| S:35492 E:35496 ||| NNP
cells  ||| S:35496 E:35502 ||| NNS
but  ||| S:35502 E:35514 ||| CC
inhibited  ||| S:35514 E:35524 ||| JJ
TNF-α  ||| S:35524 E:35530 ||| JJ
or  ||| S:35530 E:35533 ||| CC
LPS-induced  ||| S:35533 E:35545 ||| JJ
COX-2  ||| S:35545 E:35551 ||| CD
expression  ||| S:35551 E:35562 ||| NN
in  ||| S:35562 E:35565 ||| IN
the  ||| S:35565 E:35569 ||| DT
same  ||| S:35569 E:35582 ||| JJ
cell  ||| S:35582 E:35587 ||| NN
type  ||| S:35587 E:35592 ||| NN
[  ||| S:35592 E:35594 ||| -LRB-
47 ||| S:35594 E:35596 ||| CD
] ||| S:35596 E:35597 ||| -RRB-
.  ||| S:35597 E:35607 ||| .
As  ||| S:35607 E:35610 ||| IN
both  ||| S:35610 E:35615 ||| DT
MMPs  ||| S:35615 E:35620 ||| JJ
and  ||| S:35620 E:35624 ||| CC
COX-2  ||| S:35624 E:35630 ||| NNP
are  ||| S:35630 E:35634 ||| VBP
important  ||| S:35634 E:35644 ||| JJ
factors  ||| S:35644 E:35652 ||| NNS
in  ||| S:35652 E:35655 ||| IN
tumor  ||| S:35655 E:35669 ||| NN
development  ||| S:35669 E:35681 ||| NN
[  ||| S:35681 E:35683 ||| -LRB-
48 ||| S:35683 E:35685 ||| CD
,  ||| S:35685 E:35687 ||| ,
49 ||| S:35687 E:35689 ||| CD
]  ||| S:35689 E:35691 ||| -RRB-
IDO ||| S:35691 E:35694 ||| NNP
's  ||| S:35694 E:35697 ||| POS
role  ||| S:35697 E:35702 ||| NN
in  ||| S:35702 E:35705 ||| IN
tumorigenesis  ||| S:35705 E:35719 ||| NN
bears  ||| S:35719 E:35733 ||| VBZ
investigating ||| S:35733 E:35746 ||| VBG
.  ||| S:35746 E:35748 ||| .
We  ||| S:35748 E:35751 ||| PRP
have  ||| S:35751 E:35756 ||| VBP
observed  ||| S:35756 E:35765 ||| VBN
IDO  ||| S:35765 E:35769 ||| NNP
expression  ||| S:35769 E:35780 ||| NN
routinely  ||| S:35780 E:35790 ||| RB
in  ||| S:35790 E:35801 ||| IN
murine  ||| S:35801 E:35808 ||| JJ
tumors  ||| S:35808 E:35824 ||| NNS
in  ||| S:35824 E:35827 ||| IN
vivo  ||| S:35827 E:35832 ||| NN
,  ||| S:35832 E:35834 ||| ,
and  ||| S:35834 E:35838 ||| CC
are  ||| S:35838 E:35842 ||| VBP
presently  ||| S:35842 E:35860 ||| RB
investigating  ||| S:35860 E:35874 ||| VBG
the  ||| S:35874 E:35878 ||| DT
growth  ||| S:35878 E:35885 ||| NN
properties  ||| S:35885 E:35896 ||| NNS
of  ||| S:35896 E:35899 ||| IN
tumors  ||| S:35899 E:35906 ||| NNS
with  ||| S:35906 E:35911 ||| IN
altered  ||| S:35911 E:35927 ||| JJ
IDO  ||| S:35927 E:35931 ||| NNP
expression ||| S:35931 E:35941 ||| NN
.  ||| S:35941 E:35943 ||| .
In  ||| S:35943 E:35946 ||| IN
addition ||| S:35946 E:35954 ||| NN
,  ||| S:35954 E:35956 ||| ,
our  ||| S:35956 E:35960 ||| PRP$
recent  ||| S:35960 E:35967 ||| JJ
work  ||| S:35967 E:35972 ||| NN
indicates  ||| S:35972 E:35982 ||| VBZ
a  ||| S:35982 E:35992 ||| DT
role  ||| S:35992 E:35997 ||| NN
for  ||| S:35997 E:36001 ||| IN
IDO  ||| S:36001 E:36005 ||| NNP
during  ||| S:36005 E:36012 ||| IN
pregnancy ||| S:36012 E:36021 ||| NN
.  ||| S:36021 E:36023 ||| .
Pharmacological  ||| S:36023 E:36039 ||| JJ
inhibition  ||| S:36039 E:36058 ||| NN
of  ||| S:36058 E:36061 ||| IN
IDO  ||| S:36061 E:36065 ||| NNP
results  ||| S:36065 E:36073 ||| NNS
in  ||| S:36073 E:36076 ||| IN
pronounced  ||| S:36076 E:36087 ||| JJ
inflammation ||| S:36087 E:36099 ||| NN
,  ||| S:36099 E:36101 ||| ,
complement  ||| S:36101 E:36120 ||| JJ
activation  ||| S:36120 E:36131 ||| NN
and  ||| S:36131 E:36135 ||| CC
fetal  ||| S:36135 E:36141 ||| JJ
loss  ||| S:36141 E:36146 ||| NN
[  ||| S:36146 E:36148 ||| -LRB-
17 ||| S:36148 E:36150 ||| CD
,  ||| S:36150 E:36152 ||| ,
50 ||| S:36152 E:36154 ||| CD
] ||| S:36154 E:36155 ||| -RRB-
.  ||| S:36155 E:36157 ||| .
Prostaglandins  ||| S:36157 E:36172 ||| NNP
may  ||| S:36172 E:36184 ||| MD
provide  ||| S:36184 E:36192 ||| VB
a  ||| S:36192 E:36194 ||| DT
common  ||| S:36194 E:36201 ||| JJ
link  ||| S:36201 E:36206 ||| NN
between  ||| S:36206 E:36214 ||| IN
these  ||| S:36214 E:36220 ||| DT
important  ||| S:36220 E:36230 ||| JJ
biological  ||| S:36230 E:36249 ||| JJ
phenomena ||| S:36249 E:36258 ||| NNS
.  ||| S:36258 E:36282 ||| .
Conclusions  ||| S:36282 E:36302 ||| NNP
IDO  ||| S:36302 E:36306 ||| NNP
regulates  ||| S:36306 E:36316 ||| VBZ
adhesion  ||| S:36316 E:36325 ||| VBN
of  ||| S:36325 E:36328 ||| IN
cells  ||| S:36328 E:36334 ||| NNS
to  ||| S:36334 E:36337 ||| TO
normal  ||| S:36337 E:36344 ||| JJ
growth  ||| S:36344 E:36359 ||| NN
substrates ||| S:36359 E:36369 ||| NN
.  ||| S:36369 E:36371 ||| .
In  ||| S:36371 E:36374 ||| IN
so  ||| S:36374 E:36377 ||| RB
doing  ||| S:36377 E:36383 ||| VBG
it  ||| S:36383 E:36386 ||| PRP
modulates  ||| S:36386 E:36396 ||| VBD
the  ||| S:36396 E:36400 ||| DT
expression  ||| S:36400 E:36411 ||| NN
and  ||| S:36411 E:36423 ||| CC
activity  ||| S:36423 E:36432 ||| NN
of  ||| S:36432 E:36435 ||| IN
COX-2  ||| S:36435 E:36441 ||| NNP
and  ||| S:36441 E:36445 ||| CC
certain  ||| S:36445 E:36453 ||| JJ
MMPs ||| S:36453 E:36457 ||| NN
.  ||| S:36457 E:36459 ||| .
RAW  ||| S:36459 E:36463 ||| JJ
cells  ||| S:36463 E:36469 ||| NNS
and  ||| S:36469 E:36473 ||| CC
MC57  ||| S:36473 E:36486 ||| CD
cells  ||| S:36486 E:36492 ||| NNS
overexpressing  ||| S:36492 E:36507 ||| VBD
IDO  ||| S:36507 E:36511 ||| NNP
grew  ||| S:36511 E:36516 ||| VBD
as  ||| S:36516 E:36519 ||| IN
multicellular  ||| S:36519 E:36533 ||| JJ
foci ||| S:36533 E:36537 ||| NN
.  ||| S:36537 E:36539 ||| .
In  ||| S:36539 E:36542 ||| IN
the  ||| S:36542 E:36554 ||| DT
case  ||| S:36554 E:36559 ||| NN
of  ||| S:36559 E:36562 ||| IN
RAW  ||| S:36562 E:36566 ||| NNP
cells ||| S:36566 E:36571 ||| NNS
,  ||| S:36571 E:36573 ||| ,
this  ||| S:36573 E:36578 ||| DT
was  ||| S:36578 E:36582 ||| VBD
due  ||| S:36582 E:36586 ||| JJ
to  ||| S:36586 E:36589 ||| TO
elevated  ||| S:36589 E:36598 ||| VB
PGE  ||| S:36598 E:36602 ||| JJ
relative  ||| S:36602 E:36611 ||| JJ
to  ||| S:36611 E:36622 ||| TO
other  ||| S:36622 E:36628 ||| JJ
prostaglandins ||| S:36628 E:36642 ||| NN
.  ||| S:36642 E:36644 ||| .
P19  ||| S:36644 E:36648 ||| NNP
cells  ||| S:36648 E:36654 ||| NNS
in  ||| S:36654 E:36657 ||| IN
which  ||| S:36657 E:36663 ||| WDT
endogenousIDO  ||| S:36663 E:36685 ||| JJ
expression  ||| S:36685 E:36696 ||| NN
was  ||| S:36696 E:36700 ||| VBD
disrupted  ||| S:36700 E:36710 ||| VBN
by  ||| S:36710 E:36713 ||| IN
antisense  ||| S:36713 E:36723 ||| JJ
expression ||| S:36723 E:36733 ||| NN
,  ||| S:36733 E:36735 ||| ,
showed  ||| S:36735 E:36750 ||| VBD
lower  ||| S:36750 E:36756 ||| JJR
adhesiveness ||| S:36756 E:36768 ||| NN
.  ||| S:36768 E:36770 ||| .
Thus ||| S:36770 E:36774 ||| RB
,  ||| S:36774 E:36776 ||| ,
tryptophan  ||| S:36776 E:36787 ||| FW
catabolism  ||| S:36787 E:36798 ||| FW
exerts  ||| S:36798 E:36813 ||| FW
control  ||| S:36813 E:36821 ||| NN
over  ||| S:36821 E:36826 ||| IN
fundamental  ||| S:36826 E:36838 ||| JJ
cellular  ||| S:36838 E:36847 ||| JJ
functions ||| S:36847 E:36856 ||| NNS
.  ||| S:36856 E:36880 ||| .
Materials  ||| S:36880 E:36890 ||| NNS
and  ||| S:36890 E:36894 ||| CC
Methods  ||| S:36894 E:36921 ||| NNP
Cells  ||| S:36921 E:36937 ||| NNP
P19  ||| S:36937 E:36941 ||| NNP
cells  ||| S:36941 E:36947 ||| NNS
were  ||| S:36947 E:36952 ||| VBD
obtained  ||| S:36952 E:36961 ||| VBN
from  ||| S:36961 E:36966 ||| IN
the  ||| S:36966 E:36970 ||| DT
American  ||| S:36970 E:36979 ||| NNP
Type  ||| S:36979 E:36984 ||| NNP
Culture  ||| S:36984 E:37002 ||| NNP
Collection  ||| S:37002 E:37013 ||| NNP
and  ||| S:37013 E:37017 ||| CC
cultured  ||| S:37017 E:37026 ||| VBP
as  ||| S:37026 E:37029 ||| RB
described  ||| S:37029 E:37039 ||| VBN
[  ||| S:37039 E:37041 ||| -LRB-
23 ||| S:37041 E:37043 ||| CD
] ||| S:37043 E:37044 ||| -RRB-
.  ||| S:37044 E:37046 ||| .
Cells  ||| S:37046 E:37052 ||| NNS
were  ||| S:37052 E:37067 ||| VBD
differentiated  ||| S:37067 E:37082 ||| VBN
into  ||| S:37082 E:37087 ||| IN
myocytes  ||| S:37087 E:37096 ||| NN
or  ||| S:37096 E:37099 ||| CC
neurones  ||| S:37099 E:37108 ||| VBP
using  ||| S:37108 E:37114 ||| VBG
1 ||| S:37114 E:37115 ||| CD
%  ||| S:37115 E:37117 ||| NN
DMSO  ||| S:37117 E:37132 ||| NNP
and  ||| S:37132 E:37136 ||| CC
10  ||| S:37136 E:37139 ||| CD
-6M  ||| S:37139 E:37143 ||| CD
RA  ||| S:37143 E:37146 ||| NNP
respectively  ||| S:37146 E:37159 ||| RB
as  ||| S:37159 E:37162 ||| RB
previously  ||| S:37162 E:37173 ||| RB
reported  ||| S:37173 E:37182 ||| VBD
[  ||| S:37182 E:37184 ||| -LRB-
23 ||| S:37184 E:37186 ||| CD
,  ||| S:37186 E:37198 ||| ,
24 ||| S:37198 E:37200 ||| CD
] ||| S:37200 E:37201 ||| -RRB-
.  ||| S:37201 E:37203 ||| .
RAW  ||| S:37203 E:37207 ||| JJ
264.7  ||| S:37207 E:37213 ||| CD
cells  ||| S:37213 E:37219 ||| NNS
were  ||| S:37219 E:37224 ||| VBD
a  ||| S:37224 E:37226 ||| DT
gift  ||| S:37226 E:37231 ||| NN
of  ||| S:37231 E:37234 ||| IN
Dr.  ||| S:37234 E:37238 ||| NNP
D.  ||| S:37238 E:37241 ||| NNP
Greaves  ||| S:37241 E:37259 ||| NNP
( ||| S:37259 E:37260 ||| -LRB-
Oxford ||| S:37260 E:37266 ||| NNP
,  ||| S:37266 E:37268 ||| ,
England ||| S:37268 E:37275 ||| NNP
)  ||| S:37275 E:37277 ||| -RRB-
and  ||| S:37277 E:37281 ||| CC
were  ||| S:37281 E:37286 ||| VBD
cultured  ||| S:37286 E:37295 ||| VBN
in  ||| S:37295 E:37298 ||| IN
Iscove ||| S:37298 E:37304 ||| NNP
's  ||| S:37304 E:37307 ||| POS
Modified  ||| S:37307 E:37326 ||| NNP
Dulbecco ||| S:37326 E:37334 ||| NNP
's  ||| S:37334 E:37337 ||| POS
Medium  ||| S:37337 E:37344 ||| JJ
supplemented  ||| S:37344 E:37357 ||| NN
with  ||| S:37357 E:37362 ||| IN
10 ||| S:37362 E:37364 ||| CD
%  ||| S:37364 E:37366 ||| NN
fetal  ||| S:37366 E:37372 ||| JJ
calf  ||| S:37372 E:37377 ||| JJ
serum ||| S:37377 E:37382 ||| NN
.  ||| S:37382 E:37394 ||| .
MC57  ||| S:37394 E:37399 ||| NNP
cells  ||| S:37399 E:37405 ||| NNS
were  ||| S:37405 E:37410 ||| VBD
obtained  ||| S:37410 E:37419 ||| VBN
from  ||| S:37419 E:37424 ||| IN
Dr.  ||| S:37424 E:37428 ||| NNP
Dimitrios  ||| S:37428 E:37438 ||| NNP
Moskiphidis ||| S:37438 E:37449 ||| NNP
,  ||| S:37449 E:37461 ||| ,
Medical  ||| S:37461 E:37469 ||| NNP
College  ||| S:37469 E:37477 ||| NNP
of  ||| S:37477 E:37480 ||| IN
Georgia  ||| S:37480 E:37488 ||| NNP
and  ||| S:37488 E:37492 ||| CC
grown  ||| S:37492 E:37498 ||| VBN
in  ||| S:37498 E:37501 ||| IN
Iscove ||| S:37501 E:37507 ||| NNP
's  ||| S:37507 E:37510 ||| POS
Modified  ||| S:37510 E:37529 ||| NNP
Dulbecco ||| S:37529 E:37537 ||| NNP
's  ||| S:37537 E:37540 ||| POS
Medium ||| S:37540 E:37546 ||| NNP
.  ||| S:37546 E:37576 ||| .
IDO  ||| S:37576 E:37580 ||| NNP
expression  ||| S:37580 E:37601 ||| VBD
A  ||| S:37601 E:37603 ||| DT
full  ||| S:37603 E:37608 ||| JJ
length ||| S:37608 E:37614 ||| NN
,  ||| S:37614 E:37616 ||| ,
1.2  ||| S:37616 E:37620 ||| CD
kb  ||| S:37620 E:37623 ||| JJ
IDO  ||| S:37623 E:37627 ||| NNP
cDNA  ||| S:37627 E:37632 ||| NNP
was  ||| S:37632 E:37636 ||| VBD
amplified  ||| S:37636 E:37646 ||| VBN
from  ||| S:37646 E:37661 ||| IN
IFN-γ  ||| S:37661 E:37667 ||| JJ
stimulated  ||| S:37667 E:37678 ||| JJ
RAW  ||| S:37678 E:37682 ||| NN
cells  ||| S:37682 E:37688 ||| NNS
and  ||| S:37688 E:37692 ||| CC
cloned  ||| S:37692 E:37699 ||| VBN
into  ||| S:37699 E:37704 ||| IN
pGEM  ||| S:37704 E:37709 ||| JJ
T-Easy  ||| S:37709 E:37726 ||| NN
( ||| S:37726 E:37727 ||| -LRB-
Promega ||| S:37727 E:37734 ||| NNP
) ||| S:37734 E:37735 ||| -RRB-
,  ||| S:37735 E:37737 ||| ,
using  ||| S:37737 E:37743 ||| VBG
primers ||| S:37743 E:37750 ||| NNS
;  ||| S:37750 E:37752 ||| :
5 ||| S:37752 E:37753 ||| CD
'  ||| S:37753 E:37755 ||| POS
TAG  ||| S:37755 E:37759 ||| NNP
CGG  ||| S:37759 E:37763 ||| NNP
CCG  ||| S:37763 E:37767 ||| NNP
CGT  ||| S:37767 E:37771 ||| NNP
AGA  ||| S:37771 E:37775 ||| NNP
CAG  ||| S:37775 E:37779 ||| NNP
CAA  ||| S:37779 E:37793 ||| NNP
TGG  ||| S:37793 E:37797 ||| NNP
CAC  ||| S:37797 E:37801 ||| NNP
TC  ||| S:37801 E:37804 ||| NNP
3 ||| S:37804 E:37805 ||| NNP
'  ||| S:37805 E:37807 ||| POS
forward ||| S:37807 E:37814 ||| RB
,  ||| S:37814 E:37816 ||| ,
5 ||| S:37816 E:37817 ||| CD
'  ||| S:37817 E:37819 ||| POS
TAA  ||| S:37819 E:37823 ||| NNP
GAT  ||| S:37823 E:37827 ||| NNP
CTT  ||| S:37827 E:37831 ||| NNP
ACA  ||| S:37831 E:37835 ||| NNP
CTA  ||| S:37835 E:37839 ||| NNP
AGG  ||| S:37839 E:37843 ||| NNP
CCA  ||| S:37843 E:37847 ||| NNP
ACT  ||| S:37847 E:37861 ||| NNP
CAG  ||| S:37861 E:37865 ||| NNP
3 ||| S:37865 E:37866 ||| NNP
'  ||| S:37866 E:37868 ||| POS
reverse ||| S:37868 E:37875 ||| NN
,  ||| S:37875 E:37877 ||| ,
which  ||| S:37877 E:37883 ||| WDT
contain  ||| S:37883 E:37891 ||| VBP
Not  ||| S:37891 E:37895 ||| RB
I  ||| S:37895 E:37897 ||| PRP
and  ||| S:37897 E:37901 ||| CC
Bgl  ||| S:37901 E:37905 ||| NNP
II  ||| S:37905 E:37908 ||| NNP
sites  ||| S:37908 E:37924 ||| NNS
respectively ||| S:37924 E:37936 ||| RB
.  ||| S:37936 E:37938 ||| .
The  ||| S:37938 E:37942 ||| DT
1.2  ||| S:37942 E:37946 ||| CD
kb  ||| S:37946 E:37949 ||| JJ
IDO  ||| S:37949 E:37953 ||| NNP
PCR  ||| S:37953 E:37957 ||| NNP
fragment  ||| S:37957 E:37966 ||| NN
was  ||| S:37966 E:37970 ||| VBD
excised  ||| S:37970 E:37988 ||| VBN
with  ||| S:37988 E:37993 ||| IN
Not  ||| S:37993 E:37997 ||| RB
I  ||| S:37997 E:37999 ||| PRP
and  ||| S:37999 E:38003 ||| CC
Bgl  ||| S:38003 E:38007 ||| NNP
II  ||| S:38007 E:38010 ||| NNP
and  ||| S:38010 E:38014 ||| CC
cloned  ||| S:38014 E:38021 ||| VBN
into  ||| S:38021 E:38026 ||| IN
the  ||| S:38026 E:38030 ||| DT
Not  ||| S:38030 E:38034 ||| RB
I-Bgl  ||| S:38034 E:38040 ||| JJ
II  ||| S:38040 E:38053 ||| NNP
site  ||| S:38053 E:38058 ||| NN
in  ||| S:38058 E:38061 ||| IN
the  ||| S:38061 E:38065 ||| DT
pDOI  ||| S:38065 E:38070 ||| JJ
vector  ||| S:38070 E:38077 ||| NN
[  ||| S:38077 E:38079 ||| -LRB-
51 ||| S:38079 E:38081 ||| CD
] ||| S:38081 E:38082 ||| -RRB-
,  ||| S:38082 E:38084 ||| ,
previously  ||| S:38084 E:38095 ||| RB
modified  ||| S:38095 E:38104 ||| VBN
by  ||| S:38104 E:38107 ||| IN
the  ||| S:38107 E:38121 ||| DT
introduction  ||| S:38121 E:38134 ||| NN
of  ||| S:38134 E:38137 ||| IN
a  ||| S:38137 E:38139 ||| DT
Not  ||| S:38139 E:38143 ||| RB
I  ||| S:38143 E:38145 ||| PRP
site  ||| S:38145 E:38150 ||| NN
in  ||| S:38150 E:38153 ||| IN
front  ||| S:38153 E:38159 ||| NN
of  ||| S:38159 E:38162 ||| IN
the  ||| S:38162 E:38166 ||| DT
Eco  ||| S:38166 E:38170 ||| NNP
RI  ||| S:38170 E:38183 ||| NNP
cloning  ||| S:38183 E:38191 ||| JJ
site ||| S:38191 E:38195 ||| NN
.  ||| S:38195 E:38197 ||| .
Plasmid  ||| S:38197 E:38205 ||| NNP
DNA  ||| S:38205 E:38209 ||| NNP
was  ||| S:38209 E:38213 ||| VBD
linearized  ||| S:38213 E:38224 ||| JJ
and  ||| S:38224 E:38228 ||| CC
transfected  ||| S:38228 E:38250 ||| NN
into  ||| S:38250 E:38255 ||| IN
RAW  ||| S:38255 E:38259 ||| NNP
cells  ||| S:38259 E:38265 ||| NNS
by  ||| S:38265 E:38268 ||| IN
electroporation ||| S:38268 E:38283 ||| NN
.  ||| S:38283 E:38285 ||| .
Stably  ||| S:38285 E:38292 ||| JJ
transfected  ||| S:38292 E:38314 ||| JJ
lines  ||| S:38314 E:38320 ||| NNS
were  ||| S:38320 E:38325 ||| VBD
selected  ||| S:38325 E:38334 ||| VBN
in  ||| S:38334 E:38337 ||| IN
400  ||| S:38337 E:38341 ||| CD
mg ||| S:38341 E:38343 ||| CD
/ ||| S:38343 E:38344 ||| CD
ml  ||| S:38344 E:38347 ||| CD
G418  ||| S:38347 E:38352 ||| CD
and  ||| S:38352 E:38356 ||| CC
thereafter  ||| S:38356 E:38377 ||| RB
maintained  ||| S:38377 E:38388 ||| VBN
in  ||| S:38388 E:38391 ||| IN
200  ||| S:38391 E:38395 ||| CD
mg ||| S:38395 E:38397 ||| CD
/ ||| S:38397 E:38398 ||| CD
ml  ||| S:38398 E:38401 ||| CD
G418 ||| S:38401 E:38405 ||| CD
.  ||| S:38405 E:38407 ||| .
MC57  ||| S:38407 E:38412 ||| NNP
cells  ||| S:38412 E:38418 ||| NNS
were  ||| S:38418 E:38423 ||| VBD
also  ||| S:38423 E:38438 ||| RB
transfected  ||| S:38438 E:38450 ||| VBN
by  ||| S:38450 E:38453 ||| IN
electroporation  ||| S:38453 E:38469 ||| NN
and  ||| S:38469 E:38473 ||| CC
selected  ||| S:38473 E:38482 ||| VBN
in  ||| S:38482 E:38485 ||| IN
1.2  ||| S:38485 E:38489 ||| CD
mg ||| S:38489 E:38491 ||| CD
/ ||| S:38491 E:38492 ||| CD
ml  ||| S:38492 E:38505 ||| CD
G418 ||| S:38505 E:38509 ||| CD
.  ||| S:38509 E:38539 ||| .
RT-PCR  ||| S:38539 E:38556 ||| JJ
Analysis  ||| S:38556 E:38565 ||| NN
of  ||| S:38565 E:38568 ||| IN
gene  ||| S:38568 E:38573 ||| NN
expression  ||| S:38573 E:38584 ||| NN
in  ||| S:38584 E:38587 ||| IN
P19  ||| S:38587 E:38591 ||| NNP
or  ||| S:38591 E:38594 ||| CC
RAW  ||| S:38594 E:38598 ||| NNP
cells  ||| S:38598 E:38604 ||| NNS
was  ||| S:38604 E:38618 ||| VBD
performed  ||| S:38618 E:38628 ||| VBN
using  ||| S:38628 E:38634 ||| VBG
semi-quantitative  ||| S:38634 E:38652 ||| JJ
RT-PCR ||| S:38652 E:38658 ||| NN
.  ||| S:38658 E:38660 ||| .
Total  ||| S:38660 E:38666 ||| JJ
RNA  ||| S:38666 E:38670 ||| NNP
was  ||| S:38670 E:38684 ||| VBD
isolated  ||| S:38684 E:38693 ||| VBN
from  ||| S:38693 E:38698 ||| IN
cells  ||| S:38698 E:38704 ||| NNS
using  ||| S:38704 E:38710 ||| VBG
RNA  ||| S:38710 E:38714 ||| NNP
STAT-60  ||| S:38714 E:38722 ||| NNP
( ||| S:38722 E:38723 ||| -LRB-
Tel-Test  ||| S:38723 E:38732 ||| NNP
Inc. ||| S:38732 E:38736 ||| NNP
)  ||| S:38736 E:38738 ||| -RRB-
and  ||| S:38738 E:38752 ||| CC
1  ||| S:38752 E:38754 ||| CD
mg  ||| S:38754 E:38757 ||| NNS
was  ||| S:38757 E:38761 ||| VBD
amplified  ||| S:38761 E:38771 ||| VBN
for  ||| S:38771 E:38775 ||| IN
25  ||| S:38775 E:38778 ||| CD
cycles  ||| S:38778 E:38785 ||| NNS
unless  ||| S:38785 E:38792 ||| IN
otherwise  ||| S:38792 E:38802 ||| RB
stated ||| S:38802 E:38808 ||| VBN
,  ||| S:38808 E:38820 ||| ,
following  ||| S:38820 E:38830 ||| VBG
reverse  ||| S:38830 E:38838 ||| JJ
transcription  ||| S:38838 E:38852 ||| NN
in  ||| S:38852 E:38855 ||| IN
a  ||| S:38855 E:38857 ||| DT
one  ||| S:38857 E:38861 ||| CD
step  ||| S:38861 E:38866 ||| NN
reaction  ||| S:38866 E:38885 ||| NN
( ||| S:38885 E:38886 ||| -LRB-
RT-PCR  ||| S:38886 E:38893 ||| NNP
"Access ||| S:38893 E:38900 ||| NNP
" ||| S:38900 E:38901 ||| ''
,  ||| S:38901 E:38903 ||| ,
Promega ||| S:38903 E:38910 ||| NNP
) ||| S:38910 E:38911 ||| -RRB-
.  ||| S:38911 E:38913 ||| .
5  ||| S:38913 E:38915 ||| CD
μl  ||| S:38915 E:38918 ||| NN
of  ||| S:38918 E:38921 ||| IN
the  ||| S:38921 E:38925 ||| DT
50  ||| S:38925 E:38928 ||| CD
ml  ||| S:38928 E:38931 ||| JJ
reaction  ||| S:38931 E:38950 ||| NN
volume  ||| S:38950 E:38957 ||| NN
was  ||| S:38957 E:38961 ||| VBD
electrophoresed  ||| S:38961 E:38977 ||| VBN
on  ||| S:38977 E:38980 ||| IN
0.8 ||| S:38980 E:38983 ||| CD
%  ||| S:38983 E:38985 ||| NN
agarose  ||| S:38985 E:38993 ||| NNS
gels  ||| S:38993 E:38998 ||| VBP
prior  ||| S:38998 E:39004 ||| RB
to  ||| S:39004 E:39017 ||| TO
Southern  ||| S:39017 E:39026 ||| NNP
blotting  ||| S:39026 E:39035 ||| NN
and  ||| S:39035 E:39039 ||| CC
hybridization  ||| S:39039 E:39053 ||| NN
with  ||| S:39053 E:39058 ||| IN
a  ||| S:39058 E:39060 ||| DT
specific  ||| S:39060 E:39079 ||| JJ
probe ||| S:39079 E:39084 ||| NN
.  ||| S:39084 E:39086 ||| .
Primers  ||| S:39086 E:39094 ||| NNP
and  ||| S:39094 E:39098 ||| CC
amplification  ||| S:39098 E:39112 ||| JJ
conditions  ||| S:39112 E:39123 ||| NNS
for  ||| S:39123 E:39127 ||| IN
IDO  ||| S:39127 E:39141 ||| NNP
amplification  ||| S:39141 E:39155 ||| NNS
have  ||| S:39155 E:39160 ||| VBP
been  ||| S:39160 E:39165 ||| VBN
described  ||| S:39165 E:39175 ||| VBN
elsewhere  ||| S:39175 E:39185 ||| RB
[  ||| S:39185 E:39187 ||| -LRB-
17 ||| S:39187 E:39189 ||| CD
] ||| S:39189 E:39190 ||| -RRB-
.  ||| S:39190 E:39202 ||| .
Primers  ||| S:39202 E:39210 ||| NNP
for  ||| S:39210 E:39214 ||| IN
amplification  ||| S:39214 E:39228 ||| NN
of  ||| S:39228 E:39231 ||| IN
other  ||| S:39231 E:39237 ||| JJ
gene  ||| S:39237 E:39242 ||| NN
specific  ||| S:39242 E:39261 ||| JJ
transcripts  ||| S:39261 E:39273 ||| NNS
were  ||| S:39273 E:39278 ||| VBD
as  ||| S:39278 E:39281 ||| RB
follows ||| S:39281 E:39288 ||| VBZ
;  ||| S:39288 E:39290 ||| :
stromelysin-1 ||| S:39290 E:39303 ||| CD
;  ||| S:39303 E:39305 ||| :
5 ||| S:39305 E:39306 ||| CD
'  ||| S:39306 E:39318 ||| POS
GATGACAGGGAAGCTGGA  ||| S:39318 E:39337 ||| NNP
forward ||| S:39337 E:39344 ||| RB
,  ||| S:39344 E:39346 ||| ,
5 ||| S:39346 E:39347 ||| CD
'  ||| S:39347 E:39349 ||| POS
ACTGCGAAGATCCACTGA  ||| S:39349 E:39378 ||| NNP
reverse ||| S:39378 E:39385 ||| NN
.  ||| S:39385 E:39387 ||| .
Stromelysin-2 ||| S:39387 E:39400 ||| NNP
;  ||| S:39400 E:39402 ||| :
5 ||| S:39402 E:39403 ||| CD
'  ||| S:39403 E:39405 ||| POS
GATGTACCCAGTCTACAGGT  ||| S:39405 E:39426 ||| NNP
3 ||| S:39426 E:39427 ||| NNP
'  ||| S:39427 E:39439 ||| POS
forward ||| S:39439 E:39446 ||| RB
,  ||| S:39446 E:39448 ||| ,
5 ||| S:39448 E:39449 ||| CD
'  ||| S:39449 E:39451 ||| POS
TGTCTTGTCTCATCATTACT  ||| S:39451 E:39472 ||| NNP
3 ||| S:39472 E:39473 ||| NNP
'  ||| S:39473 E:39475 ||| POS
reverse ||| S:39475 E:39482 ||| NN
.  ||| S:39482 E:39494 ||| .
Stromelysin-3 ||| S:39494 E:39507 ||| NNP
;  ||| S:39507 E:39509 ||| :
5 ||| S:39509 E:39510 ||| CD
'  ||| S:39510 E:39512 ||| POS
CTGCTGCTCCTGTTGCTGCT  ||| S:39512 E:39533 ||| NNP
3 ||| S:39533 E:39534 ||| NNP
'  ||| S:39534 E:39536 ||| POS
forward ||| S:39536 E:39543 ||| RB
,  ||| S:39543 E:39545 ||| ,
5 ||| S:39545 E:39546 ||| CD
'  ||| S:39546 E:39558 ||| POS
ACCTTGGAAGAACCAAATC  ||| S:39558 E:39578 ||| NNP
3 ||| S:39578 E:39579 ||| NNP
'  ||| S:39579 E:39581 ||| POS
reverse ||| S:39581 E:39588 ||| NN
.  ||| S:39588 E:39590 ||| .
Meltrin-α ||| S:39590 E:39599 ||| NNP
;  ||| S:39599 E:39601 ||| :
5 ||| S:39601 E:39602 ||| CD
'  ||| S:39602 E:39614 ||| POS
TGCATCAGTGGTCAGCCTCA  ||| S:39614 E:39635 ||| NNP
3 ||| S:39635 E:39636 ||| NNP
'  ||| S:39636 E:39638 ||| POS
forward ||| S:39638 E:39645 ||| RB
,  ||| S:39645 E:39647 ||| ,
5 ||| S:39647 E:39648 ||| CD
'  ||| S:39648 E:39650 ||| POS
CTTTCTCTGCGGCCATTCTG  ||| S:39650 E:39681 ||| NNP
3 ||| S:39681 E:39682 ||| NNP
'  ||| S:39682 E:39684 ||| POS
reverse ||| S:39684 E:39691 ||| NN
.  ||| S:39691 E:39693 ||| .
Meltrin-β ||| S:39693 E:39702 ||| NNP
;  ||| S:39702 E:39704 ||| :
5 ||| S:39704 E:39705 ||| CD
'  ||| S:39705 E:39707 ||| POS
TTCAGTTTACACATCAGAC  ||| S:39707 E:39727 ||| NNP
3 ||| S:39727 E:39728 ||| NNP
'  ||| S:39728 E:39730 ||| POS
forward ||| S:39730 E:39737 ||| RB
,  ||| S:39737 E:39749 ||| ,
5 ||| S:39749 E:39750 ||| CD
'  ||| S:39750 E:39752 ||| POS
AGGTCACATTGCCGAACCT  ||| S:39752 E:39772 ||| NNP
3 ||| S:39772 E:39773 ||| NNP
'  ||| S:39773 E:39775 ||| POS
reverse ||| S:39775 E:39782 ||| NN
.  ||| S:39782 E:39784 ||| .
Collagenase  ||| S:39784 E:39796 ||| VBG
I ||| S:39796 E:39797 ||| PRP
;  ||| S:39797 E:39799 ||| :
5 ||| S:39799 E:39800 ||| CD
'  ||| S:39800 E:39812 ||| POS
GATTGTGAACTATACTCCT  ||| S:39812 E:39832 ||| NNP
3 ||| S:39832 E:39833 ||| NNP
'  ||| S:39833 E:39835 ||| POS
forward ||| S:39835 E:39842 ||| RB
,  ||| S:39842 E:39844 ||| ,
5 ||| S:39844 E:39845 ||| CD
'  ||| S:39845 E:39847 ||| POS
CCATAGTCTGGTTAACATCA  ||| S:39847 E:39878 ||| NNP
3 ||| S:39878 E:39879 ||| NNP
'  ||| S:39879 E:39881 ||| POS
reverse ||| S:39881 E:39888 ||| NN
.  ||| S:39888 E:39890 ||| .
Collagenase  ||| S:39890 E:39902 ||| NNP
IV ||| S:39902 E:39904 ||| NNP
;  ||| S:39904 E:39906 ||| :
5 ||| S:39906 E:39907 ||| CD
'  ||| S:39907 E:39909 ||| POS
GTATGGAGCGACGTCACT  ||| S:39909 E:39928 ||| NNP
3 ||| S:39928 E:39929 ||| NNP
'  ||| S:39929 E:39941 ||| POS
forward ||| S:39941 E:39948 ||| RB
,  ||| S:39948 E:39950 ||| ,
5 ||| S:39950 E:39951 ||| CD
'  ||| S:39951 E:39953 ||| POS
CGCTCCAGAGTGCTGGCA  ||| S:39953 E:39972 ||| NNP
3 ||| S:39972 E:39973 ||| NNP
'  ||| S:39973 E:39975 ||| POS
reverse ||| S:39975 E:39982 ||| NN
.  ||| S:39982 E:39984 ||| .
GAPDH ||| S:39984 E:39989 ||| NNP
;  ||| S:39989 E:39991 ||| :
5 ||| S:39991 E:39992 ||| CD
'  ||| S:39992 E:40004 ||| POS
TGCAGTGGCAAAGTGGAG  ||| S:40004 E:40023 ||| NNP
3 ||| S:40023 E:40024 ||| NNP
'  ||| S:40024 E:40026 ||| POS
forward  ||| S:40026 E:40034 ||| RB
5 ||| S:40034 E:40035 ||| CD
'  ||| S:40035 E:40037 ||| POS
CCATCCACAGTCTTCTG  ||| S:40037 E:40055 ||| NNP
3 ||| S:40055 E:40056 ||| NNP
'  ||| S:40056 E:40068 ||| POS
reverse ||| S:40068 E:40075 ||| NN
.  ||| S:40075 E:40105 ||| .
Antisense  ||| S:40105 E:40115 ||| JJ
inhibition  ||| S:40115 E:40126 ||| NN
of  ||| S:40126 E:40129 ||| IN
IDO  ||| S:40129 E:40133 ||| NNP
expression  ||| S:40133 E:40154 ||| NN
Constructs  ||| S:40154 E:40165 ||| NNS
which  ||| S:40165 E:40171 ||| WDT
expressed  ||| S:40171 E:40181 ||| VBD
either  ||| S:40181 E:40188 ||| DT
sense  ||| S:40188 E:40194 ||| NN
or  ||| S:40194 E:40197 ||| CC
antisense  ||| S:40197 E:40217 ||| JJ
IDO  ||| S:40217 E:40221 ||| NNP
RNA  ||| S:40221 E:40225 ||| NNP
were  ||| S:40225 E:40230 ||| VBD
produced  ||| S:40230 E:40239 ||| VBN
by  ||| S:40239 E:40242 ||| IN
cloning  ||| S:40242 E:40250 ||| VBG
a  ||| S:40250 E:40252 ||| DT
740  ||| S:40252 E:40256 ||| CD
bp  ||| S:40256 E:40259 ||| CD
RT-PCR  ||| S:40259 E:40266 ||| JJ
fragment  ||| S:40266 E:40285 ||| NN
of  ||| S:40285 E:40288 ||| IN
the  ||| S:40288 E:40292 ||| DT
IDO  ||| S:40292 E:40296 ||| NNP
gene ||| S:40296 E:40300 ||| NN
,  ||| S:40300 E:40302 ||| ,
described  ||| S:40302 E:40312 ||| VBN
in  ||| S:40312 E:40315 ||| IN
[  ||| S:40315 E:40317 ||| -LRB-
17 ||| S:40317 E:40319 ||| CD
] ||| S:40319 E:40320 ||| -RRB-
,  ||| S:40320 E:40322 ||| ,
into  ||| S:40322 E:40327 ||| IN
the  ||| S:40327 E:40331 ||| DT
T-tailed  ||| S:40331 E:40350 ||| JJ
cloning  ||| S:40350 E:40358 ||| FW
vector  ||| S:40358 E:40365 ||| FW
pGEM  ||| S:40365 E:40370 ||| FW
T-Easy  ||| S:40370 E:40377 ||| FW
( ||| S:40377 E:40378 ||| -LRB-
Promega ||| S:40378 E:40385 ||| NNP
) ||| S:40385 E:40386 ||| -RRB-
.  ||| S:40386 E:40388 ||| .
This  ||| S:40388 E:40393 ||| DT
fragment  ||| S:40393 E:40402 ||| NN
was  ||| S:40402 E:40416 ||| VBD
excised  ||| S:40416 E:40424 ||| VBN
with  ||| S:40424 E:40429 ||| IN
Not  ||| S:40429 E:40433 ||| RB
I  ||| S:40433 E:40435 ||| PRP
and  ||| S:40435 E:40439 ||| CC
subcloned  ||| S:40439 E:40449 ||| NN
into  ||| S:40449 E:40454 ||| IN
the  ||| S:40454 E:40458 ||| DT
Not  ||| S:40458 E:40462 ||| RB
I  ||| S:40462 E:40464 ||| PRP
site  ||| S:40464 E:40469 ||| NN
of  ||| S:40469 E:40482 ||| IN
the  ||| S:40482 E:40486 ||| DT
mammalian  ||| S:40486 E:40496 ||| FW
expression  ||| S:40496 E:40507 ||| FW
vector  ||| S:40507 E:40514 ||| FW
pcDNA3  ||| S:40514 E:40521 ||| FW
( ||| S:40521 E:40522 ||| -LRB-
Invitrogen ||| S:40522 E:40532 ||| NNP
) ||| S:40532 E:40533 ||| -RRB-
,  ||| S:40533 E:40535 ||| ,
in  ||| S:40535 E:40548 ||| IN
either  ||| S:40548 E:40555 ||| RB
the  ||| S:40555 E:40559 ||| DT
sense  ||| S:40559 E:40565 ||| NN
or  ||| S:40565 E:40568 ||| CC
antisense  ||| S:40568 E:40578 ||| JJ
orientation ||| S:40578 E:40589 ||| NN
.  ||| S:40589 E:40591 ||| .
Following  ||| S:40591 E:40611 ||| VBG
linearization  ||| S:40611 E:40625 ||| NN
with  ||| S:40625 E:40630 ||| IN
Bgl  ||| S:40630 E:40634 ||| NNP
II ||| S:40634 E:40636 ||| NNP
,  ||| S:40636 E:40638 ||| ,
the  ||| S:40638 E:40642 ||| DT
constructs  ||| S:40642 E:40653 ||| NN
were  ||| S:40653 E:40668 ||| VBD
transfected  ||| S:40668 E:40680 ||| VBN
into  ||| S:40680 E:40685 ||| IN
the  ||| S:40685 E:40689 ||| DT
P19  ||| S:40689 E:40693 ||| JJ
cell  ||| S:40693 E:40698 ||| NN
line  ||| S:40698 E:40703 ||| NN
using  ||| S:40703 E:40709 ||| VBG
Lipofectamine  ||| S:40709 E:40733 ||| NNP
( ||| S:40733 E:40734 ||| -LRB-
Gibco-BRL ||| S:40734 E:40743 ||| NNP
)  ||| S:40743 E:40745 ||| -RRB-
at  ||| S:40745 E:40748 ||| IN
a  ||| S:40748 E:40750 ||| DT
concentration  ||| S:40750 E:40764 ||| NN
of  ||| S:40764 E:40767 ||| IN
25  ||| S:40767 E:40770 ||| CD
μl  ||| S:40770 E:40773 ||| NN
per  ||| S:40773 E:40777 ||| IN
100  ||| S:40777 E:40781 ||| CD
ml  ||| S:40781 E:40784 ||| NN
of  ||| S:40784 E:40797 ||| IN
serum  ||| S:40797 E:40803 ||| JJ
free  ||| S:40803 E:40808 ||| JJ
medium ||| S:40808 E:40814 ||| NN
.  ||| S:40814 E:40816 ||| .
Stable  ||| S:40816 E:40823 ||| JJ
transfectants  ||| S:40823 E:40837 ||| NN
were  ||| S:40837 E:40842 ||| VBD
selected  ||| S:40842 E:40851 ||| VBN
in  ||| S:40851 E:40864 ||| IN
400  ||| S:40864 E:40868 ||| CD
mg ||| S:40868 E:40870 ||| CD
/ ||| S:40870 E:40871 ||| CD
ml  ||| S:40871 E:40874 ||| CD
G418  ||| S:40874 E:40879 ||| CD
over  ||| S:40879 E:40884 ||| IN
a  ||| S:40884 E:40886 ||| DT
period  ||| S:40886 E:40893 ||| NN
of  ||| S:40893 E:40896 ||| IN
4  ||| S:40896 E:40898 ||| CD
weeks  ||| S:40898 E:40904 ||| NNS
and  ||| S:40904 E:40908 ||| CC
subsequently  ||| S:40908 E:40931 ||| RB
maintained  ||| S:40931 E:40942 ||| VBN
in  ||| S:40942 E:40945 ||| IN
the  ||| S:40945 E:40949 ||| DT
absence  ||| S:40949 E:40957 ||| NN
of  ||| S:40957 E:40960 ||| IN
G418  ||| S:40960 E:40965 ||| CD
in  ||| S:40965 E:40968 ||| IN
normal  ||| S:40968 E:40975 ||| JJ
growth  ||| S:40975 E:40992 ||| NN
medium ||| S:40992 E:40998 ||| NN
.  ||| S:40998 E:41000 ||| .
Periodic  ||| S:41000 E:41009 ||| JJ
checks  ||| S:41009 E:41016 ||| NNS
of  ||| S:41016 E:41019 ||| IN
G418  ||| S:41019 E:41024 ||| CD
resistance  ||| S:41024 E:41035 ||| NN
revealed  ||| S:41035 E:41044 ||| VBD
no  ||| S:41044 E:41057 ||| DT
significant  ||| S:41057 E:41069 ||| JJ
loss  ||| S:41069 E:41074 ||| NN
of  ||| S:41074 E:41077 ||| IN
the  ||| S:41077 E:41081 ||| DT
resistance  ||| S:41081 E:41092 ||| NN
phenotype ||| S:41092 E:41101 ||| NN
.  ||| S:41101 E:41113 ||| .
Confirmation  ||| S:41113 E:41126 ||| NN
that  ||| S:41126 E:41131 ||| IN
resisitant  ||| S:41131 E:41142 ||| FW
clones  ||| S:41142 E:41149 ||| FW
expressed  ||| S:41149 E:41159 ||| FW
IDO  ||| S:41159 E:41173 ||| FW
antisense  ||| S:41173 E:41183 ||| FW
RNA  ||| S:41183 E:41187 ||| NNP
was  ||| S:41187 E:41191 ||| VBD
obtained  ||| S:41191 E:41200 ||| VBN
by  ||| S:41200 E:41203 ||| IN
isolating  ||| S:41203 E:41213 ||| JJ
total  ||| S:41213 E:41219 ||| JJ
RNA  ||| S:41219 E:41223 ||| NNP
from  ||| S:41223 E:41238 ||| IN
G418  ||| S:41238 E:41243 ||| CD
resistant  ||| S:41243 E:41253 ||| JJ
clones ||| S:41253 E:41259 ||| NNS
,  ||| S:41259 E:41261 ||| ,
treating  ||| S:41261 E:41270 ||| VBG
with  ||| S:41270 E:41275 ||| IN
ribonuclease  ||| S:41275 E:41288 ||| JJ
free  ||| S:41288 E:41303 ||| JJ
DNase  ||| S:41303 E:41309 ||| JJ
RQ1  ||| S:41309 E:41313 ||| NNP
( ||| S:41313 E:41314 ||| -LRB-
Promega ||| S:41314 E:41321 ||| NNP
)  ||| S:41321 E:41323 ||| -RRB-
and  ||| S:41323 E:41327 ||| CC
reverse  ||| S:41327 E:41335 ||| VB
transcribing  ||| S:41335 E:41348 ||| JJ
RNA  ||| S:41348 E:41352 ||| NNP
into  ||| S:41352 E:41367 ||| IN
cDNA  ||| S:41367 E:41372 ||| JJ
in  ||| S:41372 E:41375 ||| IN
the  ||| S:41375 E:41379 ||| DT
presence  ||| S:41379 E:41388 ||| NN
of  ||| S:41388 E:41391 ||| IN
an  ||| S:41391 E:41394 ||| DT
IDO  ||| S:41394 E:41398 ||| NNP
sense  ||| S:41398 E:41404 ||| NN
primer  ||| S:41404 E:41411 ||| NNS
[  ||| S:41411 E:41413 ||| -LRB-
17 ||| S:41413 E:41415 ||| CD
] ||| S:41415 E:41416 ||| -RRB-
.  ||| S:41416 E:41418 ||| .
An  ||| S:41418 E:41431 ||| DT
antisense  ||| S:41431 E:41441 ||| JJ
primer  ||| S:41441 E:41448 ||| NN
was  ||| S:41448 E:41452 ||| VBD
then  ||| S:41452 E:41457 ||| RB
added  ||| S:41457 E:41463 ||| VBN
and  ||| S:41463 E:41467 ||| CC
the  ||| S:41467 E:41471 ||| DT
cDNA  ||| S:41471 E:41476 ||| JJ
PCR  ||| S:41476 E:41490 ||| NNS
amplified  ||| S:41490 E:41500 ||| VBN
for  ||| S:41500 E:41504 ||| IN
25  ||| S:41504 E:41507 ||| CD
cycles ||| S:41507 E:41513 ||| NNS
.  ||| S:41513 E:41515 ||| .
Products  ||| S:41515 E:41524 ||| NNS
were  ||| S:41524 E:41529 ||| VBD
electrophoresed  ||| S:41529 E:41545 ||| VBN
in  ||| S:41545 E:41558 ||| IN
0.8 ||| S:41558 E:41561 ||| CD
%  ||| S:41561 E:41563 ||| NN
agarose ||| S:41563 E:41570 ||| NN
.  ||| S:41570 E:41600 ||| .
Western  ||| S:41600 E:41608 ||| NNP
blotting  ||| S:41608 E:41627 ||| FW
RAW  ||| S:41627 E:41631 ||| FW
cells  ||| S:41631 E:41637 ||| FW
expressing  ||| S:41637 E:41648 ||| FW
IDO  ||| S:41648 E:41652 ||| NNP
and  ||| S:41652 E:41656 ||| CC
vector  ||| S:41656 E:41663 ||| JJ
only  ||| S:41663 E:41668 ||| JJ
controls  ||| S:41668 E:41677 ||| NNS
were  ||| S:41677 E:41692 ||| VBD
harvested  ||| S:41692 E:41702 ||| VBN
in  ||| S:41702 E:41705 ||| IN
cell  ||| S:41705 E:41710 ||| NN
lysis  ||| S:41710 E:41716 ||| NN
buffer  ||| S:41716 E:41723 ||| NN
( ||| S:41723 E:41724 ||| -LRB-
PBS ||| S:41724 E:41727 ||| NNP
,  ||| S:41727 E:41729 ||| ,
1 ||| S:41729 E:41730 ||| CD
% ||| S:41730 E:41731 ||| NN
NP40 ||| S:41731 E:41735 ||| NN
,  ||| S:41735 E:41737 ||| ,
0.5 ||| S:41737 E:41740 ||| CD
%  ||| S:41740 E:41742 ||| NN
sodium  ||| S:41742 E:41759 ||| NN
deoxycholate ||| S:41759 E:41771 ||| NN
,  ||| S:41771 E:41773 ||| ,
0.1 ||| S:41773 E:41776 ||| CD
%  ||| S:41776 E:41778 ||| NN
SDS ||| S:41778 E:41781 ||| NNP
,  ||| S:41781 E:41783 ||| ,
150  ||| S:41783 E:41787 ||| CD
ng ||| S:41787 E:41789 ||| CD
/ ||| S:41789 E:41790 ||| CD
ml  ||| S:41790 E:41793 ||| JJ
PMSF ||| S:41793 E:41797 ||| NNP
,  ||| S:41797 E:41799 ||| ,
100  ||| S:41799 E:41803 ||| CD
ng ||| S:41803 E:41805 ||| CD
/ ||| S:41805 E:41806 ||| CD
ml  ||| S:41806 E:41819 ||| CD
aprotinin ||| S:41819 E:41828 ||| CD
)  ||| S:41828 E:41830 ||| -RRB-
and  ||| S:41830 E:41834 ||| CC
25  ||| S:41834 E:41837 ||| CD
μg  ||| S:41837 E:41840 ||| NN
of  ||| S:41840 E:41843 ||| IN
cell  ||| S:41843 E:41848 ||| NN
protein  ||| S:41848 E:41856 ||| NN
was  ||| S:41856 E:41860 ||| VBD
electrophoresed  ||| S:41860 E:41886 ||| VBN
on  ||| S:41886 E:41889 ||| IN
10 ||| S:41889 E:41891 ||| CD
%  ||| S:41891 E:41893 ||| NN
polyacrylamide  ||| S:41893 E:41908 ||| NNS
gels  ||| S:41908 E:41913 ||| VBP
overlayed  ||| S:41913 E:41923 ||| VBN
with  ||| S:41923 E:41928 ||| IN
a  ||| S:41928 E:41930 ||| DT
5 ||| S:41930 E:41931 ||| CD
%  ||| S:41931 E:41933 ||| NN
stacking  ||| S:41933 E:41952 ||| VBG
gel ||| S:41952 E:41955 ||| NNS
.  ||| S:41955 E:41957 ||| .
Protein  ||| S:41957 E:41965 ||| NN
was  ||| S:41965 E:41969 ||| VBD
quantitated  ||| S:41969 E:41981 ||| VBN
using  ||| S:41981 E:41987 ||| VBG
the  ||| S:41987 E:41991 ||| DT
BCA  ||| S:41991 E:41995 ||| NNP
assay  ||| S:41995 E:42011 ||| NNS
( ||| S:42011 E:42012 ||| -LRB-
Pierce ||| S:42012 E:42018 ||| NNP
) ||| S:42018 E:42019 ||| -RRB-
.  ||| S:42019 E:42021 ||| .
COX-1  ||| S:42021 E:42027 ||| NNP
and  ||| S:42027 E:42031 ||| CC
COX-2  ||| S:42031 E:42037 ||| CD
antibodies  ||| S:42037 E:42048 ||| NNS
( ||| S:42048 E:42049 ||| -LRB-
Santa  ||| S:42049 E:42055 ||| NNP
Cruz  ||| S:42055 E:42070 ||| NNP
Biotechnology  ||| S:42070 E:42084 ||| NNP
Inc ||| S:42084 E:42087 ||| NNP
)  ||| S:42087 E:42089 ||| -RRB-
were  ||| S:42089 E:42094 ||| VBD
used  ||| S:42094 E:42099 ||| VBN
in  ||| S:42099 E:42102 ||| IN
combination  ||| S:42102 E:42114 ||| NN
with  ||| S:42114 E:42119 ||| IN
standard  ||| S:42119 E:42138 ||| JJ
ECL  ||| S:42138 E:42142 ||| NN
techniques ||| S:42142 E:42152 ||| NNS
.  ||| S:42152 E:42154 ||| .
Rabbit  ||| S:42154 E:42161 ||| JJ
polyclonal  ||| S:42161 E:42172 ||| JJ
IDO-specific  ||| S:42172 E:42185 ||| JJ
antibody  ||| S:42185 E:42204 ||| NN
was  ||| S:42204 E:42208 ||| VBD
generated  ||| S:42208 E:42218 ||| VBN
against  ||| S:42218 E:42226 ||| IN
a  ||| S:42226 E:42228 ||| DT
C-terminal  ||| S:42228 E:42239 ||| JJ
peptide  ||| S:42239 E:42247 ||| NN
of  ||| S:42247 E:42250 ||| IN
42  ||| S:42250 E:42253 ||| CD
amino  ||| S:42253 E:42269 ||| CD
acids ||| S:42269 E:42274 ||| NNS
;  ||| S:42274 E:42276 ||| :
KPSKKKPTDGDKSEEPSNVESRGTGGTNPMTELRSVKDTTEK ||| S:42276 E:42318 ||| NNP
.  ||| S:42318 E:42348 ||| .
Measurement  ||| S:42348 E:42360 ||| NN
of  ||| S:42360 E:42363 ||| IN
tryptophan  ||| S:42363 E:42374 ||| JJ
depletion  ||| S:42374 E:42384 ||| NN
by  ||| S:42384 E:42387 ||| IN
HPLC  ||| S:42387 E:42402 ||| NNP
Supernatants  ||| S:42402 E:42415 ||| NNP
from  ||| S:42415 E:42420 ||| IN
cell  ||| S:42420 E:42425 ||| NN
cultures  ||| S:42425 E:42434 ||| NNS
were  ||| S:42434 E:42439 ||| VBD
extracted  ||| S:42439 E:42449 ||| VBN
with  ||| S:42449 E:42464 ||| IN
HPLC  ||| S:42464 E:42469 ||| NNP
grade  ||| S:42469 E:42475 ||| NN
methanol  ||| S:42475 E:42484 ||| NN
and  ||| S:42484 E:42488 ||| CC
analyzed  ||| S:42488 E:42497 ||| VBD
on  ||| S:42497 E:42500 ||| IN
a  ||| S:42500 E:42502 ||| DT
Beckman  ||| S:42502 E:42510 ||| NNP
Phenomenix  ||| S:42510 E:42531 ||| NNP
C18 ||| S:42531 E:42534 ||| NNP
( ||| S:42534 E:42535 ||| -LRB-
2 ||| S:42535 E:42536 ||| LS
)  ||| S:42536 E:42538 ||| -RRB-
HPLC  ||| S:42538 E:42543 ||| NNP
column  ||| S:42543 E:42550 ||| NN
and  ||| S:42550 E:42554 ||| CC
eluted  ||| S:42554 E:42561 ||| NN
with  ||| S:42561 E:42566 ||| IN
a  ||| S:42566 E:42568 ||| DT
0-80 ||| S:42568 E:42572 ||| JJ
%  ||| S:42572 E:42574 ||| NN
gradient  ||| S:42574 E:42583 ||| NN
of  ||| S:42583 E:42596 ||| IN
acetonitrile  ||| S:42596 E:42609 ||| NN
over  ||| S:42609 E:42614 ||| IN
20  ||| S:42614 E:42617 ||| CD
minutes ||| S:42617 E:42624 ||| NNS
.  ||| S:42624 E:42626 ||| .
To  ||| S:42626 E:42629 ||| TO
validate  ||| S:42629 E:42638 ||| VB
retention  ||| S:42638 E:42648 ||| JJ
times  ||| S:42648 E:42664 ||| NNS
and  ||| S:42664 E:42668 ||| CC
for  ||| S:42668 E:42672 ||| IN
the  ||| S:42672 E:42676 ||| DT
construction  ||| S:42676 E:42689 ||| NN
of  ||| S:42689 E:42692 ||| IN
a  ||| S:42692 E:42694 ||| DT
concentration  ||| S:42694 E:42708 ||| NN
curve  ||| S:42708 E:42714 ||| NN
a  ||| S:42714 E:42726 ||| DT
standard  ||| S:42726 E:42735 ||| JJ
mixture  ||| S:42735 E:42743 ||| NN
of  ||| S:42743 E:42746 ||| IN
kynurenine  ||| S:42746 E:42757 ||| NN
and  ||| S:42757 E:42761 ||| CC
tryptophan  ||| S:42761 E:42772 ||| NNS
was  ||| S:42772 E:42786 ||| VBD
analyzed  ||| S:42786 E:42795 ||| VBN
for  ||| S:42795 E:42799 ||| IN
each  ||| S:42799 E:42804 ||| DT
assay ||| S:42804 E:42809 ||| NN
.  ||| S:42809 E:42839 ||| .
Analysis  ||| S:42839 E:42848 ||| NN
of  ||| S:42848 E:42851 ||| IN
prostaglandin  ||| S:42851 E:42865 ||| JJ
production  ||| S:42865 E:42886 ||| NN
Prostaglandin  ||| S:42886 E:42900 ||| NNP
synthesis  ||| S:42900 E:42910 ||| NN
was  ||| S:42910 E:42914 ||| VBD
measured  ||| S:42914 E:42923 ||| VBN
by  ||| S:42923 E:42926 ||| IN
pulsing  ||| S:42926 E:42944 ||| JJ
IDO-expressing  ||| S:42944 E:42959 ||| JJ
RAW  ||| S:42959 E:42963 ||| NN
cells  ||| S:42963 E:42969 ||| NNS
and  ||| S:42969 E:42973 ||| CC
vector  ||| S:42973 E:42980 ||| JJ
only  ||| S:42980 E:42985 ||| JJ
controls  ||| S:42985 E:42994 ||| NNS
with  ||| S:42994 E:43009 ||| IN
14C  ||| S:43009 E:43013 ||| CD
arachidonic  ||| S:43013 E:43025 ||| JJ
acid  ||| S:43025 E:43030 ||| NN
( ||| S:43030 E:43031 ||| -LRB-
Sigma ||| S:43031 E:43036 ||| NNP
) ||| S:43036 E:43037 ||| -RRB-
.  ||| S:43037 E:43039 ||| .
5  ||| S:43039 E:43041 ||| CD
×  ||| S:43041 E:43043 ||| CD
10  ||| S:43043 E:43046 ||| CD
6cells  ||| S:43046 E:43053 ||| CD
were  ||| S:43053 E:43068 ||| VBD
harvested  ||| S:43068 E:43078 ||| VBN
and  ||| S:43078 E:43082 ||| CC
resuspended  ||| S:43082 E:43094 ||| NN
in  ||| S:43094 E:43097 ||| IN
PBS  ||| S:43097 E:43101 ||| NNP
and  ||| S:43101 E:43105 ||| CC
incubated  ||| S:43105 E:43115 ||| NN
at  ||| S:43115 E:43118 ||| IN
37°C  ||| S:43118 E:43133 ||| CD
with  ||| S:43133 E:43138 ||| IN
1.3  ||| S:43138 E:43142 ||| CD
mCi  ||| S:43142 E:43146 ||| JJ
arachidonic  ||| S:43146 E:43158 ||| JJ
acid  ||| S:43158 E:43163 ||| NN
( ||| S:43163 E:43164 ||| -LRB-
53  ||| S:43164 E:43167 ||| CD
mCi ||| S:43167 E:43170 ||| JJ
/ ||| S:43170 E:43171 ||| CD
mmol ||| S:43171 E:43175 ||| CD
)  ||| S:43175 E:43177 ||| -RRB-
for  ||| S:43177 E:43181 ||| IN
30  ||| S:43181 E:43184 ||| CD
mins ||| S:43184 E:43188 ||| NNS
.  ||| S:43188 E:43200 ||| .
Following  ||| S:43200 E:43210 ||| VBG
ether  ||| S:43210 E:43216 ||| JJ
extraction ||| S:43216 E:43226 ||| NN
,  ||| S:43226 E:43228 ||| ,
samples  ||| S:43228 E:43236 ||| NNS
were  ||| S:43236 E:43241 ||| VBD
dissolved  ||| S:43241 E:43251 ||| VBN
in  ||| S:43251 E:43264 ||| IN
ethyl  ||| S:43264 E:43270 ||| JJ
acetate  ||| S:43270 E:43278 ||| NN
and  ||| S:43278 E:43282 ||| CC
spotted  ||| S:43282 E:43290 ||| VBD
onto  ||| S:43290 E:43295 ||| IN
thin  ||| S:43295 E:43300 ||| JJ
layer  ||| S:43300 E:43306 ||| NN
chromatography  ||| S:43306 E:43331 ||| NN
plates ||| S:43331 E:43337 ||| NN
.  ||| S:43337 E:43339 ||| .
Plates  ||| S:43339 E:43346 ||| NNP
were  ||| S:43346 E:43351 ||| VBD
developed  ||| S:43351 E:43361 ||| VBN
in  ||| S:43361 E:43364 ||| IN
ethyl  ||| S:43364 E:43370 ||| JJ
acetate ||| S:43370 E:43377 ||| NN
:  ||| S:43377 E:43379 ||| :
acetic  ||| S:43379 E:43396 ||| JJ
acid ||| S:43396 E:43400 ||| NN
,  ||| S:43400 E:43402 ||| ,
90 ||| S:43402 E:43404 ||| CD
: ||| S:43404 E:43405 ||| :
1 ||| S:43405 E:43406 ||| CD
,  ||| S:43406 E:43408 ||| ,
together  ||| S:43408 E:43417 ||| RB
with  ||| S:43417 E:43422 ||| IN
unlabeled  ||| S:43422 E:43432 ||| JJ
standards ||| S:43432 E:43441 ||| NNS
.  ||| S:43441 E:43443 ||| .
Individual  ||| S:43443 E:43464 ||| JJ
spots  ||| S:43464 E:43470 ||| NNS
were  ||| S:43470 E:43475 ||| VBD
excised  ||| S:43475 E:43483 ||| VBN
from  ||| S:43483 E:43488 ||| IN
the  ||| S:43488 E:43492 ||| DT
chromatogram  ||| S:43492 E:43505 ||| NN
and  ||| S:43505 E:43519 ||| CC
radioactivity  ||| S:43519 E:43533 ||| VB
determined  ||| S:43533 E:43544 ||| VBN
by  ||| S:43544 E:43547 ||| IN
scintillation  ||| S:43547 E:43561 ||| JJ
counting ||| S:43561 E:43569 ||| NN
.  ||| S:43569 E:43599 ||| .
Cell  ||| S:43599 E:43604 ||| FW
adhesion  ||| S:43604 E:43613 ||| FW
assay  ||| S:43613 E:43629 ||| FW
Cell  ||| S:43629 E:43634 ||| FW
adhesion  ||| S:43634 E:43643 ||| FW
assays  ||| S:43643 E:43650 ||| NN
were  ||| S:43650 E:43655 ||| VBD
performed  ||| S:43655 E:43665 ||| VBN
essentially  ||| S:43665 E:43677 ||| RB
as  ||| S:43677 E:43690 ||| RB
described  ||| S:43690 E:43700 ||| VBN
[  ||| S:43700 E:43702 ||| -LRB-
36 ||| S:43702 E:43704 ||| CD
] ||| S:43704 E:43705 ||| -RRB-
.  ||| S:43705 E:43707 ||| .
Briefly ||| S:43707 E:43714 ||| RB
,  ||| S:43714 E:43716 ||| ,
cells  ||| S:43716 E:43722 ||| NNS
were  ||| S:43722 E:43727 ||| VBD
seeded  ||| S:43727 E:43734 ||| VBN
into  ||| S:43734 E:43739 ||| IN
the  ||| S:43739 E:43753 ||| DT
wells  ||| S:43753 E:43759 ||| NNS
of  ||| S:43759 E:43762 ||| IN
a  ||| S:43762 E:43764 ||| DT
24  ||| S:43764 E:43767 ||| CD
well  ||| S:43767 E:43772 ||| RB
plate  ||| S:43772 E:43778 ||| VB
coated  ||| S:43778 E:43785 ||| VBN
with  ||| S:43785 E:43790 ||| IN
various  ||| S:43790 E:43798 ||| JJ
growth  ||| S:43798 E:43815 ||| NN
substrates  ||| S:43815 E:43826 ||| VBZ
Following  ||| S:43826 E:43836 ||| VBG
incubation  ||| S:43836 E:43847 ||| NN
at  ||| S:43847 E:43850 ||| IN
37°C ||| S:43850 E:43854 ||| NNP
,  ||| S:43854 E:43856 ||| ,
for  ||| S:43856 E:43860 ||| IN
45  ||| S:43860 E:43863 ||| CD
minutes ||| S:43863 E:43870 ||| NNS
,  ||| S:43870 E:43882 ||| ,
cells  ||| S:43882 E:43888 ||| NNS
unattached  ||| S:43888 E:43899 ||| JJ
cells  ||| S:43899 E:43905 ||| NNS
were  ||| S:43905 E:43910 ||| VBD
removed  ||| S:43910 E:43918 ||| VBN
by  ||| S:43918 E:43921 ||| IN
PBS  ||| S:43921 E:43925 ||| NNP
washes  ||| S:43925 E:43932 ||| NN
and  ||| S:43932 E:43936 ||| CC
the  ||| S:43936 E:43950 ||| DT
remaining  ||| S:43950 E:43960 ||| JJ
cells  ||| S:43960 E:43966 ||| NNS
were  ||| S:43966 E:43971 ||| VBD
counted ||| S:43971 E:43978 ||| VBN
.  ||| S:43978 E:44008 ||| .
Cell  ||| S:44008 E:44013 ||| FW
migration  ||| S:44013 E:44023 ||| FW
assay  ||| S:44023 E:44039 ||| FW
P19  ||| S:44039 E:44043 ||| FW
cells  ||| S:44043 E:44049 ||| NNS
in  ||| S:44049 E:44052 ||| IN
log  ||| S:44052 E:44056 ||| JJ
phase  ||| S:44056 E:44062 ||| NN
growth  ||| S:44062 E:44069 ||| NN
were  ||| S:44069 E:44074 ||| VBD
trypsinized  ||| S:44074 E:44086 ||| JJ
and  ||| S:44086 E:44090 ||| CC
10  ||| S:44090 E:44103 ||| CD
5were  ||| S:44103 E:44109 ||| CD
seeded  ||| S:44109 E:44116 ||| NN
in  ||| S:44116 E:44119 ||| IN
quadruplicate  ||| S:44119 E:44133 ||| NN
into  ||| S:44133 E:44138 ||| IN
Falcon  ||| S:44138 E:44145 ||| NNP
cell  ||| S:44145 E:44150 ||| NN
culture  ||| S:44150 E:44168 ||| NN
inserts ||| S:44168 E:44175 ||| NNS
,  ||| S:44175 E:44177 ||| ,
with  ||| S:44177 E:44182 ||| IN
or  ||| S:44182 E:44185 ||| CC
without  ||| S:44185 E:44193 ||| IN
Matrigel  ||| S:44193 E:44202 ||| NNP
coating  ||| S:44202 E:44210 ||| NN
( ||| S:44210 E:44211 ||| -LRB-
Becton  ||| S:44211 E:44228 ||| NNP
Dickinson ||| S:44228 E:44237 ||| NNP
,  ||| S:44237 E:44239 ||| ,
Franklin  ||| S:44239 E:44248 ||| NNP
Lakes ||| S:44248 E:44253 ||| NNP
,  ||| S:44253 E:44255 ||| ,
NJ ||| S:44255 E:44257 ||| NNP
,  ||| S:44257 E:44259 ||| ,
8.0  ||| S:44259 E:44263 ||| FW
μm  ||| S:44263 E:44266 ||| FW
pore  ||| S:44266 E:44271 ||| FW
size ||| S:44271 E:44275 ||| NN
,  ||| S:44275 E:44277 ||| ,
1  ||| S:44277 E:44279 ||| CD
×  ||| S:44279 E:44281 ||| CD
10  ||| S:44281 E:44294 ||| CD
5pores ||| S:44294 E:44300 ||| CD
/ ||| S:44300 E:44301 ||| CD
sq.cm ||| S:44301 E:44306 ||| CD
) ||| S:44306 E:44307 ||| -RRB-
,  ||| S:44307 E:44309 ||| ,
in  ||| S:44309 E:44312 ||| IN
a  ||| S:44312 E:44314 ||| DT
volume  ||| S:44314 E:44321 ||| NN
of  ||| S:44321 E:44324 ||| IN
0.2  ||| S:44324 E:44328 ||| CD
ml ||| S:44328 E:44330 ||| NN
,  ||| S:44330 E:44332 ||| ,
in  ||| S:44332 E:44335 ||| IN
a  ||| S:44335 E:44337 ||| DT
24  ||| S:44337 E:44340 ||| CD
well  ||| S:44340 E:44345 ||| RB
tissue  ||| S:44345 E:44362 ||| JJ
culture  ||| S:44362 E:44370 ||| NN
plate ||| S:44370 E:44375 ||| NN
.  ||| S:44375 E:44377 ||| .
The  ||| S:44377 E:44381 ||| DT
lower  ||| S:44381 E:44387 ||| JJR
chamber  ||| S:44387 E:44395 ||| NN
contained  ||| S:44395 E:44405 ||| VBD
a  ||| S:44405 E:44407 ||| DT
volume  ||| S:44407 E:44414 ||| NN
of  ||| S:44414 E:44427 ||| IN
0.8  ||| S:44427 E:44431 ||| CD
ml  ||| S:44431 E:44434 ||| JJ
growth  ||| S:44434 E:44441 ||| NN
medium ||| S:44441 E:44447 ||| NN
,  ||| S:44447 E:44449 ||| ,
while  ||| S:44449 E:44455 ||| IN
the  ||| S:44455 E:44459 ||| DT
final  ||| S:44459 E:44465 ||| JJ
volume  ||| S:44465 E:44472 ||| NN
in  ||| S:44472 E:44475 ||| IN
the  ||| S:44475 E:44479 ||| DT
upper  ||| S:44479 E:44495 ||| JJ
chamber  ||| S:44495 E:44503 ||| NN
was  ||| S:44503 E:44507 ||| VBD
0.35  ||| S:44507 E:44512 ||| CD
ml ||| S:44512 E:44514 ||| NNS
.  ||| S:44514 E:44516 ||| .
Chambers  ||| S:44516 E:44525 ||| NNP
were  ||| S:44525 E:44530 ||| VBD
incubated  ||| S:44530 E:44540 ||| VBN
for  ||| S:44540 E:44544 ||| IN
18  ||| S:44544 E:44547 ||| CD
hours  ||| S:44547 E:44563 ||| NNS
after  ||| S:44563 E:44569 ||| IN
which  ||| S:44569 E:44575 ||| WDT
time  ||| S:44575 E:44580 ||| NN
the  ||| S:44580 E:44584 ||| DT
number  ||| S:44584 E:44591 ||| NN
of  ||| S:44591 E:44594 ||| IN
cells  ||| S:44594 E:44600 ||| NNS
in  ||| S:44600 E:44603 ||| IN
the  ||| S:44603 E:44607 ||| DT
lower  ||| S:44607 E:44613 ||| JJR
chamber  ||| S:44613 E:44631 ||| NN
was  ||| S:44631 E:44635 ||| VBD
determined ||| S:44635 E:44645 ||| VBN
.  ||| S:44645 E:44675 ||| .
Image  ||| S:44675 E:44681 ||| NN
analysis  ||| S:44681 E:44700 ||| NN
The  ||| S:44700 E:44704 ||| DT
size  ||| S:44704 E:44709 ||| NN
of  ||| S:44709 E:44712 ||| IN
individual  ||| S:44712 E:44723 ||| JJ
P19  ||| S:44723 E:44727 ||| CD
aggregates  ||| S:44727 E:44738 ||| NNS
was  ||| S:44738 E:44742 ||| VBD
determined  ||| S:44742 E:44763 ||| VBN
by  ||| S:44763 E:44766 ||| IN
capturing  ||| S:44766 E:44776 ||| VBG
fields  ||| S:44776 E:44783 ||| NNS
of  ||| S:44783 E:44786 ||| IN
40-50  ||| S:44786 E:44792 ||| CD
aggregates  ||| S:44792 E:44803 ||| NNS
at  ||| S:44803 E:44806 ||| IN
10x  ||| S:44806 E:44820 ||| CD
magnification  ||| S:44820 E:44834 ||| NNS
and  ||| S:44834 E:44838 ||| CC
then  ||| S:44838 E:44843 ||| RB
calculating  ||| S:44843 E:44855 ||| VBG
the  ||| S:44855 E:44859 ||| DT
area  ||| S:44859 E:44864 ||| NN
of  ||| S:44864 E:44867 ||| IN
each  ||| S:44867 E:44882 ||| DT
aggregate  ||| S:44882 E:44892 ||| NN
using  ||| S:44892 E:44898 ||| VBG
the  ||| S:44898 E:44902 ||| DT
NIH  ||| S:44902 E:44906 ||| NNP
Image  ||| S:44906 E:44912 ||| NNP
( ||| S:44912 E:44913 ||| -LRB-
1.62 ||| S:44913 E:44917 ||| CD
)  ||| S:44917 E:44919 ||| -RRB-
analysis  ||| S:44919 E:44928 ||| NN
program  ||| S:44928 E:44936 ||| NN
(  ||| S:44936 E:44948 ||| -LRB-
http://rsb.info.nih.gov/nih-image/download.html ||| S:44948 E:44995 ||| NNP
) ||| S:44995 E:44996 ||| -RRB-
.  ||| S:44996 E:45029 ||| .
Abbreviations  ||| S:45029 E:45051 ||| NNP
CMV ||| S:45051 E:45054 ||| NNP
:  ||| S:45054 E:45056 ||| :
cytomegalovirus  ||| S:45056 E:45080 ||| JJ
COX ||| S:45080 E:45083 ||| NNP
:  ||| S:45083 E:45085 ||| :
cyclooxygenase  ||| S:45085 E:45108 ||| JJ
IDO ||| S:45108 E:45111 ||| NNP
:  ||| S:45111 E:45113 ||| :
indoleamine  ||| S:45113 E:45125 ||| CD
2 ||| S:45125 E:45126 ||| CD
, ||| S:45126 E:45127 ||| ,
3  ||| S:45127 E:45129 ||| CD
dioxygenase  ||| S:45129 E:45149 ||| FW
IFN-γ  ||| S:45149 E:45155 ||| FW
interferon  ||| S:45155 E:45166 ||| FW
gamma  ||| S:45166 E:45180 ||| FW
LPS ||| S:45180 E:45183 ||| FW
:  ||| S:45183 E:45185 ||| :
lipopolysaccharide  ||| S:45185 E:45212 ||| JJ
MMP ||| S:45212 E:45215 ||| NNP
:  ||| S:45215 E:45217 ||| :
matrix  ||| S:45217 E:45224 ||| FW
metalloproteinase  ||| S:45224 E:45250 ||| FW
NSAID ||| S:45250 E:45255 ||| FW
:  ||| S:45255 E:45257 ||| :
non-steroidal  ||| S:45257 E:45271 ||| JJ
anti-inflammatory  ||| S:45271 E:45289 ||| JJ
drug  ||| S:45289 E:45302 ||| NN
PG ||| S:45302 E:45304 ||| NNP
:  ||| S:45304 E:45306 ||| :
prostaglandin  ||| S:45306 E:45328 ||| JJ
TDO ||| S:45328 E:45331 ||| NNP
:  ||| S:45331 E:45333 ||| :
tryptophan  ||| S:45333 E:45344 ||| CD
2 ||| S:45344 E:45345 ||| CD
,  ||| S:45345 E:45347 ||| ,
3  ||| S:45347 E:45349 ||| CD
dioxygenase  ||| S:45349 E:45376 ||| CD
